合成路线1
该中间体在本合成路线中的序号:
(B) 3-Chloro-4-fluoroaniline (I), condensed by heating at 125 C with diethyl ethoxymethylenemalonate (A), gives diethyl 3-chloro-4-fluoroanilinomethylenemalonate (II). The thermal cyclization of (II) by reflux in A Dowtherm gives ethyl 6-fluoro-7-chloro-4-hydroxyquinoline-3-carboxylate (III), which, alkylated by ethyliodide in DMF with potassium carbonate, leads to ethyl 1-ethyl-6 fluoro-7-chloro-4-oxo-1,4-dihydroquinoline-3-carboxylate (IV), purified by recrystallization. The ester (IV), after saponification and acidification, provides the corresponding acid (V). 1-Ethyl-6-fluoro-7-chloro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (V), heated to 100 C in pyridine with 1-methylpiperazine (B), leads to 1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (VI). The salification of (VI) with methanesulfonic acid provides the salt.
【1】
Pesson, M.; Montay, G.; Goueffon, Y.; Roquet, F.; Microbiologie: Sur un nouvel antibacterien de synthese:l¡Acide ethyl-2-fluoro-6-(methyl-4-piperazinyl-1)-oxo-4-dihydro-1,4-quinoleine-3-carboxylique (1589 RB). CR Acad Sci Paris 1981, 292.
|
【2】
Bellon, A.; Pefloxacin mesylate. Drugs Fut 1982, 7, 9, 646.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(A) |
14088 |
Diethyl ethoxymethylenemalonate; Diethyl 2-(ethoxymethylene)malonate
|
87-13-8 |
C10H16O5 |
详情 | 详情
|
(I) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|
(II) |
32073 |
Diethyl 2-[[(3-chloro-4-fluorophenyl)imino]methyl]malonate; Diethyl 3-chloro-4-fluoroanilinomethylenemalonate
|
|
C14H15ClFNO4 |
详情 |
详情
|
(III) |
32074 |
Ethyl 7-chloro-6-fluoro-4-hydroxy-1,4-dihydro-3-quinolinecarboxylate
|
|
C12H11ClFNO3 |
详情 |
详情
|
(IV) |
32075 |
ethyl 7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C14H13ClFNO3 |
详情 |
详情
|
(V) |
32076 |
7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
68077-26-9 |
C12H9ClFNO3 |
详情 | 详情
|
(VI) |
32077 |
1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C17H20FN3O3 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(IV) A new synthesis of fleroxacin, labeled with fluorine-18, has been described:
The reaction of 6,7,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester (I) with 2-bromoethanol (II) gives 6,7,8-trifluoro-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester (III), which is condensed with N-methylpiperazine (IV), yielding 6,8-difluoro-1-(2-hydroxyethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester (V). The reaction of (V) with methanesulfonyl chloride affords the corresponding mesylate (VI), which is treated with [18F]-KF in dichloromethane at 80 C to give 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester (VII). Finally, this compound is hydrolyzed with NaOH.
【1】
Liu, Y.Y.; Cleeland, R.; Livni, E.; Rubin, R.H.; Thom, E.; Strauss, H.W.; Fischman, A.J.; Fleroxacin, a quinolone antibacterial agent. Labeling with fluorine-18 for pharmacokinetic studies. J Label Compd Radiopharm 1993, 32, 576.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10058 |
ethyl 6,7,8-trifluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
79660-46-1 |
C12H8F3NO3 |
详情 | 详情
|
(II) |
10059 |
Ethylene bromohydrin; 2-Bromo-1-ethanol
|
540-51-2 |
C2H5BrO |
详情 | 详情
|
(III) |
10060 |
ethyl 6,7,8-trifluoro-1-(2-hydroxyethyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C14H12F3NO4 |
详情 |
详情
|
(IV) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(V) |
10062 |
ethyl 6,8-difluoro-1-(2-hydroxyethyl)-7-(4-methylpiperazino)-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C19H23F2N3O4 |
详情 |
详情
|
(VI) |
10063 |
ethyl 6,8-difluoro-7-(4-methylpiperazino)-1-[2-[(methylsulfonyl)oxy]ethyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C20H25F2N3O6S |
详情 |
详情
|
(VII) |
10064 |
ethyl 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazino)-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C19H22F3N3O3 |
详情 |
详情
|
(VII) |
44571 |
ethyl 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C19H22F3N3O3 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(IV) The reaction of 6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (I) with 1-bromo-2-fluoroethane (II) by means of NaI in hot DMF gives 6,7,8-trifluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (III), which is then condensed with N-methylpiperazine (IV) in refluxing pyridine.
【1】
Irikura, T.; Koga, H.; Murayama, S. (Kyorin Pharmaceutical Co., Ltd.); Quinoline carboxylic acid derivatives and process for the preparation. BE 0887574; DE 3106013; FR 2499990; FR 2507183; US 4398029 .
|
【2】
Serradell, M.N.; Castaner, J.; AM-833. Drugs Fut 1984, 9, 4, 246.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30588 |
6,7,8-trifluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C10H4F3NO3 |
详情 |
详情
|
(II) |
28769 |
1-bromo-2-fluoroethane
|
762-49-2 |
C2H4BrF |
详情 | 详情
|
(III) |
30589 |
1,4-dihydro-1-(2-fluoroethyl)-4-oxo-6,7,8-trifluoro-3-quinolinecarboxylic acid; 6,7,8-trifluoro-1-(2-fluoroethyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C12H7F4NO3 |
详情 |
详情
|
(IV) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(C) Methiothepin can be prepared in several ways, two of which have been described with experimental details. The common intermediate of both is the ketone (VIII).
4-Bromothioanisol (I) is converted to the Grignard reagent, which is treated with sulfur yielding 4-(methylthio)thiophenol (II). The same compound is accessible by reduction of 4-(methylthio)benzenesulfonyl chloride (A), done best with phosphorus and iodine in acetic acid. The potassium salt of (II) is treated with a boiling solution of potassium 2-iodobenzoate (B) in the presence of copper giving 2-(4-methylthiophenylthio)benzoic acid (III). Further reduction with LiAlH4 results in 2-(4-methylthiophenylthio)benzyl alcohol (IV). This reduction proceeds very well with NaAlH2(OCH2CH2OCH3)2 in benzene. (IV) is then converted with SOCl2 in benzene to the chloride (V), which is treated with NaCN or KCN in boiling aqueous ethanol to give the nitrile (VI). Hydroysis with KOH in aqueous ethanol yields 2-(4-methylthiophenylthio)phenylacetic acid (VII), which is cyclized with polyphosphoric acid to 8-(methylthio)dibenzo[b,f]thiepin-10(11H)-one (VIII). The ketone (VIII) may be reduced with NaBH4 to the alcohol (IX), which is transformed by treatment with anhydrous HCl in benzene to the chloride (X). Substitution reaction with 1-methylpiperazine (C) at 120-130 C or more in boiling chloroform gives 80% crude metitepine base, which is transformed to the maleate.
The other method consists first in transforming the ketone (VIII) into the methylpiperazine enamine (XI) by treatment with 1-methylpiperazine (C) and TiCl4 in boiling benzene. The enamine (XI) is then reduced to metitepine; the best method of reduction for this particular case seems to be the treatment with diborane generated by interaction of NaBH4 with acetic acid in tetrahydrofuran.
An additional three methods of metitepine synthesis are covered by patents; howewer, they do not describe experimental details for the particular case of metitepine.
【1】
Jilek, J.O.; et al.; Neurotropic and psychotropic substances. XLIV. 10-Aminoalkoxy and 10-piperazino derivatives of dibenzo[b,f]thiepin and related systems. Czech Chem Commun 1970, 35, 3721-32.
|
【2】
Kyburz, E.; Methiothepin, octoclothepin and related neuroleptic agents. Commun at the Rest Inst Pharm Biochem in Prague, June 5, 1974 1974, 25, 1, 20.
|
【3】
Pelz, K.; et al.; Neurotrope und psychotrope Substanzen. XXV. Uber die in 8.Stellung durch die Methyl-, -tert-Butyl-, Methoxy-, Methylthio- und Methansulfonylgruppe substituierten 10-(4-Methylpiperazino)-10,11-dihydrodibenzo[b,f]thiepin-Derivate. Coll Czech Chem Commun 1968, 33, 1895-1910. |
【4】
Kaplan, J.P.; Kyburz, E.; Process for benzothiepins. CH 555856; CH 563389; DE 2216883; FR 2135174; GB 1361717; US 3811026 .
|
【5】
Protiva, M.; et al.; Piperazinyldibenzothiepines. DE 1620382; FR 1484332; GB 1123400; US 3379729 .
|
【6】
Jilek, J.O.; et al.; 8-Chlor-10-(4-methylpiperazino)dibenzo[b,f]thiepin und Analoga; neue hoch wirksame Neuroleptica. Naturwissencshaften 1969, 56, 374.
|
【7】
Protiva, M.; et al.; Procede de preparation de la methyl-piperazine et de leurs sels, ainsi que les produits obtenus. FR 2151568; ZA 7104647 .
|
【8】
Protiva, M.; et al.; Procede de preparation d'amines heterocycliques et de leurs sels et produits obtenus par ce procede. ES 394172; FR 2099683 .
|
【9】
Protiva, M.; et al.; Verfahren zur Herstellung von neuroleptisch wirksamen 10-Piperazino-10,11-dihydrodibenzo[b,f]thiepinen. AT 310170B; CH 544771; ES 385836; NL 7017200; ZA 7007985 .
|
【10】
Protiva, M.; et al.; Pharmacodynamically effective 10-4-substituted piperazino-10,11- dihydrodibenzo[b,f]thiepins and a method of preparing same. DE 2026027; ES 380127; FR 2043741; GB 1313428 .
|
【11】
Kyburz, E.; Uber Methiothepin und verwandte Dibenzo[b,f]thiepin und -oxepin-Derivate. Schweiz Chem Ges, Herbstversammlung, Neuchatel, Oct. 12, 1974 1974, 106, 19, Suppl. 2.
|
【12】
Jilek, J.O.; et al.; 8-Alkylthio-10-piperazinodibenzo[b,f]thiepins. Coll Czech Chem Commun 1974, 39, 3338-51.
|
【13】
Protiva, M.; Metitepine. Drugs Fut 1977, 2, 4, 250.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
40103 |
4-methanesulfonylbenzene-1-thiol |
|
C7H8O2S2 |
详情 |
详情
|
(B) |
40105 |
potassium 2-iodobenzoate
|
|
C7H4IKO2 |
详情 |
详情
|
(I) |
19266 |
4-bromophenyl methyl sulfide; 1-bromo-4-(methylsulfanyl)benzene
|
104-95-0 |
C7H7BrS |
详情 | 详情
|
(II) |
40104 |
4-(methylsulfanyl)benzenethiol; 4-(methylsulfanyl)phenylhydrosulfide
|
1122-97-0 |
C7H8S2 |
详情 | 详情
|
(III) |
40106 |
2-[[4-(methylsulfanyl)phenyl]sulfanyl]benzoic acid
|
|
C14H12O2S2 |
详情 |
详情
|
(IV) |
40107 |
(2-[[4-(methylsulfanyl)phenyl]sulfanyl]phenyl)methanol
|
|
C14H14OS2 |
详情 |
详情
|
(V) |
40108 |
1-(chloromethyl)-2-[[4-(methylsulfanyl)phenyl]sulfanyl]benzene; 2-(chloromethyl)phenyl 4-(methylsulfanyl)phenyl sulfide
|
|
C14H13ClS2 |
详情 |
详情
|
(VI) |
40109 |
2-(2-[[4-(methylsulfanyl)phenyl]sulfanyl]phenyl)acetonitrile
|
|
C15H13NS2 |
详情 |
详情
|
(VII) |
40114 |
2-(2-[[4-(methylsulfanyl)phenyl]sulfanyl]phenyl)acetic acid
|
|
C15H14O2S2 |
详情 |
详情
|
(VIII) |
40110 |
8-(methylsulfanyl)dibenzo[b,f]thiepin-10(11H)-one
|
|
C15H12OS2 |
详情 |
详情
|
(IX) |
40111 |
8-(methylsulfanyl)-10,11-dihydrodibenzo[b,f]thiepin-10-ol
|
|
C15H14OS2 |
详情 |
详情
|
(X) |
40112 |
11-chloro-2-(methylsulfanyl)-10,11-dihydrodibenzo[b,f]thiepine; 11-chloro-10,11-dihydrodibenzo[b,f]thiepin-2-yl methyl sulfide
|
|
C15H13ClS2 |
详情 |
详情
|
(XI) |
40113 |
methyl 11-(4-methyl-1-piperazinyl)dibenzo[b,f]thiepin-2-yl sulfide; 1-methyl-4-[8-(methylsulfanyl)dibenzo[b,f]thiepin-10-yl]piperazine
|
|
C20H22N2S2 |
详情 |
详情
|
(C) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(A) The reaction of 2-aminothiophenol (I) with diethyl benzylidenemalonate (II) by heating at 90 C gives diethyl 2-(2-aminophenylthio)-2-phenylethane-1,1-dicarboxylate (III), which is cyclized by heating at 180 C with triethylamine hydrochloride yielding 2,3-dihydro-3-ethoxycarbonyl-2-phenyl-1,5-benzothiazepin-4(5H)-one (IV). The reduction of (IV) with LiAlH4 in THF affords 2,3-dihydro-3-hydroxymethyl-2-phenyl-1,5-benzothiazepin-4(5H)-one (V), which by reaction with SOCl2 in refluxing benzene is converted into 2,3-dihydro-3-chloromethyl-2-phenyl-1,5-benzothiazepin-4(5H)-one (VII). Finally, this compound is treated with N-methylpiperazine at reflux temperature, and acidified with HCl. An alternative way is the reaction of (V) with methanesulfonyl chloride in pyridine affording 2,3-dihydro-3-methanesulfonyloxymethyl-2-phenyl-1,5-benzothiazepin-4(5H)-one (VI), which is then treated with N-methylpiperazine and HCl as before.
【1】
Izumi, K.; et al.; FR 2416890 .
|
【2】
Hillier, K.; Castaner, J.; BTM-1042. Drugs Fut 1981, 6, 9, 534.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(I) |
25182 |
2-aminobenzenethiol
|
137-07-5 |
C6H7NS |
详情 | 详情
|
(II) |
37482 |
diethyl 2-benzylidenemalonate
|
5292-53-5 |
C14H16O4 |
详情 | 详情
|
(III) |
37483 |
diethyl 2-[[(2-aminophenyl)sulfanyl](phenyl)methyl]malonate
|
|
C20H23NO4S |
详情 |
详情
|
(IV) |
37484 |
ethyl (2R,3R)-4-oxo-2-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepine-3-carboxylate
|
|
C18H17NO3S |
详情 |
详情
|
(V) |
37485 |
(2R,3S)-3-(hydroxymethyl)-2-phenyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
|
|
C16H15NO2S |
详情 |
详情
|
(VI) |
37486 |
(2R,3S)-3-([[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]methyl)-2-phenyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
|
|
C19H21NO2S2 |
详情 |
详情
|
(VII) |
37487 |
(2R,3S)-3-(chloromethyl)-2-phenyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
|
|
C16H14ClNOS |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
Condensation of 2,4-dichoro-5-fluoroacetophenone (I) with diethyicarbonate (II) in the presence of sodium hydride gives ethyl 2,4-dichloro-5-fluorobenzoylacetate (III). The condensation of (III) with triethylorthoformate in reftuxing acetic anhydride yields ethyl 2-(2,4-dichloro-5-fluornbenzoyl)-3-ethoxyacrylate (IV), which is treated with p-fluoroaniline in methylene chloride to yield ethyl 2-(2,4-dichloro-5-fluorobenzoyl)-3-(p-fluoroanilino)acrylate (V). Cyclization of (V) with sodium hydride in tetrahydrofuran followed by hydrolysis yields 7-chloro-1-(p-fluorophenyl)-8 fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (VI). Condensation of (VI) with N-methylpiperazine in 1-methyl-2-pyrrolidinone followed by treatment with hydrochloric acid yields A-56619.
【1】
Clairbone, A.K.; Pihuleac, E.; Nordeen, C.; Fernandes, P.B.; Pernet, A.; Chu, D.T.W.; O'Donell, T.J.; A-56619 and A-56620: Synthesis and antibacterial activities of the novel aryl-fluoro-quinolones and their analogs. 24th Intersci Conf Antimicrob Agents Chemother (Oct 8-10, Washington, D.C) 1984, Abs 72. |
【2】
Granneman, G.R.; Chu, D.T.W.; Fernandes, P.B.; Abbott-56619. Drugs Fut 1985, 10, 7, 543.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
|
37690 |
4-fluorophenylamine; 4-fluoroaniline
|
371-40-4 |
C6H6FN |
详情 | 详情
|
(I) |
24574 |
1-(2,4-dichloro-5-fluorophenyl)-1-ethanone
|
704-10-9 |
C8H5Cl2FO |
详情 | 详情
|
(II) |
17470 |
diethyl carbonate; diethylcarbonate
|
105-58-8 |
C5H10O3 |
详情 | 详情
|
(III) |
22096 |
ethyl 3-(2,4-dichloro-5-fluorophenyl)-3-oxopropanoate
|
|
C11H9Cl2FO3 |
详情 |
详情
|
(IV) |
22098 |
ethyl (Z)-2-(2,4-dichloro-5-fluorobenzoyl)-3-ethoxy-2-propenoate
|
|
C14H13Cl2FO4 |
详情 |
详情
|
(V) |
24578 |
ethyl (Z)-2-(2,4-dichloro-5-fluorobenzoyl)-3-(4-fluoroanilino)-2-propenoate
|
|
C18H13Cl2F2NO3 |
详情 |
详情
|
(VI) |
24579 |
7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C16H8ClF2NO3 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(VII) The reaction of ethyl 7-chloro-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylate (I) with O-(2,4-dinitrophenyl)hydroxylamine (II) by means of K2CO3 in DMF gives ethyl 1-amino-6-fluoro-7-chloro-1,4-dihydro-4-oxo-3-quinolinecarboxylate (III), which is formylated with HCOOH in acetic anhydride yielding the corresponding 1-(formylamino) compound (IV). The methylation of (IV) with MeI and K2CO3 in DMF affords the 1-(formylmethylamino) compound (V), which is hydrolyzed with NaOH in refluxing water to give 7-chloro-6-fluoro-1,4-dihydro-4-oxo-1-(methylamino)quinoline-3-carboxylic acid (VI). Finally, this compound is condensed with N-methylpiperazine (VII) in refluxing pyridine.
【1】
Powles, R.G.; Wentland, M.P.; Wagner, R.B.; Dobson, .A.; Bailey, D.M.; Cornett, J.B.; Novel amino-substituted 3-quinolinecarboxylic acid antibacterial agents: Synthesis and stucture-activity relationships. J Med Chem 1984, 27, 9, 1103.
|
【2】
Wentland, M.P.; Bailey, D.M. (Sterling Winthrop Inc.); New quinolone compounds and preparation thereof. EP 0090424; JP 8401468 .
|
【3】
Castaner, J.; Serradell, M.N.; Burnie, J.; Matthews, R.; Amifloxacin. Drugs Fut 1985, 10, 3, 183.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19904 |
ethyl 7-chloro-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C12H9ClFNO3 |
详情 |
详情
|
(II) |
29034 |
1-(aminooxy)-2,4-dinitrobenzene
|
|
C6H5N3O5 |
详情 |
详情
|
(III) |
29035 |
ethyl 1-amino-7-chloro-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C12H10ClFN2O3 |
详情 |
详情
|
(IV) |
29036 |
ethyl 7-chloro-6-fluoro-1-(formylamino)-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C13H10ClFN2O4 |
详情 |
详情
|
(V) |
29037 |
ethyl 7-chloro-6-fluoro-1-[formyl(methyl)amino]-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C14H12ClFN2O4 |
详情 |
详情
|
(VI) |
29038 |
7-chloro-6-fluoro-1-(methylamino)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C11H8ClFN2O3 |
详情 |
详情
|
(VII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) By condensation of 3-fluoro-5,6-dihydromorphanthridin-6-one (I) with N-methylpiperazine (II) by means of POCl3 and N,N-dimethylaniline.
【1】
Hunziker, F.; Fischer, R.; Morphanthridine derivatives. DE 2748920; FR 2370745; GB 1592329; GB 1592330; JP 53059686; US 4308207 .
|
【2】
Hunziker, F.; Fischer, R.; 3-Fluor-morphanthridine, ihre Herstellung und Verwengung. DE 2803542 .
|
【3】
Serradell, M.N.; Castaner, J.; Fluperlapine. Drugs Fut 1984, 9, 5, 326.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34157 |
3-fluoro-5,11-dihydro-6H-dibenzo[b,e]azepin-6-one
|
|
C14H10FNO |
详情 |
详情
|
(II) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(B) The condensation of 1 2-benzenediamine (I) with methyltetrahydro-5-methyl 4-oxo-3-thiophenecarboxylate (II) in toluene using a Dean-Stark trap gives the triyclic system (III), which is dehydrogenated to 4,9-dihydro-3-methyl-10H-thienol[3,4-b][1,5]benzodiazepin-10-one (IV). Treatment of (IV) with chloroacetyl chloride in dioxane in the presence of K2CO3 yields 4-chloroacetyl-4,9-dihydro-3-methyl-10H-thieno[3,4-b][1,5]benzodiazepin-10-one (V), which is finally reacted with N-methylpiperazine to produce telenzepine, which is isolated as the hydrochloride.
【1】
Borner, H.; Haffer, G.; Sauer, G. (Schering AG); Process for the preparation of 2-bromo-8-ergolinyl. DE 3340025; US 4970314 .
|
【2】
Galvan, M.; Eltze, M.; Figala, V.; TELENZEPINE HYDROCHLORIDE < Rec INN >. Drugs Fut 1988, 13, 4, 327.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(A) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(I) |
12824 |
2-Aminophenylamine; o-Phenylenediamine; 1,2-Benzenediamine
|
95-54-5 |
C6H8N2 |
详情 | 详情
|
(II) |
11372 |
Methyl (E)-3-amino-2-butenoate; Methyl 3-aminocrotonate
|
|
C5H9NO2 |
详情 |
详情
|
(II) |
22082 |
methyl (5R)-5-methyl-4-oxotetrahydro-3-thiophenecarboxylate
|
|
C7H10O3S |
详情 |
详情
|
(III) |
22083 |
(3R)-3-methyl-1,3,4,9-tetrahydro-10H-thieno[3,4-b][1,5]benzodiazepin-10-one
|
|
C12H12N2OS |
详情 |
详情
|
(III) |
22088 |
2-[4-(3,4-dichlorophenyl)-1-piperazinyl]ethyl 3-oxobutanoate
|
|
C16H20Cl2N2O3 |
详情 |
详情
|
(IV) |
22084 |
3-methyl-4,9-dihydro-10H-thieno[3,4-b][1,5]benzodiazepin-10-one
|
|
C12H10N2OS |
详情 |
详情
|
(V) |
22085 |
4-(2-chloroacetyl)-3-methyl-4,9-dihydro-10H-thieno[3,4-b][1,5]benzodiazepin-10-one
|
|
C14H11ClN2O2S |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(V) The reaction of 5alpha-androst-2-ene-17-one (I) with isopropenyl acetate (II) by means of H2SO4 as catalyst gives 17beta-acetoxy-5alpha-androsta-2,16-diene (III), which is epoxidized by means of perbenzoic acid (A) in benezene yielding 2alpha, 3alpha:16alpha,17alpha-diepoxy-17beta-acetoxy-5alpha-androstane (IV). The reaction of (IV) with N-methylpiperazine (V) in refluxing water affords 2beta,16beta-bis(4-methyl-1-piperazino)-3alpha-hydroxy-5alpha-androstane-17-one (VI), which is reduced with NaBH4 in THF methanol to give 2,16-bis(4-methyl-1-piperazino)-3alpha,17beta-dihydroxy-5alpha-androstane (VII). The acetylation of (VII) with acetic anhydride by means of ZnCl2 in acetic acid yields 2beta,16beta-bis(4-methyl-1-piperazino)-3alpha, 17beta-diacetoxy-5alpha-androstane (VIII), which is finally treated with methyl bromide in acetone.
【1】
US 312398 .
|
【2】
Tuba, Z.; et al.; GB 1398050 .
|
【3】
Blancafort, P.; Castaner, J.; Serradell, M.N.; Hopkins, S.J.; Pipecuronium bromide. Drugs Fut 1980, 5, 12, 621.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
39215 |
benzenecarboperoxoic acid
|
93-59-4 |
C7H6O3 |
详情 | 详情
|
(I) |
32178 |
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,4,5,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one
|
|
C19H28O |
详情 |
详情
|
(II) |
21178 |
isopropenyl acetate
|
108-22-5 |
C5H8O2 |
详情 | 详情
|
(III) |
32179 |
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-4,5,6,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate
|
|
C21H30O2 |
详情 |
详情
|
(IV) |
13647 |
(1aR,2aS,2bS,4aS,5aR,6aS,6bR,8aS,9aS)-2a,4a-dimethylhexadecahydro-4bH-oxireno[2'',3'':4',5']cyclopenta[1',2':7,8]phenanthro[2,3-b]oxiren-4-yl acetate
|
|
C21H30O4 |
详情 |
详情
|
(V) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(VI) |
39216 |
(2S,3S,5S,8R,9S,10S,13S,14S,16S)-3-hydroxy-10,13-dimethyl-2,16-bis(4-methyl-1-piperazinyl)hexadecahydro-17H-cyclopenta[a]phenanthren-17-one
|
|
C29H50N4O2 |
详情 |
详情
|
(VII) |
39217 |
(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-dimethyl-2,16-bis(4-methyl-1-piperazinyl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol
|
|
C29H52N4O2 |
详情 |
详情
|
(VIII) |
39218 |
(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-(acetoxy)-10,13-dimethyl-2,16-bis(4-methyl-1-piperazinyl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
|
|
C33H56N4O4 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(C) The reaction of 5-(2-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-thione (I) with glycine (A) by means of Na2CO3 in refluxing ethanol-water gives 2-carboxymethylamino-7-nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepine (II), which is cyclized by means of dicyclohexylcarbodiimide in methylene chloride to afford 8-nitro-(2-chlorophenyl)-1,2-dihydro-1H,4H-imidazo[1,2-a][1,4]benzodiazepin-1-one (III). The reaction of (III) with dimethylformamide diethylacetal (B) by means of triethylamine in benzene yields 8-nitro-2-(dimethylaminomethylene)-6-(2-chlorophenyl)-1,2-dihydro-1H,4H-imidazo[1,2a][1,4]benzodiazepin-1-one (IV), which is treated with N-methylpiperazine (C) in refluxing toluene to produce 8-nitro-(2-chlorophenyl)-2-(N-methylpiperazin-1-ylmethylene)-1,2-dihydro-1H,4H-imidazo [1,2-a][1,4]benzodiazepin-1-one (V). This compound is finally treated with methanesulfonic acid.
【1】
Taylor, J.B.; Harrison D.R.; 1,2-Dihydro-6-phenyl-1H,4H-imidazobenzodiazepin-1-ones. US 4044142 .
|
【2】
Ager, J.R.; et al.; Central nervous system activity of a novel class of annelated 1,4-benzodiazwpines, aminomethylene-2,4-dihydro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-ones. J Med Chem 1977, 20, 8, 1035-41.
|
【3】
Thorpe, P.J.; Castaner, J.; Blancafort, P.; Serradell, M.N.; RU-31,158. Drugs Fut 1980, 5, 3, 144.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
40922 |
N,N'-dicyclohexylurea
|
2387-23-7 |
C13H24N2O |
详情 | 详情
|
(A) |
20436 |
glycine
|
56-40-6 |
C2H5NO2 |
详情 | 详情
|
(B) |
31457 |
N-(diethoxymethyl)-N,N-dimethylamine; diethoxy-N,N-dimethylmethanamine
|
1188-33-6 |
C7H17NO2 |
详情 | 详情
|
(I) |
32632 |
5-(2-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepine-2-thione
|
|
C15H10ClN3O2S |
详情 |
详情
|
(II) |
32633 |
2-[[5-(2-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-yl]amino]acetic acid
|
|
C17H13ClN4O4 |
详情 |
详情
|
(III) |
30373 |
6-(2-chlorophenyl)-8-nitro-2,4-dihydro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-one
|
|
C17H11ClN4O3 |
详情 |
详情
|
(IV) |
32634 |
6-(2-chlorophenyl)-2-[(Z)-(dimethylamino)methylidene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1(4H)-one
|
|
C20H16ClN5O3 |
详情 |
详情
|
(V) |
30375 |
6-(2-chlorophenyl)-2-[(Z)-(4-methyl-1-piperazinyl)methylidene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1(4H)-one
|
|
C23H21ClN6O3 |
详情 |
详情
|
(C) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(X) The partial hydrolysis ot 2,3,4-trifluoronitrobenzene (I) with KOH in DMSO gives 2,3-difluoro-6-nitrophenol (II), which by condensation with chloroacetone (III) by means of K2CO3 - KI in refluxing acetone yields 2-acetonyloxy-3,4-difluoronitrobenzene (IV). The reductive cyclization of (IV) with H2 over Raney-Ni in ethanol affords 7,8-difluoro-2,3-dihydro-3-methyl-4H-benzoxazine (V), which is condensed with diethyl ethoxymethylenemalonate (VI) by heating at 145 C giving the malonic derivative (VII). The cyclization of (VII) by heating at 145 C with ethyl polyphosphate (PPE) yields ethyl 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate (VIII), which is hydrolyzed with HCl in refluxing acetic acid affording the corresponding free acid (IX). Finally, this compound is condensed with N-methylpiperazine (X) in DMSO at 110 C.
【1】
Hayakawa, I.; Hiramitsu, T.; Tanaka, Y. (Daiichi Pharmaceutical Co., Ltd.); Benzoxazine derivs.. EP 0047005; US 4382892 .
|
【2】
Serradell, M.N.; Blancafort, P.; Castaner, J.; DL-8280. Drugs Fut 1983, 8, 5, 395.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30677 |
1,2,3-trifluoro-4-nitrobenzene; 2,3,4-trifluoronitrobenzene
|
771-69-7 |
C6H2F3NO2 |
详情 | 详情
|
(II) |
30678 |
2,3-difluoro-6-nitrophenol
|
82419-26-9 |
C6H3F2NO3 |
详情 | 详情
|
(III) |
15288 |
1-Chloroacetone; Chloroacetone
|
78-95-5 |
C3H5ClO |
详情 | 详情
|
(IV) |
30679 |
1-(2,3-difluoro-6-nitrophenoxy)acetone
|
|
C9H7F2NO4 |
详情 |
详情
|
(V) |
30680 |
7,8-difluoro-3-methyl-3,4-dihydro-2H-1,4-benzoxazine
|
|
C9H9F2NO |
详情 |
详情
|
(VI) |
14088 |
Diethyl ethoxymethylenemalonate; Diethyl 2-(ethoxymethylene)malonate
|
87-13-8 |
C10H16O5 |
详情 | 详情
|
(VII) |
30681 |
diethyl 2-[(7,8-difluoro-3-methyl-2,3-dihydro-4H-1,4-benzoxazin-4-yl)methylene]malonate
|
|
C17H19F2NO5 |
详情 |
详情
|
(VIII) |
30682 |
ethyl 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate
|
|
C15H13F2NO4 |
详情 |
详情
|
(IX) |
12058 |
9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; 8,9-Difluoro-3-me-6-oxo-2,3-dihydro-6h-1-oxa-3a-aza-phenalene-5-carboxylic acid
|
82419-35-0 |
C13H9F2NO4 |
详情 | 详情
|
(X) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(VIII) 9,10-Difluoro-3-(hydroxymethyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid ethyl ester (I), a racemic intermediate in the synthesis of racemic ofloxacin, is esterified with 3,5-dinitrobenzoyl chloride (II) in the usual way to give the racemic ester (III), which is resolved into its optical isomers by HPLC over a SUMIPAX OA-4200 column, using hexane-1,2-dichloroethane-ethanol as carrier solvent. The (-)-optical isomer (IV) is partially hydrolyzed with ethanolic aqueous NaHCO3 to afford the (-)-alcohol (V), which is treated with triphenylphosphite methiodide in DMF giving the corresponding (-)-iodomethyl derivative (VI). The reduction and simultaneous hydrolysis of (VI) with tributyltin hydride in ethanol yields (-)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (VII), which is finally treated with N-methylpiperazine (VIII) to give (-)-ofloxacin.
【1】
Yoneda, N.; Kato, J.; Hayashi, K.; Ochiani, T.; Kinashi, K. (Tanabe Seiyaku Co., Ltd.); Quinolinecarboxylic acid derivs. and method for their preparation. EP 0095163; ES 8603427; US 4508727 .
|
【2】
Böshagen, H.; Stoltefuss, J.; Berschauer, F.; De Jong, A.; Scheer, M. (Bayer AG); Pure enantiomeric 1,8-bridged-4-quinolo-3-carboxylic acids, process for their preparation and medicaments containing them, and their use in the preparation of medicaments. DE 3543513; EP 0225552; JP 1987145088 . |
【3】
Egawa, H.; Miyamoto, H.; Matsumoto, J. (Dainippon Pharmaceutical Co., Ltd.); Method for the preparation of pyridobenzoxazin derivs. and their intermediates. JP 1987215591 .
|
【4】
Gershon, N.; Wizel, S.; Niddam-Hildesheim, V.; Amir, E. (Teva Pharmaceutical Industries Ltd.; Teva Pharmaceuticals USA, Inc.); Preparation of levofloxacin and forms thereof. WO 0328664 .
|
【5】
Sharma, P.N.; Pernet, A.G.; Shen, L.L.; Mitscher, L.A.; Chu, D.T.W.; Chiral DNA gyrase inhibitors. 2. Asymmetric synthesis and biological activity of the enantiomers of 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (ofloxacin). J Med Chem 1987, 30, 12, 2283-6. |
【6】
Prous, J.; Castaner, J.; Levofloxacin. Drugs Fut 1992, 17, 7, 559.
|
【7】
Hayakawa, I.; Atarashi, S.; Yokohama, S.; Imamura, M.; Sakano, K.-I.; Furukawa, M.; Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob Agents Chemother 1986, 29, 1, 163-4.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12052 |
ethyl 9,10-difluoro-3-(hydroxymethyl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate
|
|
C15H13F2NO5 |
详情 |
详情
|
(II) |
12053 |
3,5-Dinitrobenzoyl chloride
|
99-33-2 |
C7H3ClN2O5 |
详情 | 详情
|
(III) |
12054 |
ethyl 3-[[(3,5-dinitrobenzoyl)oxy]methyl]-9,10-difluoro-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate
|
|
C22H15F2N3O10 |
详情 |
详情
|
(IV) |
12055 |
ethyl 3-[[(3,5-dinitrobenzoyl)oxy]methyl]-9,10-difluoro-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate
|
|
C22H15F2N3O10 |
详情 |
详情
|
(V) |
12056 |
ethyl 9,10-difluoro-3-(hydroxymethyl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate
|
|
C15H13F2NO5 |
详情 |
详情
|
(VI) |
12057 |
ethyl 9,10-difluoro-3-(iodomethyl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate
|
|
C15H12F2INO4 |
详情 |
详情
|
(VII) |
12058 |
9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; 8,9-Difluoro-3-me-6-oxo-2,3-dihydro-6h-1-oxa-3a-aza-phenalene-5-carboxylic acid
|
82419-35-0 |
C13H9F2NO4 |
详情 | 详情
|
(VIII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(A) The reaction of 10-bromo-5H-dibenzo[a,d]cyclohepten-5-one (I) with N-methylpiperazine (A) by means of potassium tert-butoxide in refluxing tert-butanol gives 10-(N-methylpiperazin-1-yl)-5H-dibenzo[a,d]cyclohepten-5-one (II), which by treatment first with methyllithium in ether and then with refluxing ethanolic HCl is converted into 5-methylene-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-10-one (III). The reaction of (III) with hydroxylamine in refluxing methanol yields 5-methylene-10-hydroxyimino-10,11-dihydro-5H-dibenzo[a,d]cycloheptene (IV), which is reduced with sodium cyanoborohydride in methanol to afford 5-methylene-10-hydroxamino-10,11-dihydro-5H-dibenzo[a,d]cycloheptene (V). The internal reaction of (V) in refluxing xylene gives 5-(hydroxymethyl)-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (V), which is reduced with Zn in hot acetic acid.
【1】
Evans, B.E.; Engelhardt, E.L.; Remy, D.C.; Britcher, S.F.; Andderson, P.S.; Colton, C.D.; Christy, M.E.; Transannular reaction of dibenzo[a,d]cycloalkenes. 1. Synthesis of dibenzo[a,d]cycloocten-6,12-imines and dibenzo[a,d]cyclohepten-5,10-imines. J Org Chem 1979, 44, 18, 3117-27. |
【2】
Thorpe, P.J.; Castaner, J.; Serradell, M.N.; Blancafort, P.; MK-801. Drugs Fut 1983, 8, 2, 120.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(I) |
35924 |
10-bromo-5H-dibenzo[a,d]cyclohepten-5-one
|
|
C15H9BrO |
详情 |
详情
|
(II) |
35925 |
10-(4-methyl-1-piperazinyl)-5H-dibenzo[a,d]cyclohepten-5-one
|
|
C20H20N2O |
详情 |
详情
|
(III) |
35926 |
5-methylene-5,11-dihydro-10H-dibenzo[a,d]cyclohepten-10-one
|
|
C16H12O |
详情 |
详情
|
(IV) |
35927 |
5-methylene-5,11-dihydro-10H-dibenzo[a,d]cyclohepten-10-one oxime
|
|
C16H13NO |
详情 |
详情
|
(V) |
35928 |
10-(hydroxyamino)-5-methylene-5H-dibenzo[a,d]cycloheptene; N-(5-methylene-5H-dibenzo[a,d]cyclohepten-10-yl)hydroxylamine
|
|
C16H13NO |
详情 |
详情
|
(VI) |
35929 |
16-azatetracyclo[7.6.1.0(2,7).0(10,15)]hexadeca-2,4,6,10,12,14-hexaen-1-ylmethanol
|
|
C16H15NO |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(XII) A new synthesis for KB-5246 has been described:
The reaction of 2,3,4-trifluoroaniline (I) with carbon disulfide (II) and triethylamine gives the corresponding dithiocarbamate (III), which by cyclization with 1-acetoxy-3-chloro-2-propanone (IV) in ethyl acetate yields 4-(acetoxymethyl)-3-(2,3,4-trifluorophenyl)thiazole-2(3H)-thione (V). The cyclization of (V) with potassium hydroxide in refluxing ethanol-water affords 6,7-difluoro-1H,4H-thiazolo[4,3-c][1,4]benzoxazine-1-thione (VI), which is treated with trichloromethyl chloroformate in hot toluene to give the thiazolium chloride (VII), which is not isolated. The in situ reaction of (VII) with diethyl malonate by means of triethylamine in toluene gives (6,7-difluoro-1H,4H-thiazolo[4,3-c][1,4]benzoxazin-1-ylidene)malonic acid diethyl ester (IX), which is cyclized again with polyphosphoric acid (PPA) at 115 C to afford 7,8-difluoro-5-oxo-9,1-(epoxymethano)-5H-thiazolo[3,2-a]quinoline-4-carboxylic acid ethyl ester (X). The hydrolysis of (X) with oleum gives the corresponding acid (XI), which is finally condensed with N-methylpiperazine (XII) in hot DMSO.
【1】
Kondo, H.; Tsukamoto, G.; Taguchi, M.; Jinbo, Y.; Kawahata, Y.; Sakamoto, F.; Inoue, Y.; Synthesis and antibacterial activity of new tetracyclic quinolone antibacterials. J Med Chem 1992, 35, 1, 94.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13059 |
2,3,4-Trifluorophenylamine; 2,3,4-Trifluoroaniline
|
3862-73-5 |
C6H4F3N |
详情 | 详情
|
(III) |
13060 |
2,3,4-trifluorophenylcarbamodithioate
|
|
C7H3F3NS2 |
详情 |
详情
|
(IV) |
13061 |
2-(chlorooxy)-2-oxoethyl acetate
|
|
C4H5ClO4 |
详情 |
详情
|
(V) |
13062 |
[2-thioxo-3-(2,3,4-trifluorophenyl)-2,3-dihydro-1,3-thiazol-4-yl]methyl acetate
|
|
C12H8F3NO2S2 |
详情 |
详情
|
(VI) |
13063 |
6,7-Difluoro-4H-[1,3]thiazolo[4,3-c][1,4]benzoxazine-1-thione
|
|
C10H5F2NOS2 |
详情 |
详情
|
(VII) |
13064 |
1-Chloro-6,7-difluoro-4H-[1,3]thiazolo[4,3-c][1,4]benzoxazin-10-ium chloride
|
|
C10H5Cl2F2NOS |
详情 |
详情
|
(VIII) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(IX) |
13066 |
diethyl 2-(6,7-difluoro-4H-[1,3]thiazolo[4,3-c][1,4]benzoxazin-1-ylidene)malonate
|
|
C17H15F2NO5S |
详情 |
详情
|
(X) |
13067 |
ethyl 5,6-difluoro-8-oxo-3H,8H-4-oxa-1-thia-9b-azacyclopenta[cd]phenalene-9-carboxylate
|
|
C15H9F2NO4S |
详情 |
详情
|
(XI) |
13068 |
5,6-Difluoro-8-oxo-3H,8H-4-oxa-1-thia-9b-azacyclopenta[cd]phenalene-9-carboxylic acid
|
|
C13H5F2NO4S |
详情 |
详情
|
(XII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(XI) The reaction of 2,3,4-trifluoroaniline (I) with carbon disulfide and triethylamine gives triethylammonium N-(2,3,4-trifluorophenyl)dithiocarbamate (II), which by reaction with ethyl chlorocarbonate in chloroform yields the corresponding isothiocyanate (III). The condensation of (III) with diethyl malonate (IV) by means of NaH in THF affords the sodium salt of diethyl [(2,3,4-trifluoroanilino)(mercapto)methylene]malonate (V), which is condensed with 1-acetoxy-3-chloroacetone in DMF to give the substituted thioester (VII). The cyclization of (VII) by means of sulfuric acid yields the thiazoline derivative (VIII), which is cyclized again by means of NaH in refluxing dioxane to afford diethyl (6,7-difluoro-1H,4H-thiazolo[4,3-c][1,4]benzoxazin-1-ylidene)malonate (IX). A final, new cyclization of (IX) by means of ethyl polyphosphate (PPE) at 138 C, followed by hydrolysis of the intermediate ester with sulfuric acid gives 7,8-difluoro-9,1-epoxymethano-5-oxo-5H-thiazolo[3,2-a]quinoline-4-carboxylic acid (X). This compound is then condensed with 1-methylpiperazine (XI) in hot DMSO and treated with aqueous HCl.
【1】
Taguchi, M.; Kondo, H.; Inoue, Y.; Kawahata, Y.; Tsukamoto, G. (Kanebo Pharmaceuticals, Ltd.); Quinolinecarboxylic acid derivs., a compsns. comprising the same, process for preparing the same, and the use of the same for the manufacture of medicaments. EP 0286089; JP 1989199979; US 4808584 . |
【2】
Prous, J.; Castaner, J.; KB-5246. Drugs Fut 1989, 14, 6, 519.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13059 |
2,3,4-Trifluorophenylamine; 2,3,4-Trifluoroaniline
|
3862-73-5 |
C6H4F3N |
详情 | 详情
|
(II) |
20905 |
N,N-dipropyl-1-propanaminium 2,3,4-trifluorophenylcarbamodithioate
|
|
C16H25F3N2S2 |
详情 |
详情
|
(III) |
20906 |
1,2,3-trifluoro-4-isothiocyanatobenzene; 2,3,4-trifluorophenyl isothiocyanate
|
119474-40-7 |
C7H2F3NS |
详情 | 详情
|
(IV) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(V) |
20908 |
sodium 3-ethoxy-2-(ethoxycarbonyl)-3-oxo-1-(2,3,4-trifluoroanilino)-1-propene-1-thiolate
|
|
C14H13F3NNaO4S |
详情 |
详情
|
(VI) |
20909 |
4-chloro-3-oxobutyl acetate
|
|
C6H9ClO3 |
详情 |
详情
|
(VII) |
20910 |
diethyl 2-[[[2-(acetoxy)acetyl]sulfanyl](2,3,4-trifluoroanilino)methylene]malonate
|
|
C18H18F3NO7S |
详情 |
详情
|
(VIII) |
20911 |
diethyl 2-[4-(hydroxymethyl)-3-(2,3,4-trifluorophenyl)-1,3-thiazol-2(3H)-ylidene]malonate
|
|
C17H16F3NO5S |
详情 |
详情
|
(IX) |
13066 |
diethyl 2-(6,7-difluoro-4H-[1,3]thiazolo[4,3-c][1,4]benzoxazin-1-ylidene)malonate
|
|
C17H15F2NO5S |
详情 |
详情
|
(X) |
13068 |
5,6-Difluoro-8-oxo-3H,8H-4-oxa-1-thia-9b-azacyclopenta[cd]phenalene-9-carboxylic acid
|
|
C13H5F2NO4S |
详情 |
详情
|
(XI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
The reaction of 11-methylene-6,11-dihydrodibenzo[b,e]oxepine-2-carboxylic acid methyl ester (I) with N-methylpiperazine and paraformaldehyde by means of trifluoroacetic acid in hot tetrachloroethane gives 11-[2-(4-methylpiperazin-1-yl)ethylidene]-6,11-dihydrodibenzo[b,e]oxepine-2-carboxylic acid methyl ester (II), which by reaction with ethyl chloroformate and sodium acetate in dichloromethane yields the corresponding 2-chloroethylidene derivative (III). The condensation of (III) with 5,6-dimethyl-1H-benzimidazole (IV) in refluxing toluene affords the methyl ester (V) of the desired product, which is finally hydrolyzed with sodium methoxide in methanol.
【1】
Oshima, E.; Obase, H.; Karasawa, A.; Kubo, K.; Miki, I.; Ishii, A. (Kyowa Hakko Kogyo Co., Ltd.); Tricyclic cpds. EP 0345747; JP 1990091040; US 4999363; US 5118701; US 5242931; US 5302596 .
|
【2】
Prous, J.; Castaner, J.; KW-3635. Drugs Fut 1992, 17, 9, 782.
|
【3】
Ishii, A.; Higo, K.; Miki, I.; Kubo, K.; Ohshima, E.; Takami, H.; Karasawa, A.; Sato, H.; Obase, H.; Shirakura, S.; Synthesis and biological activity of a novel thromboxane A2 receptor antagonist, KW-3635, and its related derivatives. 11th Symp Med Chem (Dec 4-5, Tokushima) 1990, Abst P-6. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(I) |
14066 |
methyl 11-methylene-6,11-dihydrodibenzo[b,e]oxepine-2-carboxylate
|
|
C17H14O3 |
详情 |
详情
|
(II) |
14067 |
methyl 11-[(E)-2-(4-methylpiperazino)ethylidene]-6,11-dihydrodibenzo[b,e]oxepine-2-carboxylate
|
|
C23H26N2O3 |
详情 |
详情
|
(III) |
14068 |
methyl 11-[(E)-2-chloroethylidene]-6,11-dihydrodibenzo[b,e]oxepine-2-carboxylate
|
|
C18H15ClO3 |
详情 |
详情
|
(IV) |
14069 |
5,6-Dimethylbenzimidazole; 5,6-Dimethyl-1H-benzimidazole
|
582-60-5 |
C9H10N2 |
详情 | 详情
|
(V) |
14070 |
methyl 11-[(E)-2-(5,6-dimethyl-1H-benzimidazol-1-yl)ethylidene]-6,11-dihydrodibenzo[b,e]oxepine-2-carboxylate
|
|
C27H24N2O3 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(III) Treatment of thiourea (I) with iodomethane provided S-methylthiouronium iodide (II). This was further condensed with N-methylpiperazine (III) to afford the intermediate piperazine-1-carboxamidine (IV)
【1】
Miller, A.A.; Nobbs, M.S.; Hyde, R.M.; Leach, M.J. (Glaxo Wellcome plc); Pharmacologically active CNS cpds.. AU 8945964; EP 0372934; EP 0713703; EP 0715851; EP 0727212; EP 0727213; EP 0727214; JP 1990202876; US 5587380; US 5597828; US 5635507; US 5684005 . |
【2】
Patel, R.; Packham, T.W.; Germain, A.L.; Barras, J.R.; Milne, D.J. (GlaxoSmithKline plc); Process of preparing 2,3,5-trihalobenzaldehyde. WO 9507877 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10180 |
Thiourea
|
62-56-6 |
CH4N2S |
详情 | 详情
|
(II) |
62329 |
|
|
C3H10N2S |
详情 |
详情
|
(III) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(IV) |
62330 |
|
|
C7H18N4 |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(IV) The reaction of 8(S)-(bromomethyl)-4-hydroxy-2-methyl-1-oxo-6-(5,6,7-trimethoxyindol-2-ylcarbonyl)-1,2,3,6,7,8-hexahydrobenzo[1,2-b:4,3-b']dipyrrole-2-carboxylic acid methyl ester (I) with tert-butyl-dimethylsilyl chloride in DMF gives the corresponding O-silyl derivative (II), which is treated with camphorsulfonic acid (CPS) in hot chloroform to afford 8(S)-(bromomethyl)-4-hydroxy-2-methyl-6-(5,6,7-trimethoxyindol-2-ylcarbonyl)-3,6,7,8-tetrahydrobenzo[1,2-b:4,3-b']dipyrrole-1-carboxylic acid methyl ester (III). Finally, this compound is desilylated with tetrabutylammonium fluoride in THF and condensed with N-methylpiperazine (IV) and 4-nitrophenyl chloroformate by means of triethylamine in dichloromethane.
【1】
Kanda, Y.; Uosaki, Y.; Saito, H.; Sano, H.; Kobayashi, E.; Morimoto, M.; Nagamura, S. (Kyowa Hakko Kogyo Co., Ltd.); DC-88A derivs. EP 0406749; JP 1991128379; US 5070092; US 5187186 .
|
【2】
Castaner, J.; Hoshi, A.; KW-2189. Drugs Fut 1993, 18, 12, 1112.
|
【3】
Saito, H.; Gomi, K.; Nagamura, S.; Kanda, Y.; Asai, A.; Kobayashi, E.; Synthesis, antitumor activity and DNA alkylation of duocarmycin analogs. Development of KW2189. 203rd ACS Natl Meet (April 5-10, San Francisco) 1992, Abst MEDI 44.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14658 |
methyl (8S)-8-(bromomethyl)-4-hydroxy-2-methyl-1-oxo-6-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]-1,2,3,6,7,8-hexahydropyrrolo[3,2-e]indole-2-carboxylate
|
|
C26H26BrN3O8 |
详情 |
详情
|
(II) |
14659 |
methyl (8S)-8-(bromomethyl)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-methyl-1-oxo-6-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]-1,2,3,6,7,8-hexahydropyrrolo[3,2-e]indole-2-carboxylate
|
|
C32H40BrN3O8Si |
详情 |
详情
|
(III) |
14660 |
methyl (8S)-8-(bromomethyl)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-methyl-6-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate
|
|
C32H40BrN3O7Si |
详情 |
详情
|
(IV) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线20
该中间体在本合成路线中的序号:
(XV) The condensation of indoline (I) with methyl acetoacetate (II) by means of Ts-OH in refluxing benzene gives the adduct (III), which is cyclized by means of Pd(OAc)2 in hot DMA to yield the pyrroloindole (IV). The hydrolysis of the acetate group of (IV) by means of K2CO3 in methanol affords the hydroxymethyl compound (V), which is treated with CCl4 and PPh3 to provide the chloromethyl derivative (VI). The cleavage of the benzyl protecting group of (VI) by means of HCOONH4 and Pd/C in THF gives the hydroxy derivative (VII), which is N-deprotected by means of HCl in ethyl acetate to yield the intermediate (VIII). The condensation of (VIII) with 5,6,7-trimethoxy-1H-indole-2-carboxylic acid (IX) by means of EDC in DMF affords the carboxamide (X), which is treated with DBU in acetonitrile to provide the cyclopropapyrroloindole (XI). The reaction of (XI) with HBr in acetonitrile gives the bromomethyl derivative (XII), which is treated with 4-nitrophenyl chloroformate (XIII) to yield the active carbonate ester (XIV). Finally, this compound is treated with 1-methylpiperazine (XV) to provide the target Pibrozelesin.
【1】
Fukuda, Y.; et al.; Novel syntheses of optically active CC-1065, U-73,975 (adozelesin), U-80,244 (carzelesin), U-77,779 (bizelesin), KW-2189, and DU-86. Heterocycles 1997, 45, 12, 2303.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
59123 |
tert-butyl (3S)-3-[(acetyloxy)methyl]-5-amino-6-(benzyloxy)-2,3-dihydro-1H-indole-1-carboxylate
|
|
C23H28N2O5 |
详情 |
详情
|
(II) |
11791 |
methyl 3-oxobutanoate; Methyl acetoacetate
|
105-45-3 |
C5H8O3 |
详情 | 详情
|
(III) |
61767 |
tert-butyl (3S)-3-[(acetyloxy)methyl]-6-(benzyloxy)-5-{[(E)-3-methoxy-1-methyl-3-oxo-1-propenyl]amino}-2,3-dihydro-1H-indole-1-carboxylate
|
|
C28H34N2O7 |
详情 |
详情
|
(IV) |
61768 |
6-(tert-butyl) 1-methyl (8S)-8-[(acetyloxy)methyl]-4-(benzyloxy)-2-methyl-7,8-dihydropyrrolo[3,2-e]indole-1,6(3H)-dicarboxylate
|
|
C28H32N2O7 |
详情 |
详情
|
(V) |
61769 |
6-(tert-butyl) 1-methyl (8S)-4-(benzyloxy)-8-(hydroxymethyl)-2-methyl-7,8-dihydropyrrolo[3,2-e]indole-1,6(3H)-dicarboxylate
|
|
C26H30N2O6 |
详情 |
详情
|
(VI) |
61770 |
6-(tert-butyl) 1-methyl (8S)-4-(benzyloxy)-8-(chloromethyl)-2-methyl-7,8-dihydropyrrolo[3,2-e]indole-1,6(3H)-dicarboxylate
|
|
C26H29ClN2O5 |
详情 |
详情
|
(VII) |
61771 |
6-(tert-butyl) 1-methyl (8S)-8-(chloromethyl)-4-hydroxy-2-methyl-7,8-dihydropyrrolo[3,2-e]indole-1,6(3H)-dicarboxylate
|
|
C19H23ClN2O5 |
详情 |
详情
|
(VIII) |
61772 |
methyl (8S)-8-(chloromethyl)-4-hydroxy-2-methyl-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate
|
|
C14H15ClN2O3 |
详情 |
详情
|
(IX) |
61773 |
5,6,7-trimethoxy-1H-indole-2-carboxylic acid
|
|
C12H13NO5 |
详情 |
详情
|
(X) |
61774 |
methyl (8S)-8-(chloromethyl)-4-hydroxy-2-methyl-6-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate
|
|
C26H26ClN3O7 |
详情 |
详情
|
(XI) |
40881 |
methyl (3bR,4aS)-2-methyl-8-oxo-6-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate
|
|
C26H25N3O7 |
详情 |
详情
|
(XII) |
61775 |
methyl (8S)-8-(bromomethyl)-4-hydroxy-2-methyl-6-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate
|
|
C26H26BrN3O7 |
详情 |
详情
|
(XIII) |
16605 |
4-Nitrophenyl chloroformate; 1-[(Chlorocarbonyl)oxy]-4-nitrobenzene
|
7693-46-1 |
C7H4ClNO4 |
详情 | 详情
|
(XIV) |
61776 |
methyl (8S)-8-(bromomethyl)-2-methyl-4-{[(4-nitrophenoxy)carbonyl]oxy}-6-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate
|
|
C33H29BrN4O11 |
详情 |
详情
|
(XV) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线21
该中间体在本合成路线中的序号:
(V) The condensation of o-chloronitrobenzene (I) with 2-amino-5-methylthiophene-3-carbonitrile (II) by means of lithium hydroxide in DMSO gives 2-(2-nitroanilino)-5-methylthiophene-3-carbonitrile (III). The reductive cyclization of (III) using stannous chloride in aqueous ethanolic hydrochloric acid gives the primary amidine hydrochloride (IV), which is condensed with N-methylpiperazine (V) in a mixture of 4:1 toluene:DMSO.
【1】
Larsen, S.D.; Stephenson, G.A.; Bunnell, C.A.; Reutzel, S.M.; Nichols, J.R. (Eli Lilly and Company); Intermediates and process for preparing olanzapine. US 6020487 .
|
【2】
Moore, N.A.; Hotten, T.M.; Tupper, D.E.; Olanzapine. Drugs Fut 1994, 19, 2, 114.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15248 |
1-chloro-2-nitrobenzene
|
88-73-3 |
C6H4ClNO2 |
详情 | 详情
|
(II) |
15249 |
5-Amino-4-cyano-2-methylthiophene; 2-amino-5-methyl-3-thiophenecarbonitrile
|
138564-58-6 |
C6H6N2S |
详情 | 详情
|
(III) |
15250 |
5-methyl-2-(2-nitroanilino)-3-thiophenecarbonitrile
|
|
C12H9N3O2S |
详情 |
详情
|
(IV) |
15251 |
2-methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-ylamine hydrochloride; 2-methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-amine hydrochloride; 4-Amino-2-methyl-10H-thieno[2,3-b][1,5]benzodiazepine hydrochloride
|
138564-60-0 |
C12H12ClN3S |
详情 | 详情
|
(V) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线22
该中间体在本合成路线中的序号:
(V) 2) Synthesis of olanzapine 4'-N-oxide: The condensation of 2-fluoronitrobenzene (I) with 5-methylthiophene-2-amine (II) by means of LiOH in DMSO gives the expected secondary amine (III), which is cyclized by means of SnCl2 in ethanol yielding 2-methyl-10H-thieno[2,3-b][1,5]benzodiazepine-4-amine (IV). The condensation of (IV) with N-methylpiperazine (V) in toluene/DMSO affords 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepin e (olanzapine) (VI), which is finally oxidized with m-chloroperbenzoic acid (m-CPBA) in dichloromethane to give the metabolite 2-methyl-4-(4-methyl-4-oxidopiperazinyl-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine.
【1】
Calligaro, D.O.; Moore, N.A.; Tupper, D.E.; Fairhurst, J.; Hotten, T.M.; The synthesis and biological activity of some known and putative metabolites of the atypical antipsychotic agent olanzapine (LY170053). Bioorg Med Chem Lett 1997, 7, 1, 25.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13463 |
o-Fluoronitrobenzene; 1-fluoro-2-nitrobenzene
|
1493-27-2 |
C6H4FNO2 |
详情 | 详情
|
(II) |
15249 |
5-Amino-4-cyano-2-methylthiophene; 2-amino-5-methyl-3-thiophenecarbonitrile
|
138564-58-6 |
C6H6N2S |
详情 | 详情
|
(III) |
15250 |
5-methyl-2-(2-nitroanilino)-3-thiophenecarbonitrile
|
|
C12H9N3O2S |
详情 |
详情
|
(IV) |
15255 |
2-methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-ylamine; 2-methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-amine
|
|
C12H11N3S |
详情 |
详情
|
(V) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(VI) |
15262 |
2-methyl-4-(4-methylpiperazino)-10H-thieno[2,3-b][1,5]benzodiazepine
|
|
C17H20N4S |
详情 |
详情
|
合成路线23
该中间体在本合成路线中的序号:
(VII) 3) Synthesis of 2-hydroxymethyl olanzapine:
The condensation of 2-fluoronitrobenzene (I) with thiophene-2-amine (II) by means of LiOH in DMSO gives the expected secondary amine (III), which is formylated with DMF by means of POCl3 yielding the aldehyde (IV). The reducticyclization of (IV) with SnCl2 in ethanol affords 4-amino-10H-thieno[2,3-b][1,5]benzodiazepine-2-carbaldehyde (V), which is reduced with NaBH4 in ethanol to the corresponding hydroxymethyl derivative (VI). Finally, this compound is condensed with N-methylpiperazine (VII) in toluene/DMSO to give the metabolite 2-(hydroxymethyl)-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benz odiazepine.
【1】
Calligaro, D.O.; Moore, N.A.; Tupper, D.E.; Fairhurst, J.; Hotten, T.M.; The synthesis and biological activity of some known and putative metabolites of the atypical antipsychotic agent olanzapine (LY170053). Bioorg Med Chem Lett 1997, 7, 1, 25.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13463 |
o-Fluoronitrobenzene; 1-fluoro-2-nitrobenzene
|
1493-27-2 |
C6H4FNO2 |
详情 | 详情
|
(II) |
15263 |
2-amino-3-thiophenecarbonitrile
|
4651-82-5 |
C5H4N2S |
详情 | 详情
|
(III) |
15264 |
2-(2-nitroanilino)-3-thiophenecarbonitrile
|
|
C11H7N3O2S |
详情 |
详情
|
(IV) |
15265 |
5-formyl-2-(2-nitroanilino)-3-thiophenecarbonitrile
|
|
C12H7N3O3S |
详情 |
详情
|
(V) |
15266 |
4-amino-10H-thieno[2,3-b][1,5]benzodiazepine-2-carbaldehyde
|
|
C12H9N3OS |
详情 |
详情
|
(VI) |
15267 |
(4-amino-10H-thieno[2,3-b][1,5]benzodiazepin-2-yl)methanol
|
|
C12H11N3OS |
详情 |
详情
|
(VII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线24
该中间体在本合成路线中的序号:
(XI) The methylation of 3-propylpyrazole-5-carboxylic acid ethyl ester (I) with hot dimethyl sulfate gives 1-methyl-3-propylpyrazole-5-carboxylic acid ethyl ester (II), which is hydrolyzed with aqueous NaOH to the corresponding free acid (III). The nitration of (III) with oleum/fuming nitric acid yields the 4-nitro derivative (IV), which is treated first with refluxing SOCl2 and then with NH4OH to afford the corresponding carboxamide (V). The reduction of the nitro group of (V) with SnCl2 dihydrate in refluxing ethanol gives 4-amino-1-methyl-3-propylpyrazole-5-carboxamide (VI), which is acylated with 2-ethoxybenzoyl chloride (VII) by means of triethylamine in dichloromethane yielding 4-(2-ethoxybenzamido)-1-methyl-3-propylpyrazole-5-carboxamide (VIII). The cyclization of (VIII) by means of NaOH and H2O2 in refluxing ethanol affords 5-(2-ethoxyphenyl)-1-methyl-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d] pyrimidin-7-one (IX), which is sulfonated with chlorosulfonic acid affording the chlorosulfonyl derivative (X). Finally, this compound is condensed with 1-methylpiperazine in ethanol at room temperature.
【1】
Martel, A.M.; Graul, A.; Rabasseda, X.; Castaner, R.M.; Sildenafil. Drugs Fut 1997, 22, 2, 138.
|
【2】
Terrett, N.K.; Bell, A.S.; Brown, D.; Ellis, P.; Sildenafil (Viagra(TM)), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction. Bioorg Med Chem Lett 1996, 6, 15, 1819-24.
|
【3】
Bell, A.S.; Brown, D.; Terrett, N.K. (Pfizer Inc.); Pyrazolopyrimidinone antianginal agents. EP 0463756; JP 1994041133; US 5250534; US 5346901 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15622 |
ethyl 3-propyl-1H-pyrazole-5-carboxylate
|
|
C9H14N2O2 |
详情 |
详情
|
(II) |
15623 |
ethyl 1-methyl-3-propyl-1H-pyrazole-5-carboxylate
|
|
C10H16N2O2 |
详情 |
详情
|
(III) |
15624 |
1-methyl-3-propyl-1H-pyrazole-5-carboxylic acid
|
|
C8H12N2O2 |
详情 |
详情
|
(IV) |
15625 |
1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxylic acid
|
|
C8H11N3O4 |
详情 |
详情
|
(V) |
15626 |
1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide; 4-Nitro-1-methyl-3-propyl-5-pyrazolecarboxamide
|
139756-01-8 |
C8H12N4O3 |
详情 | 详情
|
(VI) |
15627 |
4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide; 4-amino-1-methyl-3-propyl-5-pyrazolecarboxamide
|
139756-02-8 |
C8H14N4O |
详情 | 详情
|
(VII) |
15628 |
2-ethoxybenzoyl chloride
|
42926-52-3 |
C9H9ClO2 |
详情 | 详情
|
(VIII) |
15629 |
4-[(2-ethoxybenzoyl)amino]-1-methyl-3-propyl-1H-pyrazole-5-carboxamide
|
|
C17H22N4O3 |
详情 |
详情
|
(IX) |
15630 |
5-(2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one; 5-(2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one
|
139756-21-1 |
C17H20N4O2 |
详情 | 详情
|
(X) |
15631 |
4-ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)benzenesulfonyl chloride
|
|
C17H19ClN4O4S |
详情 |
详情
|
(XI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线25
该中间体在本合成路线中的序号:
(III) A more efficient process for preparing clinical-grade sildenafil has been described:
The reaction of 2-ethoxybenzoic acid (I) with SOCl2 and ClSO3H gives 5-(chlorosulfonyl)-2-ethoxybenzoic acid (II), which is condensed with 1-methylpiperazine (III) by means of triethylamine in water yielding 2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)benzoic acid (IV). The condensation of (IV) with 4-amino-1-methyl-3-propylpyrazole-5-carboxamide (V), obtained by reduction of the corresponding 4-nitro compound (VI) with H2 over Pd/C in ethyl acetate, by means of carbonyldiimidazole (CDI) in refluxing ethyl acetate affords the corresponding amide (VII), which is finally cyclized by means of potassium tert-butoxide in refluxing tert-butanol. Other cyclizing agents such as KOH, KHCO3, BaO, sodium ethoxide, sodium tert-butoxide, NaH, NaNH2, sodium decyloxide, sodium cyclohexylamide, sodium 4-methylpiperazide, Cs2CO3, magnesium ethoxide, barium ethoxide, cupric ethoxide, aluminum tert-butoxide, titanium ethoxide, lithium diisopropylamide, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), KF or several Lewis acids, as well as other solvents such as methanol, ethanol, tert-amyl alcohol, 1-methylcyclohexanol, THF, 1,4-dioxan, 1,2-dimethoxyethane, 3,7-dimethyloctan-3-ol, DMSO, pyridine, acetonitrile, or methyl isobutyl ketone have also been used; the reaction temperature is normally 100 C.
【1】
Dale, D.J.; et al.; The chemical development of the commercial route to sildenafil: A case history. Org Process Res Dev 2000, 4, 1, 17.
|
【2】
Dunn, P.J.; Wood, A.S. (Pfizer Inc.); Process for preparing sildenafil. EP 0812845; JP 1998081688; JP 1999171879 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21185 |
2-ethoxybenzoic acid
|
134-11-2 |
C9H10O3 |
详情 | 详情
|
(II) |
21186 |
5-(chlorosulfonyl)-2-ethoxybenzoic acid
|
200575-16-2 |
C9H9ClO5S |
详情 | 详情
|
(III) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(IV) |
21188 |
2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]benzoic acid
|
194602-23-8 |
C14H20N2O5S |
详情 | 详情
|
(V) |
15626 |
1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide; 4-Nitro-1-methyl-3-propyl-5-pyrazolecarboxamide
|
139756-01-8 |
C8H12N4O3 |
详情 | 详情
|
(VI) |
15627 |
4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide; 4-amino-1-methyl-3-propyl-5-pyrazolecarboxamide
|
139756-02-8 |
C8H14N4O |
详情 | 详情
|
(VII) |
21191 |
4-([2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]benzoyl]amino)-1-methyl-3-propyl-1H-pyrazole-5-carboxamide
|
|
C22H32N6O5S |
详情 |
详情
|
合成路线26
该中间体在本合成路线中的序号:
(XV) Synthesis of sildenafil: Reaction of 5-(chlorosulfonyl)-2-hydroxybenzoic acid (XIV) with 1-methylpiperazine (XV) by means of DIEA gives the sulfonamide (XVI), which is treated with diethyl sulfate yielding 2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)benzoic acid (XVII). The activation of (XVII) with a polymer-supported 1-hydroxybenzotriazole (HOBt) variant (XVIII) and bromotris(pyrrolidino)phosphonium (PyBrOP) as catalyst affords the activated ester (XIX), which is condensed with the aminopyrazole intermediate (XIII), and treated with the methyl isocyanate resin (X) in order to eliminate the excess of aminopyrazole (XIII), to provide the diamide (XX). Finally, the cyclization and dehydration to sildenafil are performed by microwave irradiation of an ethanolic solution of compound (XX) containig a catalytic amount of NaOEt.
【1】
Baxendale, I.R.; Ley, S.V.; Polymer-supported reagents for multi-step organic synthesis: Application to the synthesis of sildenafil. Bioorg Med Chem Lett 2000, 10, 17, 1983.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(X) |
11019 |
(Methylimino)(oxo)methane; methyl isocyanate
|
|
C2H3NO |
详情 |
详情
|
(XIII) |
15627 |
4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide; 4-amino-1-methyl-3-propyl-5-pyrazolecarboxamide
|
139756-02-8 |
C8H14N4O |
详情 | 详情
|
(XIV) |
44346 |
5-(chlorosulfonyl)-2-hydroxybenzoic acid
|
|
C7H5ClO5S |
详情 |
详情
|
(XV) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(XVI) |
44347 |
2-hydroxy-5-[(4-methyl-1-piperazinyl)sulfonyl]benzoic acid
|
|
C12H16N2O5S |
详情 |
详情
|
(XVII) |
21188 |
2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]benzoic acid
|
194602-23-8 |
C14H20N2O5S |
详情 | 详情
|
(XVIII) |
44348 |
1-hydroxy-1H-1,2,3-benzotriazole-6-carbaldehyde
|
|
C7H5N3O2 |
详情 |
详情
|
(XIX) |
44349 |
1-([2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]benzoyl]oxy)-1H-1,2,3-benzotriazole-6-carbaldehyde
|
|
C21H23N5O6S |
详情 |
详情
|
(XX) |
21191 |
4-([2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]benzoyl]amino)-1-methyl-3-propyl-1H-pyrazole-5-carboxamide
|
|
C22H32N6O5S |
详情 |
详情
|
合成路线27
该中间体在本合成路线中的序号:
(V) The condensation of 1-(benzylideneamino)imidazolidine-2,4-dione (I) with 1-bromo-4-chlorobutane (II) by means of NaH in DMF at 100 C yields 1-(benzylideneamino)-3-(4-chlorobutyl)imidazolidine-2,4-dione (III), which is treated with NaI in refluxing acetone affording the corresponding 4-iodobutyl derivative (IV). The thermal condensation of (IV) with 1-methylpiperazine (V) in refluxing DMF gives the expected condensation product (VI), which is debenzylated by hydrogenation with H2 over Pd/C in 2N HCl giving 1-amino-3-[4-(4-methylpiperazin-1-yl)butyl]imidazolidine-2,4-dione (VII). Finally, this compound is condensed with 5-(4-chlorophenyl)furan-2-carbaldehyde (VIII) in DMF at room temperature.
【1】
Robinson, C.P.; Robinson, K.A.; Castaner, J.; Azimilide Hydrochloride. Drugs Fut 1997, 22, 6, 601.
|
【2】
Pelosi, S.S. Jr.; Yu, C.-NN.; Calcagno, M.A. (The Procter & Gamble Co.); Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents. EP 0598061; JP 1994509804; US 5462940; WO 9304061 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16140 |
1-[[(E)-benzylidene]amino]-1H-imidazole-2,4(3H,5H)-dione
|
|
C10H9N3O2 |
详情 |
详情
|
(II) |
16141 |
1-bromo-4-chlorobutane
|
6940-78-9 |
C4H8BrCl |
详情 | 详情
|
(III) |
16142 |
3-(4-chlorobutyl)-1-[[(E)-benzylidene]amino]-1H-imidazole-2,4(3H,5H)-dione
|
|
C14H16ClN3O2 |
详情 |
详情
|
(IV) |
16143 |
3-(4-iodobutyl)-1-[[(E)-benzylidene]amino]-1H-imidazole-2,4(3H,5H)-dione
|
|
C14H16IN3O2 |
详情 |
详情
|
(V) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(VI) |
16145 |
3-[4-(4-methylpiperazino)butyl]-1-[[(E)-benzylidene]amino]-1H-imidazole-2,4(3H,5H)-dione
|
|
C19H27N5O2 |
详情 |
详情
|
(VII) |
16146 |
1-amino-3-[4-(4-methylpiperazino)butyl]-1H-imidazole-2,4(3H,5H)-dione
|
|
C12H23N5O2 |
详情 |
详情
|
(VIII) |
16147 |
5-(4-Chloro-phenyl)-furan-2-carbaldehyde; 5-(4-Chlorophenyl)-2-furaldehyde
|
34035-03-5 |
C11H7ClO2 |
详情 | 详情
|
合成路线28
该中间体在本合成路线中的序号:
(IX) Benzodioxan-6-amine (I) was protected as the corresponding acetanilide (II), which was subsequently subjected to Friedel-Crafts condensation with chloroacetyl chloride (III) in the presence of ZnCl2, yielding the chloro ketone (IV). Acidic hydrolysis of the acetamide function of (IV) provided amino ketone (V). Alternatively, intermediate (V) was prepared by direct acylation of aniline (I) employing chloroacetonitrile (VI) in the presence of BCl3. The 7-(chloromethyl)camptothecin derivative (VIII) was synthesized through a Friedlander condensation between amino ketone (V) and the known keto lactone (VII). Finally, displacement of the chloride of (VIII) with N-methylpiperazine (IX) gave rise to the title piperazinylmethyl camptothecin.
【1】
Luzzio, M.J.; et al.; Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I. J Med Chem 1995, 38, 3, 395.
|
【2】
Luzzio, M.J.; Besterman, J.M.; Evans, M.G.; Myers, P.L. (GlaxoSmithKline plc); Water soluble camptothecin derivs.. EP 0540099; JP 1993222048; JP 2000109475; US 5559235 .
|
【3】
Sternbach, D.D.; Lackey, K. (GlaxoSmithKline Inc.); Preparation of water soluble camptothecin derivs.. US 5342947 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
54867 |
1,4-Benzodioxan-6-amine; 3,4-Ethylenedioxyaniline; 6-Amino-1,4-benzodioxane
|
22013-33-8 |
C8H9NO2 |
详情 | 详情
|
(II) |
54868 |
N-(2,3-dihydro-1,4-benzodioxin-6-yl)acetamide
|
|
C10H11NO3 |
详情 |
详情
|
(III) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(IV) |
54869 |
N-[7-(2-chloroacetyl)-2,3-dihydro-1,4-benzodioxin-6-yl]acetamide
|
|
C12H12ClNO4 |
详情 |
详情
|
(V) |
54870 |
1-(7-amino-2,3-dihydro-1,4-benzodioxin-6-yl)-2-chloro-1-ethanone
|
|
C10H10ClNO3 |
详情 |
详情
|
(VI) |
14443 |
2-chloroacetonitrile; chloroacetonitrile
|
107-14-2 |
C2H2ClN |
详情 | 详情
|
(VII) |
10841 |
(4S)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione
|
|
C13H13NO5 |
详情 |
详情
|
(VIII) |
54871 |
(8S)-15-(chloromethyl)-8-ethyl-8-hydroxy-2,3-dihydro-11H-[1,4]dioxino[2,3-g]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-9,12(8H,14H)-dione
|
|
C23H19ClN2O6 |
详情 |
详情
|
(IX) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线29
该中间体在本合成路线中的序号:
(IX) In a different strategy, the dioxinoquinoline system (XII) was prepared by acylation of amino ketone (X) with methyl malonyl chloride (XI), followed by intramolecular Knoevenagel condensation of the intermediate keto malonamide. Chlorination of (XII) with POCl3 afforded the dichloro derivative (XIII), which was subsequently condensed with N-methylpiperazine (IX) to give (XIV). Reduction of the ester group of (XIV) by means of DIBAL provided alcohol (XV). Replacement of the 7-chloro of (XV) by an iodide group required previous oxidation of (XV) to the more reactive aldehyde (XVI). Treatment of (XVI) with NaI and HCl led to the corresponding iodo aldehyde, which was further reduced to alcohol (XVII) using NaBH4.
【1】
Fang, F.G.; Xie, S.; Lowery, M.W. (GlaxoSmithKline Inc.); Intermediates in pharmaceutical camptothecin preparation. WO 9529917 .
|
【2】
Huie, E.M.; Fang, F.G.; Xie, S.; Comins, D.L. (GlaxoSmithKline Inc.; North Carolina State University); Preparation of a camptothecin deriv. by intramolecular cyclisation. WO 9529919 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(X) |
54870 |
1-(7-amino-2,3-dihydro-1,4-benzodioxin-6-yl)-2-chloro-1-ethanone
|
|
C10H10ClNO3 |
详情 |
详情
|
(XI) |
50272 |
Malonic acid monomethyl ester chloride; Methyl (chloroformyl)acetate; Methyl malonyl chloride
;Methyl 3-chloro-3-oxopropionate |
37517-81-0 |
C4H5ClO3 |
详情 | 详情
|
(XII) |
54872 |
methyl 9-(chloromethyl)-7-oxo-2,3,6,7-tetrahydro[1,4]dioxino[2,3-g]quinoline-8-carboxylate
|
|
C14H12ClNO5 |
详情 |
详情
|
(XIII) |
54873 |
methyl 7-chloro-9-(chloromethyl)-2,3-dihydro[1,4]dioxino[2,3-g]quinoline-8-carboxylate
|
|
C14H11Cl2NO4 |
详情 |
详情
|
(XIV) |
54874 |
methyl 7-chloro-9-[(4-methyl-1-piperazinyl)methyl]-2,3-dihydro[1,4]dioxino[2,3-g]quinoline-8-carboxylate
|
|
C19H22ClN3O4 |
详情 |
详情
|
(XV) |
54875 |
{7-chloro-9-[(4-methyl-1-piperazinyl)methyl]-2,3-dihydro[1,4]dioxino[2,3-g]quinolin-8-yl}methanol
|
|
C18H22ClN3O3 |
详情 |
详情
|
(XVI) |
54876 |
7-chloro-9-[(4-methyl-1-piperazinyl)methyl]-2,3-dihydro[1,4]dioxino[2,3-g]quinoline-8-carbaldehyde
|
|
C18H20ClN3O3 |
详情 |
详情
|
(XVII) |
54877 |
{7-iodo-9-[(4-methyl-1-piperazinyl)methyl]-2,3-dihydro[1,4]dioxino[2,3-g]quinolin-8-yl}methanol
|
|
C18H22IN3O3 |
详情 |
详情
|
合成路线30
该中间体在本合成路线中的序号:
(IX) The silylated pyranopyridine (XXXIV) was prepared by an analoguos route to that of Scheme 3 starting from 2-methoxy-6-(trimethylsilyl)pyridine (XXX). Halogenation-desilylation of (XXXIV) by means of ICl-furnished iodide (XXXV). Subsequent demethylation of (XXXV) to give lactam (XXXVI) was performed employing either aqueous HI or iodotrimethylsane. Alkylation of lactam (XXXVI) with 1,4-dichloro-2-butyne (XXXVII) to (XXXVIII), followed by reaction with piperazine (IX), yielded (XXXIX). The cascade radical cyclization of (XXXIX) with isonitrile (XL) under sunlamp irradiation in the presence of hexamethyldistannane led to an inseparable mixture of the title compound and its regioisomer (XLI).
【1】
Josien, H.; et al.; A general synthetic approach to the (20S)-camptothecin family of antitumor agents by a regiocontrolled cascade radical cyclization of aryl isonitriles. Chemistry (Weinheim) 1998, 4, 1, 67.
|
【2】
Curran, D.P.; et al.; Cascade radical reactions of isonitriles: A second-generation synthesis of (20S)-camptothecin, topotecan, irinotecan, and GI-147211C. Angew Chem. Int Ed 1995, 34, 23-24, 2683.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(XIX) |
54879 |
2-(dimethylamino)ethyl(methyl)formamide
|
|
C6H14N2O |
详情 |
详情
|
(XXII) |
54882 |
2-Butene-1-ol; Crotyl Alcohol; trans-Propenylcarbinol
|
504-61-0 |
C4H8O |
详情 | 详情
|
(XXX) |
54890 |
methyl 6-(trimethylsilyl)-2-pyridinyl ether; 2-methoxy-6-(trimethylsilyl)pyridine
|
|
C9H15NOSi |
详情 |
详情
|
(XXXI) |
54891 |
4-iodo-2-methoxy-6-(trimethylsilyl)nicotinaldehyde
|
|
C10H14INO2Si |
详情 |
详情
|
(XXXII) |
54892 |
3-{[(E)-2-butenyloxy]methyl}-4-iodo-2-methoxy-6-(trimethylsilyl)pyridine; (E)-2-butenyl [4-iodo-2-methoxy-6-(trimethylsilyl)-3-pyridinyl]methyl ether
|
|
C14H22INO2Si |
详情 |
详情
|
(XXXIII) |
35096 |
4-ethyl-6-(trimethylsilyl)-1H-pyrano[3,4-c]pyridin-8-yl methyl ether; 4-ethyl-8-methoxy-6-(trimethylsilyl)-1H-pyrano[3,4-c]pyridine
|
|
C14H21NO2Si |
详情 |
详情
|
(XXXIV) |
54893 |
(4S)-4-ethyl-4-hydroxy-8-methoxy-6-(trimethylsilyl)-1,4-dihydro-3H-pyrano[3,4-c]pyridin-3-one
|
|
C14H21NO4Si |
详情 |
详情
|
(XXXV) |
54894 |
(4S)-4-ethyl-4-hydroxy-6-iodo-8-methoxy-1,4-dihydro-3H-pyrano[3,4-c]pyridin-3-one
|
|
C11H12INO4 |
详情 |
详情
|
(XXXVI) |
49255 |
(4S)-4-ethyl-4-hydroxy-6-iodo-1H-pyrano[3,4-c]pyridine-3,8(4H,7H)-dione
|
|
C10H10INO4 |
详情 |
详情
|
(XXXVII) |
50923 |
1,4-Dichloro-2-butyne
|
821-10-3 |
C4H4Cl2 |
详情 | 详情
|
(XXXVIII) |
54895 |
(4S)-7-(4-chloro-2-butynyl)-4-ethyl-4-hydroxy-6-iodo-1H-pyrano[3,4-c]pyridine-3,8(4H,7H)-dione
|
|
C14H13ClINO4 |
详情 |
详情
|
(XXXIX) |
54886 |
(4S)-4-ethyl-8-methoxy-3,4-dihydro-1H-pyrano[3,4-c]pyridine-3,4-diol
|
|
C11H15NO4 |
详情 |
详情
|
(XL) |
54898 |
|
|
C9H7NO2 |
详情 |
详情
|
(XLI) |
54897 |
(9S)-9-ethyl-9-hydroxy-16-[(4-methyl-1-piperazinyl)methyl]-2,3-dihydro-12H-[1,4]dioxino[2,3-f]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-10,13(9H,15H)-dione
|
|
C28H30N4O6 |
详情 |
详情
|
合成路线31
该中间体在本合成路线中的序号:
(VI) The condensation of 2,5-difluoronitrobenzene (I) with ethyl 2-amino-5-methylthiophene-3-carboxylate (II) by means of triethylamine in hot DMSO or 2-methoxyethanol giving ethyl 2-(4-fluoro-2-nitroanilino)-5-methylthiophene-3-carboxylate (III), which is reduced with H2 over Pd/C in ethanol to ethyl 2-(4-fluoro-2-aminoanilino)-5-methylthiophene-3-carboxylate (IV). The cyclization of (IV) by means of NaH in DMSO affords 9,10-dihydro-7-fluoro-2-methyl-4H-thieno[2,3b][1,5]benzodiazepin-2-one (V), which is finally condensed with N-methylpiperazine by means of TiCl4 in anisole at 120 C.
【1】
Chakrabarti, J.K.; Tupper, D.E.; Benzodiazepine derivatives. DE 2552403; FR 2292479; GB 1533235; JP 51076296 .
|
【2】
Pullar, I.A.; Chakrabarti, J.K.; Horsman, L.; Wright, F.C.; Tupper, D.E.; Hotten, T.M.; Heterooarenobenzodiazepines. 3. 4-Piperazinyl-10H-thieno[2,3-b][1,5]benzodiazepines as potential neuroleptics. J Med Chem 1980, 23, 8, 878-884.
|
【3】
Blancafort, P.; Castañer, J.; Serradell, M.N.; Flumezapine. Drugs Fut 1983, 8, 2, 110.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(II) |
35949 |
ethyl 2-amino-5-methyl-3-thiophenecarboxylate
|
|
C8H11NO2S |
详情 |
详情
|
(III) |
35950 |
ethyl 2-(5-fluoro-2-nitroanilino)-5-methyl-3-thiophenecarboxylate
|
|
C14H13FN2O4S |
详情 |
详情
|
(IV) |
35951 |
ethyl 2-(2-amino-5-fluoroanilino)-5-methyl-3-thiophenecarboxylate
|
|
C14H15FN2O2S |
详情 |
详情
|
(V) |
35952 |
7-fluoro-2-methyl-5,10-dihydro-4H-thieno[2,3-b][1,5]benzodiazepin-4-one
|
|
C12H9FN2OS |
详情 |
详情
|
(VI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线32
该中间体在本合成路线中的序号:
(XVI) Treatment of 3,4-difluoroaniline (I) with CS2 and Et3N gives triethylammonium dithiocarbamate (II), which reacts with ethyl chloroformate in chloroform to yield (III). Isothiocyanate (III) is converted into the potassium salt (IV) by reaction with diethyl malonate and KOH in dioxane and then transformed into methoxymethyl thioether (VI) by means of reagent (V) and Et3N in toluene. Cyclization of (VI) by heating in diphenyl ether affords quinoline (VII), which then reacts with benzoyl chloride (VIII) in pyridine to furnish (IX). Benzoyloxy derivative (IX) is converted into (X) by means of HCl in EtOH, and its reaction with 1-bromo-2-fluoroethane (XI) and NaHCO3 yields compound (XII). Chlorination of (XII) with SO2Cl2 in hexane provides (XIII), which by simultaneous hydrolysis and intramolecular cyclization by means of Et3N /H2O in THF provides the mixture of isomers (XIV). (+)-(XV) is obtained by HPLC chromatography of (XIV) on a chiral stationary phase. Treatment of (+)-(XV) with 1-methylpiperazine (XVI) in DMF provides ethyl ester (+)-(XVII), which is finally hydrolyzed by means of H2SO4 in H2O.
【1】
Segawa, J.; Matsuoka, M.; Tomii, Y. (Nippon Shinyaku Co., Ltd.); Quinolinecarboxylic acid deriv. and process for producing the same. EP 0675127; WO 9414819 .
|
【2】
Kise, M.; Amimoto, I.; Kitano, M.; Segawa, J.; Tomii, Y.; Matsuoka, M.; Masui, Y.; Synthesis and antibacterial activity of novel 7-substituted-6-fluoro-1-fluoromethyl-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid derivatives. Chem Pharm Bull 1999, 47, 12, 1765. |
【3】
Segawa, J.; Kitano, M.; Kazuno, K.; Matsuoka, M.; Shirahase, I.; Ozaki, M.; Matsuda, M.; Tomii, Y.; Kise, M.; Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1,3]thiazeto[3, 2-a]quinoline-3-carboxylic acids. J Med Chem 1992, 35, 25, 4727. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13451 |
3,4-Difluoroaniline; 3,4-Difluorophenylamine
|
3863-11-4 |
C6H5F2N |
详情 | 详情
|
(II) |
42953 |
3,4-difluorophenylcarbamodithioic acid
|
|
C7H5F2NS2 |
详情 |
详情
|
(III) |
13453 |
1,2-Difluoro-4-isothiocyanatobenzene; 3,4-difluorophenyl isothiocyanate
|
113028-75-4 |
C7H3F2NS |
详情 | 详情
|
(IV) |
42954 |
potassium 1-(3,4-difluoroanilino)-3-ethoxy-2-(ethoxycarbonyl)-3-oxo-1-propene-1-thiolate
|
|
C14H14F2KNO4S |
详情 |
详情
|
(V) |
18319 |
Chloro(methoxy)methane; Chloromethyl methyl ether
|
107-30-2 |
C2H5ClO |
详情 | 详情
|
(VI) |
13455 |
diethyl 2-[(3,4-difluoroanilino)[(methoxymethyl)sulfanyl]methylene]malonate
|
|
C16H19F2NO5S |
详情 |
详情
|
(VII) |
13456 |
ethyl 6,7-difluoro-4-hydroxy-2-[(methoxymethyl)sulfanyl]-3-quinolinecarboxylate
|
|
C14H13F2NO4S |
详情 |
详情
|
(VIII) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(IX) |
42955 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-[(methoxymethyl)sulfanyl]-3-quinolinecarboxylate
|
|
C21H17F2NO5S |
详情 |
详情
|
(X) |
42956 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-sulfanyl-3-quinolinecarboxylate
|
|
C19H13F2NO4S |
详情 |
详情
|
(XI) |
28769 |
1-bromo-2-fluoroethane
|
762-49-2 |
C2H4BrF |
详情 | 详情
|
(XII) |
42957 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-[(2-fluoroethyl)sulfanyl]-3-quinolinecarboxylate
|
|
C21H16F3NO4S |
详情 |
详情
|
(XIII) |
42958 |
ethyl 4-(benzoyloxy)-2-[(1-chloro-2-fluoroethyl)sulfanyl]-6,7-difluoro-3-quinolinecarboxylate
|
|
C21H15ClF3NO4S |
详情 |
详情
|
(XIV) |
42959 |
ethyl 6,7-difluoro-1-(fluoromethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C14H10F3NO3S |
详情 |
详情
|
(XV) |
42960 |
ethyl (1R)-6,7-difluoro-1-(fluoromethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C14H10F3NO3S |
详情 |
详情
|
(XVI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(XVII) |
42961 |
ethyl (1R)-6-fluoro-1-(fluoromethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C19H21F2N3O3S |
详情 |
详情
|
合成路线33
该中间体在本合成路线中的序号:
(XVI) Alternatively, (+)-(XVII) can be obtained as follows: Treatment of (X) with 1-acetoxy-2-bromoethane (XVIII) in DMF in the presence of NaHCO3 yields derivative (XIX), which is then chlorinated by means of SO2Cl2 in CH2Cl2 to provide (XX). Simultaneous hydrolysis and intramolecular cyclization of (XX) by means of Et3N /H2O in THF affords (XXI), which is then converted into butyl ester derivative (XXII) by treatment with refluxing butanol (B). Resolution of the racemic mixture (XXII) by treatment with Lipase PL in vinyl acetate followed by chromatographic separation provides alcohol (-)-(XXIII) and acetoxy (+)-(XXIV). Hydrolysis of (+)-(XXIV) with hot H2SO4/EtOH gives alcohol (+)-(XXV), which is then condensed with 1-methylpiperazine (XVI) in DMF to yield derivative (+)-(XXVI). Finally, treatment with (diethylamino)sulfur trifluoride (DAST) in CH2Cl2 provides fluoro derivative (+)-(XVII).
Alternatively, (+)-(XXV) can be obtained by conversion of (XXI) into octyl ester (XXVII) by means of refluxing octanol (A), followed by its enantiomer enzymatic resolution with Liposyme IM in vinyl acetate and chromatographic separation to afford (-)-(XXVIII) and (+)-(XXIX). Finally, hydrolysis of (+)-(XXIX) with hot H2SO4/EtOH yields (+)-(XXV).
An analogous procedure comprising enantiomer separation and subsequent hydrolysis can be performed from ethyl esters (XX) or (XXI) by treatment with the corresponding lipases in an appropriate solvent.
【1】
Segawa, J.; Matsuoka, M.; Tomii, Y. (Nippon Shinyaku Co., Ltd.); Quinolinecarboxylic acid deriv. and process for producing the same. EP 0675127; WO 9414819 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
24543 |
vinyl acetate
|
108-05-4 |
C4H6O2 |
详情 | 详情
|
(A) |
12970 |
(8R,9S,10R,13S,14R)-14-Hydroxy-3-methoxy-10,13-dimethyl-1,2,7,8,9,10,11,12,13,14,15,16-dodecahydro-17H-cyclopenta[a]phenanthren-17-one
|
|
C20H28O3 |
详情 |
详情
|
(B) |
29766 |
butanol; n-butanol; 1-butanol
|
71-36-3 |
C4H10O |
详情 | 详情
|
(X) |
42956 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-sulfanyl-3-quinolinecarboxylate
|
|
C19H13F2NO4S |
详情 |
详情
|
(XVI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(XVII) |
42961 |
ethyl (1R)-6-fluoro-1-(fluoromethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C19H21F2N3O3S |
详情 |
详情
|
(XVIII) |
33463 |
2-bromoethyl acetate
|
927-68-4 |
C4H7BrO2 |
详情 | 详情
|
(XIX) |
42962 |
ethyl 2-[[2-(acetoxy)ethyl]sulfanyl]-4-(benzoyloxy)-6,7-difluoro-3-quinolinecarboxylate
|
|
C23H19F2NO6S |
详情 |
详情
|
(XX) |
42963 |
ethyl 2-[[2-(acetoxy)-1-chloroethyl]sulfanyl]-4-(benzoyloxy)-6,7-difluoro-3-quinolinecarboxylate
|
|
C23H18ClF2NO6S |
详情 |
详情
|
(XXI) |
42964 |
ethyl 1-[(acetoxy)methyl]-6,7-difluoro-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C16H13F2NO5S |
详情 |
详情
|
(XXII) |
42965 |
butyl 6,7-difluoro-1-(hydroxymethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C16H15F2NO4S |
详情 |
详情
|
(XXIII) |
42966 |
butyl (1S)-6,7-difluoro-1-(hydroxymethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C16H15F2NO4S |
详情 |
详情
|
(XXIV) |
42967 |
butyl (1R)-1-[(acetoxy)methyl]-6,7-difluoro-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C18H17F2NO5S |
详情 |
详情
|
(XXV) |
42968 |
ethyl (1R)-6,7-difluoro-1-(hydroxymethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C14H11F2NO4S |
详情 |
详情
|
(XXVI) |
42969 |
ethyl (1R)-6-fluoro-1-(hydroxymethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C19H22FN3O4S |
详情 |
详情
|
(XXVII) |
42971 |
octyl 2-[6,7-difluoro-1-(hydroxymethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinolin-3-yl]acetate
|
|
C21H25F2NO4S |
详情 |
详情
|
(XXVIII) |
42972 |
octyl 2-[(1S)-1-[(acetoxy)methyl]-6,7-difluoro-4-oxo-4H-[1,3]thiazeto[3,2-a]quinolin-3-yl]acetate
|
|
C23H27F2NO5S |
详情 |
详情
|
(XXIX) |
42973 |
octyl 2-[(1R)-6,7-difluoro-1-(hydroxymethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinolin-3-yl]acetate
|
|
C21H25F2NO4S |
详情 |
详情
|
合成路线34
该中间体在本合成路线中的序号:
(XVI) Treatment of 3,4-difluoroaniline (I) with CS2 and Et3N gives triethylammonium dithiocarbamate (II), which reacts with ethyl chloroformate in chloroform to yield (III). Isothiocyanate (III) is converted into the potassium salt (IV) by reaction with diethyl malonate and KOH in dioxane, and then transformed into methoxymethyl thioether (VI) by means of reagent (V) and Et3N in toluene. Cyclization of (VI) by heating in diphenyl ether affords quinoline (VII), which is then converted into (IX) by means of benzoyl chloride (VIII) in pyridine. Benzoyloxy derivative (IX) is converted into (X) by means of HCl in EtOH, and its reaction with 1-bromo-2-fluoroethane (XI) and NaHCO3 yields compound (XII). Chlorination of (XII) with SO2Cl2 in hexane provides (XIII), which by simultaneous hydrolysis and intramolecular cyclization by means of Et3N /H2O in THF provides the mixture of isomers (XIV). (-)-(XV) is then obtained by HPLC chromatography on a chiral stationary phase. Treatment of (-)-(XV) with 1-methylpiperazine (XVI) in DMF provides ethyl ester (-)-(XVII), which is finally hydrolyzed by means of H2SO4 in H2O.
【1】
Segawa, J.; Matsuoka, M.; Tomii, Y. (Nippon Shinyaku Co., Ltd.); Quinolinecarboxylic acid deriv. and process for producing the same. EP 0675127; WO 9414819 .
|
【2】
Kise, M.; Amimoto, I.; Kitano, M.; Segawa, J.; Tomii, Y.; Matsuoka, M.; Masui, Y.; Synthesis and antibacterial activity of novel 7-substituted-6-fluoro-1-fluoromethyl-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid derivatives. Chem Pharm Bull 1999, 47, 12, 1765. |
【3】
Segawa, J.; Kitano, M.; Kazuno, K.; Matsuoka, M.; Shirahase, I.; Ozaki, M.; Matsuda, M.; Tomii, Y.; Kise, M.; Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1,3]thiazeto[3, 2-a]quinoline-3-carboxylic acids. J Med Chem 1992, 35, 25, 4727. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13451 |
3,4-Difluoroaniline; 3,4-Difluorophenylamine
|
3863-11-4 |
C6H5F2N |
详情 | 详情
|
(II) |
42953 |
3,4-difluorophenylcarbamodithioic acid
|
|
C7H5F2NS2 |
详情 |
详情
|
(III) |
13453 |
1,2-Difluoro-4-isothiocyanatobenzene; 3,4-difluorophenyl isothiocyanate
|
113028-75-4 |
C7H3F2NS |
详情 | 详情
|
(IV) |
42954 |
potassium 1-(3,4-difluoroanilino)-3-ethoxy-2-(ethoxycarbonyl)-3-oxo-1-propene-1-thiolate
|
|
C14H14F2KNO4S |
详情 |
详情
|
(V) |
18319 |
Chloro(methoxy)methane; Chloromethyl methyl ether
|
107-30-2 |
C2H5ClO |
详情 | 详情
|
(VI) |
13455 |
diethyl 2-[(3,4-difluoroanilino)[(methoxymethyl)sulfanyl]methylene]malonate
|
|
C16H19F2NO5S |
详情 |
详情
|
(VII) |
13456 |
ethyl 6,7-difluoro-4-hydroxy-2-[(methoxymethyl)sulfanyl]-3-quinolinecarboxylate
|
|
C14H13F2NO4S |
详情 |
详情
|
(VIII) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(IX) |
42955 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-[(methoxymethyl)sulfanyl]-3-quinolinecarboxylate
|
|
C21H17F2NO5S |
详情 |
详情
|
(X) |
42956 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-sulfanyl-3-quinolinecarboxylate
|
|
C19H13F2NO4S |
详情 |
详情
|
(XI) |
28769 |
1-bromo-2-fluoroethane
|
762-49-2 |
C2H4BrF |
详情 | 详情
|
(XII) |
42957 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-[(2-fluoroethyl)sulfanyl]-3-quinolinecarboxylate
|
|
C21H16F3NO4S |
详情 |
详情
|
(XIII) |
42958 |
ethyl 4-(benzoyloxy)-2-[(1-chloro-2-fluoroethyl)sulfanyl]-6,7-difluoro-3-quinolinecarboxylate
|
|
C21H15ClF3NO4S |
详情 |
详情
|
(XIV) |
42959 |
ethyl 6,7-difluoro-1-(fluoromethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C14H10F3NO3S |
详情 |
详情
|
(XV) |
42971 |
octyl 2-[6,7-difluoro-1-(hydroxymethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinolin-3-yl]acetate
|
|
C21H25F2NO4S |
详情 |
详情
|
(XVI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(XVII) |
42975 |
ethyl (1S)-6-fluoro-1-(fluoromethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C19H21F2N3O3S |
详情 |
详情
|
合成路线35
该中间体在本合成路线中的序号:
(XVI) Alternatively, (-)-(XVII) can be obtained as follows: Treatment of (X) with 1-acetoxy-2-bromoethane (XVIII) in DMF in the presence of NaHCO3 yields derivative (XIX), which is then chlorinated by means of SO2Cl2 in CH2Cl2 to provide (XX). Simultaneous hydrolysis and intramolecular cyclization of (XX) by means of Et3N /H2O in THF affords (XXI), which is then converted into octyl ester derivative (XXII) by treatment with refluxing octanol (A). Resolution of the racemic mixture (XXII) by treatment with Liposyme IM in vinyl acetate followed by chromatographic separation provides alcohol (+)-(XXIII) and acetoxy (-)-(XXIV). Hydrolysis of (-)-(XXIV) with hot H2SO4/EtOH gives alcohol (-)-(XXV), which then reacts with 1-methylpiperazine (XVI) in DMF to yield derivative (-)-(XXVI). Finally, treatment with (diethylamino)sulfur trifluoride (DAST) in CH2Cl2 provides fluoro derivative (-)-(XVII).
Alternatively, (-)-(XXV) can be obtained by conversion of (XXI) into butyl ester (XXVII) by means of refluxing butanol (B), followed by its enantiomer enzymatic resolution with Lipase PL in vinyl acetate and chromatographic separation to afford (+)-(XXVIII) and (-)-(XXIX). Finally, hydrolysis of (-)-(XXIX) with hot H2SO4/EtOH yields (-)-(XXV).
An analogous procedure comprising enantiomer separation and subsequent hydrolysis can be performed from ethyl esters (XX) or (XXI) by treatment with the corresponding lipases in an appropriate solvent.
【1】
Segawa, J.; Matsuoka, M.; Tomii, Y. (Nippon Shinyaku Co., Ltd.); Quinolinecarboxylic acid deriv. and process for producing the same. EP 0675127; WO 9414819 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
24543 |
vinyl acetate
|
108-05-4 |
C4H6O2 |
详情 | 详情
|
(A) |
12970 |
(8R,9S,10R,13S,14R)-14-Hydroxy-3-methoxy-10,13-dimethyl-1,2,7,8,9,10,11,12,13,14,15,16-dodecahydro-17H-cyclopenta[a]phenanthren-17-one
|
|
C20H28O3 |
详情 |
详情
|
(B) |
29766 |
butanol; n-butanol; 1-butanol
|
71-36-3 |
C4H10O |
详情 | 详情
|
(X) |
42956 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-sulfanyl-3-quinolinecarboxylate
|
|
C19H13F2NO4S |
详情 |
详情
|
(XVI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(XVII) |
42975 |
ethyl (1S)-6-fluoro-1-(fluoromethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C19H21F2N3O3S |
详情 |
详情
|
(XVIII) |
33463 |
2-bromoethyl acetate
|
927-68-4 |
C4H7BrO2 |
详情 | 详情
|
(XIX) |
42962 |
ethyl 2-[[2-(acetoxy)ethyl]sulfanyl]-4-(benzoyloxy)-6,7-difluoro-3-quinolinecarboxylate
|
|
C23H19F2NO6S |
详情 |
详情
|
(XX) |
42963 |
ethyl 2-[[2-(acetoxy)-1-chloroethyl]sulfanyl]-4-(benzoyloxy)-6,7-difluoro-3-quinolinecarboxylate
|
|
C23H18ClF2NO6S |
详情 |
详情
|
(XXI) |
42964 |
ethyl 1-[(acetoxy)methyl]-6,7-difluoro-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C16H13F2NO5S |
详情 |
详情
|
(XXII) |
42971 |
octyl 2-[6,7-difluoro-1-(hydroxymethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinolin-3-yl]acetate
|
|
C21H25F2NO4S |
详情 |
详情
|
(XXIII) |
42973 |
octyl 2-[(1R)-6,7-difluoro-1-(hydroxymethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinolin-3-yl]acetate
|
|
C21H25F2NO4S |
详情 |
详情
|
(XXIV) |
42972 |
octyl 2-[(1S)-1-[(acetoxy)methyl]-6,7-difluoro-4-oxo-4H-[1,3]thiazeto[3,2-a]quinolin-3-yl]acetate
|
|
C23H27F2NO5S |
详情 |
详情
|
(XXV) |
42976 |
ethyl (1S)-6,7-difluoro-1-(hydroxymethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C14H11F2NO4S |
详情 |
详情
|
(XXVI) |
42977 |
ethyl (1S)-6-fluoro-1-(hydroxymethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C19H22FN3O4S |
详情 |
详情
|
(XXVII) |
42965 |
butyl 6,7-difluoro-1-(hydroxymethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C16H15F2NO4S |
详情 |
详情
|
(XXVIII) |
42967 |
butyl (1R)-1-[(acetoxy)methyl]-6,7-difluoro-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C18H17F2NO5S |
详情 |
详情
|
(XXIX) |
42966 |
butyl (1S)-6,7-difluoro-1-(hydroxymethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C16H15F2NO4S |
详情 |
详情
|
合成路线36
该中间体在本合成路线中的序号:
(XI) Condensation of benzodiazepinone (IV) with 4-nitrobenzoyl chloride (V) afforded amide (VI), which was alkylated with ethyl bromoacetate in the presence of NaH to give (VII). The nitro group of (VII) was reduced to aniline (VIII) using Fe and AcOH. Subsequent coupling of (VIII) with the acid chloride generated from biphenyl carboxylic acid (III) and oxalyl chloride produced the corresponding amide (IX). The ester group of (IX) was then hydrolyzed with NaOH, and the resulting carboxylic acid (X) was finally condensed with N-methylpiperazine (XI) using 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and 1-hydroxybenzotriazole as the coupling reagents.
【1】
Hosogai, N.; Tanaka, H.; Tomita, M.; Ohkawa, T.; Hemmi, K.; Setoi, H.; Zenkoh, O.; Synthesis and characterization of orally active nonpeptide vasopressin V2 receptor antagonists. Chem Pharm Bull 1999, 47, 4, 501.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
16640 |
Ethyl 2-bromoacetate; Ethyl bromoacetate
|
105-36-2 |
C4H7BrO2 |
详情 | 详情
|
(III) |
16915 |
4'-methyl[1,1'-biphenyl]-2-carboxylic acid
|
7148-03-0 |
C14H12O2 |
详情 | 详情
|
(IV) |
18498 |
1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one
|
|
C9H10N2O |
详情 |
详情
|
(V) |
18941 |
p-nitrobenzoyl chloride; 4-nitrobenzoyl chloride
|
122-04-3 |
C7H4ClNO3 |
详情 | 详情
|
(VI) |
27975 |
5-(4-nitrobenzoyl)-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one
|
|
C16H13N3O4 |
详情 |
详情
|
(VII) |
27976 |
ethyl 2-[5-(4-nitrobenzoyl)-2-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-1-yl]acetate
|
|
C20H19N3O6 |
详情 |
详情
|
(VIII) |
27977 |
ethyl 2-[5-(4-aminobenzoyl)-2-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-1-yl]acetate
|
|
C20H21N3O4 |
详情 |
详情
|
(IX) |
27978 |
ethyl 2-[5-(4-[[(4'-methyl[1,1'-biphenyl]-2-yl)carbonyl]amino]benzoyl)-2-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-1-yl]acetate
|
|
C34H31N3O5 |
详情 |
详情
|
(X) |
27979 |
2-[5-(4-[[(4'-methyl[1,1'-biphenyl]-2-yl)carbonyl]amino]benzoyl)-2-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-1-yl]acetic acid
|
|
C32H27N3O5 |
详情 |
详情
|
(XI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线37
该中间体在本合成路线中的序号:
(IX) The cyclization of 2,5-dimethoxy-1,3,4-trimethylbenzene (I) with 2-bromo-2-methylpropionyl bromide (II) by means of FeCl3 and NaOH in methanol/water gives 5-hydroxy-2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-3-one (III), which is treated with benzyl bromide (IV) and K2CO3 to yield the benzyl ether (V). The reaction of (V) with methylmagnesium bromide, followed by dehydration of the intermediate carbinol affords the methylene derivative (VI), which is hydroxylated with borane / dimethylsulfide and NaOH/H2O2 to furnish the hydroxymethyl compound (VII). The reaction of (VII) with MsCl and TEA gives the mesylate (VIII), which is finally condensed with 1-methylpiperazine (IX) by means of K2CO3 and debenzylated by hydrogenation with H2 over Pd/C in ethanol/HOAc to afford the target compound as a racemic mixture.
【1】
Petty, M.A.; Marciniak, G.; Design and biological evaluation of new antioxidants for use in cerebrovascular disorders. Drugs Fut 1996, 21, 10, 1037.
|
【2】
Ayers, T.A.; Schnettler, R.A.; Marciniak, G.; Krysan, D.J. (Hoechst Marion Roussel Inc.); Novel process for preparing derivatives of 2,2,4,6,7-pentaalkyl-2,2-dihydrobenzofuranols. EP 0813530 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41220 |
1,4-dimethoxy-2,3,5-trimethylbenzene; 4-methoxy-2,3,5-trimethylphenyl methyl ether
|
|
C11H16O2 |
详情 |
详情
|
(II) |
19367 |
2-bromo-2-methylpropanoyl bromide
|
20769-85-1 |
C4H6Br2O |
详情 | 详情
|
(III) |
41221 |
5-hydroxy-2,2,4,6,7-pentamethyl-1-benzofuran-3(2H)-one
|
|
C13H16O3 |
详情 |
详情
|
(IV) |
12912 |
1-(Bromomethyl)benzene; Alpha-bromotoluene
|
100-39-0 |
C7H7Br |
详情 | 详情
|
(V) |
41222 |
5-(benzyloxy)-2,2,4,6,7-pentamethyl-1-benzofuran-3(2H)-one
|
|
C20H22O3 |
详情 |
详情
|
(VI) |
41223 |
5-(benzyloxy)-2,2,4,6,7-pentamethyl-3-methylene-2,3-dihydro-1-benzofuran; benzyl 2,2,4,6,7-pentamethyl-3-methylene-2,3-dihydro-1-benzofuran-5-yl ether
|
|
C21H24O2 |
详情 |
详情
|
(VII) |
30773 |
[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methanol
|
|
C21H26O3 |
详情 |
详情
|
(VIII) |
26455 |
5-(benzyloxy)-2,2,4,6,7-pentamethyl-3-([[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]methyl)-2,3-dihydro-1-benzofuran
|
|
C24H32O3S |
详情 |
详情
|
(IX) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线38
该中间体在本合成路线中的序号:
(IX) The enantiomers of the title product have been obtained by optical resolution of the racemic hydroxymethyl compound (rac)-(VII) by means of "Candida cylindracea" and vinyl acetate to give (S)-(VII) and (R)-(VII). Finally both chiral intermediates are condensed with 1-methylpiperazine (IX) and debenzylated by hydrogenation with H2 over Pd/C in ethanol/HOAc for the racemic mixture (rac)-(VII).
【1】
Petty, M.A.; Marciniak, G.; Design and biological evaluation of new antioxidants for use in cerebrovascular disorders. Drugs Fut 1996, 21, 10, 1037.
|
【2】
Ayers, T.A.; Schnettler, R.A.; Marciniak, G.; Krysan, D.J. (Hoechst Marion Roussel Inc.); Novel process for preparing derivatives of 2,2,4,6,7-pentaalkyl-2,2-dihydrobenzofuranols. EP 0813530 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(rac)-(VII) |
30773 |
[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methanol
|
|
C21H26O3 |
详情 |
详情
|
(S)-(VII) |
41224 |
[(3S)-5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methanol
|
|
C21H26O3 |
详情 |
详情
|
(R)-(VII) |
41225 |
[(3R)-5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methanol
|
|
C21H26O3 |
详情 |
详情
|
(IX) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线39
该中间体在本合成路线中的序号:
(VI) Condensation of ethyl 2,4,5-trifluorobenzoylacetate (I) with triethyl orthoformate in refluxing Ac2O produced the benzoyl ethoxyacrylate (II), which was further condensed with 2-amino-5-fluoropyridine (III) to afford enamine (IV). Cyclization of (IV) in the presence of K2CO3 gave rise to the quinolone (V). The 7-fluoride group of (V) was then displaced by N-methylpiperazine (VI) in cold pyridine to furnish the piperazinyl quinolone (VII). Finally, ester hydrolysis in (VII) under acidic conditions yielded the target compound. In a closely related procedure, ester (V) was hydrolyzed to acid (VIII) using HCl. Subsequent displacement of the 7-fluoride of (VIII) with N-methylpiperazine (VI) provided the desired piperazinyl quinolone.
【1】
Yoon, S.J.; et al.; Synthesis, pharmacokinetics, and biological activity of a series of new pyridonecarboxylic acid antibacterial agents bearing a 5-fluoro-2-pyridyl group or a 3-fluoro-4-pyridyl group at N-1. J Heterocycl Chem 1997, 34, 3, 1021.
|
【2】
Skuballa, W.; Buchmann, B.; Heindl, J.; Frohlich, W.; Ekerdt, R.; Giesen, C. (Schering AG); Leukotriene B4 derivs., methods of preparing them and their use as drugs. EP 0741687; JP 1997511487; WO 9520564 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
55875 |
Ethyl 2,4,5-trifluorobenzoylacetate
|
|
C11H9F3O3 |
详情 |
详情
|
(II) |
55876 |
ethyl (Z)-3-ethoxy-2-(2,4,5-trifluorobenzoyl)-2-propenoate
|
|
C14H13F3O4 |
详情 |
详情
|
(III) |
55877 |
5-fluoro-2-pyridinamine; 5-fluoro-2-pyridinylamine
|
|
C5H5FN2 |
详情 |
详情
|
(IV) |
55878 |
ethyl (Z)-3-[(5-fluoro-2-pyridinyl)amino]-2-(2,4,5-trifluorobenzoyl)-2-propenoate
|
|
C17H12F4N2O3 |
详情 |
详情
|
(V) |
55879 |
ethyl 6,7-difluoro-1-(5-fluoro-2-pyridinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C17H11F3N2O3 |
详情 |
详情
|
(VI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(VII) |
55880 |
ethyl 6-fluoro-1-(5-fluoro-2-pyridinyl)-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C22H22F2N4O3 |
详情 |
详情
|
(VIII) |
55881 |
6,7-difluoro-1-(5-fluoro-2-pyridinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
|
C15H7F3N2O3 |
详情 |
详情
|
合成路线40
该中间体在本合成路线中的序号:
(III) The title compound has been prepared by treatment of carboxylic acid (I) with oxalyl chloride, followed by condensation of the resulting acid chloride (II) with N-methylpiperazine (III).
【1】
Doherty, J.B.; Finke, P.E.; Dorn, C.P.; Maccoss, M.; Durette, P.L.; Mills, S.G.; Shah, S.K.; Lanza, T.J.; Sahoo, S.P.; Hagmann, W.K.; Hale, J.J. (Merck & Co., Inc.); New substd. azetidinones as antiinflammatory and antidegenerative agents. EP 0595557; JP 1994263723; US 5591737; US 5747485; WO 9410142 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
53619 |
4-{[(2S)-1-({[(1R)-1-(1,3-benzodioxol-5-yl)butyl]amino}carbonyl)-3,3-diethyl-4-oxoazetidinyl]oxy}benzoic acid
|
n/a |
C26H30N2O7 |
详情 | 详情
|
(II) |
53620 |
4-{[(2S)-1-({[(1R)-1-(1,3-benzodioxol-5-yl)butyl]amino}carbonyl)-3,3-diethyl-4-oxoazetidinyl]oxy}benzoyl chloride
|
n/a |
C26H29ClN2O6 |
详情 | 详情
|
(III) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线41
该中间体在本合成路线中的序号:
(III) In a different procedure, displacement of the propionate group of azetidinone (IV) by benzyl 4-hydroxybenzoate (V) in the presence of Cs2CO3 afforded the racemic adduct (VI). Subsequent transfer hydrogenolysis of (VI) with cyclohexene and Pd/C provided the carboxylic acid (VII), which was resolved employing (S)-alpha-methylbenzylamine. Alternatively, a kinetic enzymatic resolution of the benzyl ester (VI) was developed. Treatment of ester (VI) with lipase PS-800 provided the desired (S)-acid (VIII), while leaving the unchanged (R)-benzyl ester. Coupling of acid (VIII) with N-methylpiperazine (III) in the presence of DCC and HOBt furnished the corresponding amide (IX).
【1】
Cvetovich, R.J.; et al.; An asymmetric synthesis of L-694,458, a human leukocyte elastase inhibitor, via novel enzyme resolution of beta-lactam esters. J Org Chem 1996, 61, 19, 6575.
|
【2】
Li, H.-Y.; Fortunak, J.M.; Storace, L.; Sheeran, P.J.; Anzalone, L. (DuPont Pharmaceuticals Co.); An efficient process for the preparation of a human leukocyte elastase inhibitor. WO 0012474 .
|
【3】
Amato, J.S.; Cvetovich, R.; Hartner, F.W. (Merck & Co., Inc.); Process for preparing substd. azetidinones. WO 9716448 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(IV) |
53621 |
3,3-diethyl-4-oxo-2-azetidinyl propionate
|
n/a |
C10H17NO3 |
详情 | 详情
|
(V) |
53622 |
4-Hydroxybenzoic acid benzyl ester; Benzyl 4-hydroxybenzoate; Benzyl-p-Hydroxybenzoate; Benzylparaben
|
94-18-8 |
C14H12O3 |
详情 | 详情
|
(VI) |
53623 |
benzyl 4-[(3,3-diethyl-4-oxo-2-azetidinyl)oxy]benzoate
|
n/a |
C21H23NO4 |
详情 | 详情
|
(VII) |
53624 |
4-[(3,3-diethyl-4-oxo-2-azetidinyl)oxy]benzoic acid
|
n/a |
C14H17NO4 |
详情 | 详情
|
(VIII) |
53625 |
4-{[(2S)-3,3-diethyl-4-oxoazetidinyl]oxy}benzoic acid
|
n/a |
C14H17NO4 |
详情 | 详情
|
(IX) |
53626 |
(4S)-3,3-diethyl-4-{4-[(4-methyl-1-piperazinyl)carbonyl]phenoxy}-2-azetidinone
|
n/a |
C19H27N3O3 |
详情 | 详情
|
合成路线42
该中间体在本合成路线中的序号:
(III) In a further procedure, 4-hydroxybenzoic acid (XIX) was converted to amide (XXII) via formation of the mixed anhydride-ester (XX) with pivaloyl chloride, followed by coupling with N-methylpiperazine (III) and alcoholysis of the resultant amide-ester (XXI) or, alternatively, by direct coupling of acid (XIX) with piperazine (III) in the presence of DCC. The propionate group of azetidinone (IV) was then displaced by the 4-hydroxybenzamide (XXII) to give the racemic adduct (XXIII). Resolution of (XXIII) by means of (-)-diisopropylidene ketogulonic acid (DAG) provided the desired enantiomer (IX), which was finally converted into the title compound by condensation with isocyanate (XVIII) in the presence of DBU in acetonitrile.
【1】
Storace, L.; et al.; An efficient large-scale process for the human leukocyte elastase inhibitor, DMP 777. Org Process Res Dev 2002, 6, 1, 54.
|
【2】
Li, H.-Y.; Fortunak, J.M.; Storace, L.; Sheeran, P.J.; Anzalone, L. (DuPont Pharmaceuticals Co.); An efficient process for the preparation of a human leukocyte elastase inhibitor. WO 0012474 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(IV) |
53621 |
3,3-diethyl-4-oxo-2-azetidinyl propionate
|
n/a |
C10H17NO3 |
详情 | 详情
|
(IX) |
53626 |
(4S)-3,3-diethyl-4-{4-[(4-methyl-1-piperazinyl)carbonyl]phenoxy}-2-azetidinone
|
n/a |
C19H27N3O3 |
详情 | 详情
|
(XVIII) |
53632 |
5-[(1R)-1-isocyanatobutyl]-1,3-benzodioxole; (1R)-1-(1,3-benzodioxol-5-yl)butyl isocyanate
|
n/a |
C12H13NO3 |
详情 | 详情
|
(XIX) |
28205 |
4-hydroxybenzoic acid
|
99-96-7 |
C7H6O3 |
详情 | 详情
|
(XX) |
53634 |
1,1-dimethylpropanoic 4-[(2,2-dimethylpropanoyl)oxy]-1-benzenecarboxylic anhydride
|
n/a |
C17H22O5 |
详情 | 详情
|
(XXI) |
53635 |
4-[(4-methyl-1-piperazinyl)carbonyl]phenyl pivalate
|
n/a |
C17H24N2O3 |
详情 | 详情
|
(XXII) |
53633 |
(4-hydroxyphenyl)(4-methyl-1-piperazinyl)methanone
|
n/a |
C12H16N2O2 |
详情 | 详情
|
(XXIII) |
53636 |
3,3-diethyl-4-{4-[(4-methyl-1-piperazinyl)carbonyl]phenoxy}-2-azetidinone
|
n/a |
C19H27N3O3 |
详情 | 详情
|
合成路线43
该中间体在本合成路线中的序号:
(X) Condensation of 2-chloronitrobenzene (I) with 2-hydroxy-4-methoxybenzaldehyde (II) by means of Cu/KOH in refluxing DMF provides derivative (III), which is then oxidized with KMnO4 in pyridine/H2O to afford carboxylic acid (IV). Reduction of the nitro moiety of (IV) by hydrogenation over Pd/C yields amine (V), which is then cyclized at high temperatures to furnish the dibenzo[b,f][1,4]oxazepinone intermediate (VI) (1). O-Demethylation of (VI) by treatment with AlCl3 in ethylmercaptan (EtSH) gives hydroxy derivative (VII), which then reacts with triflic anhydride in CH2Cl2 in the presence of Et3N to provide compound (VIII). Treatment of (VIII) with POCl3 in refluxing toluene in the presence of N,N-dimethylaniline yields chloro derivative (IX), which is finally condensed with N-methylpiperazine (X) in refluxing toluene to give the desired product.
【1】
Wikstrom, H.; Liao, Y.; Venhuis, B.J.; Rodenhuis, N.; Timmerman, W.; New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: Chemistry and pharmacological evaluation. J Med Chem 1999, 42, 12, 2235.
|
【2】
De Boer, P.; Liao, Y.; Wikstrom, H.; New sulfone ester analogues of iso-clozapine and related structures: Atypical neuroleptics. WO 9629316 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15248 |
1-chloro-2-nitrobenzene
|
88-73-3 |
C6H4ClNO2 |
详情 | 详情
|
(II) |
29301 |
2-hydroxy-5-methoxybenzaldehyde
|
672-13-9 |
C8H8O3 |
详情 | 详情
|
(III) |
45965 |
5-methoxy-2-(2-nitrophenoxy)benzaldehyde
|
|
C14H11NO5 |
详情 |
详情
|
(IV) |
45966 |
5-methoxy-2-(2-nitrophenoxy)benzoic acid
|
|
C14H11NO6 |
详情 |
详情
|
(V) |
45967 |
2-(2-aminophenoxy)-5-methoxybenzoic acid
|
|
C14H13NO4 |
详情 |
详情
|
(VI) |
45968 |
2-methoxydibenzo[b,f][1,4]oxazepin-11(10H)-one
|
|
C14H11NO3 |
详情 |
详情
|
(VII) |
45969 |
2-hydroxydibenzo[b,f][1,4]oxazepin-11(10H)-one
|
|
C13H9NO3 |
详情 |
详情
|
(VIII) |
45970 |
11-oxo-10,11-dihydrodibenzo[b,f][1,4]oxazepin-2-yl trifluoromethanesulfonate
|
|
C14H8F3NO5S |
详情 |
详情
|
(IX) |
45971 |
11-chlorodibenzo[b,f][1,4]oxazepin-2-yl trifluoromethanesulfonate
|
|
C14H7ClF3NO4S |
详情 |
详情
|
(X) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线44
该中间体在本合成路线中的序号:
(III) 2-(2-Naphthyl)acetic acid (I) is activated as the corresponding acid chloride (II) upon refluxing with SOCl2. Subsequent condensation of acid chloride (II) with N-methyl piperazine (III) affords the title amide.
【1】
Hayes, E.S. (Cardiome Pharma Corp.); Serotonin ligands as pro-erectile cpds.. WO 0028993 .
|
【2】
Zolotoy, A.B.; Hayes, E.S. (Cardiome Pharma Corp.); Aroylpiperazines for modulating sexual activity. WO 9902159 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
50657 |
2-Naphthylacetic acid; beta-Naphthylacetic acid
|
581-96-4 |
C12H10O2 |
详情 | 详情
|
(II) |
13970 |
2-(2-Naphthyl)acetyl chloride
|
|
C12H9ClO |
详情 |
详情
|
(III) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线45
该中间体在本合成路线中的序号:
(XV) The reaction of 4-bromothiophene-2-carbaldehyde (I) with triethyl orthoformate gives the corresponding acetal (II), which is treated with NaOMe, CuO and KI in hot methanol yielding 5-methoxythiophene-2-carbaldehyde diethylacetal (III). The hydrolysis of (III) with HCl in methanol affords the carbaldehyde (IV), which is condensed with the phosphonate (V) by means of NaH in THF to provide the ethyl acrylate (VI). The hydrolysis of (VI) with KOH in methanol gives the acrylic acid (VII), which is esterified with 4-nitrophenol, TEA and 2-chloro-1-methylpyridinium iodide in dichloromethane yielding the activate ester (VIII). The condensation of (VIII) with the tetracyclic ketone (IX) (obtained by treatment of the dimeric ketonic compound (X) with NaOMe in methanol) affords the adduct (XI), which is treated with HBr in acetonitrile to open the cyclopropane ring and provide the bromomethyl compound (XII). The aromatization of (XII) with p-nitrophenyl chloroformate (XIII) and TEA in dichloromethane affords the activated carbonate ester (XIV), which is finally treated with 1-methylpiperazine (XV) to furnish the target carbamate.
【1】
Saito, H.; Kobayashi, E.; Gomi, K.; Okamoto, A.; Nagamura, S.; Amishiro, N.; Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing 5-membered heteroarylacryloyl groups. Chem Pharm Bull 1999, 47, 10, 1393.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11236 |
4-Nitrophenol; p-Nitrophenol
|
100-02-7 |
C6H5NO3 |
详情 | 详情
|
(I) |
24142 |
4-bromo-2-thiophenecarbaldehyde
|
18791-75-8 |
C5H3BrOS |
详情 | 详情
|
(II) |
38358 |
(4-bromo-2-thienyl)(ethoxy)methyl ethyl ether; 4-bromo-2-(diethoxymethyl)thiophene
|
|
C9H13BrO2S |
详情 |
详情
|
(III) |
38359 |
5-(diethoxymethyl)-3-thienyl methyl ether; 2-(diethoxymethyl)-4-methoxythiophene
|
|
C10H16O3S |
详情 |
详情
|
(IV) |
35360 |
|
|
C47H75N3O14 |
详情 |
详情
|
(V) |
38361 |
ethyl 2-(dimethoxyphosphoryl)acetate
|
|
C6H13O5P |
详情 |
详情
|
(VI) |
38362 |
ethyl (E)-3-(4-methoxy-2-thienyl)-2-propenoate
|
|
C10H12O3S |
详情 |
详情
|
(VII) |
38363 |
(E)-3-(4-methoxy-2-thienyl)-2-propenoic acid
|
|
C8H8O3S |
详情 |
详情
|
(VIII) |
38364 |
4-nitrophenyl (E)-3-(4-methoxy-2-thienyl)-2-propenoate
|
|
C14H11NO5S |
详情 |
详情
|
(IX) |
38365 |
methyl (3bR,4aS)-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate
|
|
C14H14N2O3 |
详情 |
详情
|
(X) |
38366 |
methyl (2R,3bR,4aS)-2-methyl-3,8-dioxo-6-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]-1,2,3,4,4a,5,6,8-octahydrocyclopropa[c]pyrrolo[3,2-e]indole-2-carboxylate
|
|
C26H25N3O8 |
详情 |
详情
|
(XI) |
38367 |
methyl (3bR,4aS)-6-[(E)-3-(4-methoxy-2-thienyl)-2-propenoyl]-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate
|
|
C22H20N2O5S |
详情 |
详情
|
(XII) |
38368 |
methyl (8S)-8-(bromomethyl)-6-[(E)-3-(4-methoxy-2-thienyl)-2-propenoyl]-2-methyl-4-oxo-3,4,6,7,8,8a-hexahydropyrrolo[3,2-e]indole-1-carboxylate
|
|
C22H21BrN2O5S |
详情 |
详情
|
(XIII) |
16605 |
4-Nitrophenyl chloroformate; 1-[(Chlorocarbonyl)oxy]-4-nitrobenzene
|
7693-46-1 |
C7H4ClNO4 |
详情 | 详情
|
(XIV) |
38369 |
methyl (8S)-8-(bromomethyl)-6-[(E)-3-(4-methoxy-2-thienyl)-2-propenoyl]-2-methyl-4-[[(4-nitrophenoxy)carbonyl]oxy]-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate
|
|
C29H24BrN3O9S |
详情 |
详情
|
(XV) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线46
该中间体在本合成路线中的序号:
(XII) Friedel-Crafts acetylation of 4-chlorothioanisole (I) gave acetophenone (II), which was then brominated to afford the corresponding bromoketone (III). Further reaction of (III) with hexamethylenetetramine, followed by acid hydrolysis yielded the aminoketone (IV). The Clauson-Kaas reaction of amine (IV) with 2,5-dimethoxytetrahydrofuran (V) in the presence of AcOH-AcONa provided pyrrole (VI), and then the thioether function of (VI) was oxidized to sulfoxide (VII) with sodium periodate. The subsequent Pummerer cyclization using trifluoroacetic anhydride produced an intermediate tricyclic sulfonium salt (VIII) that, upon losing a methyl group, yielded the pyrrolobenzothiazepine (IX). Reduction of the ketone function of (IX) to alcohol (X) with NaBH4, followed by treatment with PBr3, furnished bromide (XI). Finally, displacement of the bromide of (XI) at 130 C with N-methylpiperazine (XII) provided the title compound, which was isolated as the dihydrochloride salt on treating with methanolic HCl.
【1】
Campiani, G.; Nacci, V.; Bechelli, S.; Ciani, S.M.; Garofalo, A.; Fiorini, I.; Wikstrom, H.; de Boer, P.; Liao, Y.; Tepper, P.G.; Cagnotto, A.; Mennini, T.; New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure. J Med Chem 1998, 41, 20, 3763. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20423 |
4-chlorophenyl methyl sulfide; 1-chloro-4-(methylsulfanyl)benzene
|
123-09-1 |
C7H7ClS |
详情 | 详情
|
(II) |
20424 |
1-[5-chloro-2-(methylsulfanyl)phenyl]-1-ethanone
|
|
C9H9ClOS |
详情 |
详情
|
(III) |
20425 |
2-bromo-1-[5-chloro-2-(methylsulfanyl)phenyl]-1-ethanone
|
|
C9H8BrClOS |
详情 |
详情
|
(IV) |
20426 |
2-amino-1-[5-chloro-2-(methylsulfanyl)phenyl]-1-ethanone
|
|
C9H10ClNOS |
详情 |
详情
|
(V) |
12132 |
2,5-Dimethoxytetrahydrofuran; 5-Methoxytetrahydro-2-furanyl methyl ether
|
696-59-3 |
C6H12O3 |
详情 | 详情
|
(VI) |
20428 |
1-[5-chloro-2-(methylsulfanyl)phenyl]-2-(1H-pyrrol-1-yl)-1-ethanone
|
|
C13H12ClNOS |
详情 |
详情
|
(VII) |
20429 |
1-[5-chloro-2-(methylsulfinyl)phenyl]-2-(1H-pyrrol-1-yl)-1-ethanone
|
|
C13H12ClNO2S |
详情 |
详情
|
(VIII) |
20430 |
7-chloro-4-methyl-9-oxo-9,10-dihydropyrrolo[2,1-b][1,3]benzothiazepin-4-ium
|
|
C13H11ClNOS |
详情 |
详情
|
(IX) |
20431 |
7-chloropyrrolo[2,1-b][1,3]benzothiazepin-9(10H)-one
|
|
C12H8ClNOS |
详情 |
详情
|
(X) |
20432 |
7-chloro-9,10-dihydropyrrolo[2,1-b][1,3]benzothiazepin-9-ol
|
|
C12H10ClNOS |
详情 |
详情
|
(XI) |
20433 |
9-bromo-7-chloro-9,10-dihydropyrrolo[2,1-b][1,3]benzothiazepine
|
|
C12H9BrClNS |
详情 |
详情
|
(XII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线47
该中间体在本合成路线中的序号:
(XV) The reaction of 2-chloropyrimidine (I) with NaOMe in methanol gives 2-methoxypyrimidine (II), which is iodinated with N-iodosuccinimide (NIS) and trifluoroacetic anhydride in refluxing THF to yield 5-iodo-2-methoxypyrimidine (III). The condensation of (III) with methyl acrylate (IV) by means of Pd(OAc)2, K2CO3 and Bu4NCl at 120 C affords 3-(2-methoxypyrimidin-5-yl)acrylic acid methyl ester (V), which is hydrolyzed with KOH in methanol to provide the free acid (VI). The esterification of (VI) with p-nitrophenol (VII) by means of DCC and DMAP in dichloromethane gives the activate ester (VIII). The condensation of (VIII) with the tetracyclic ketone (IX) (obtained by treatment of the dimeric ketonic compound (X) with NaOMe in methanol) affords the adduct (XI), which is treated with HBr in acetonitrile to open the cyclopropane ring and provide the bromomethyl compound (XII). The aromatization of (XII) with p-nitrophenyl chloroformate (XIII) and TEA in dichloromethane affords the activated carbonate ester (XIV), which is finally treated with 1-methylpiperazine (XV) to furnish the target carbamate.
【1】
Nagamura, S.; et al.; Synthesis and antitumor activity of duocarmycin derivatives: Modification of affinity moiety to DNA minor groove. 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst MEDI 206.
|
【2】
Saito, H.; Nagamura, S.; Amishiro, N.; Kobayashi, E.; Gomi, K.; New water-soluble duocarmycin derivatives: Synthesis and antitumor activity of A-ring pyrrole compounds bearing beta-heteroarylacryloyl groups. J Med Chem 1999, 42, 4, 669.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11191 |
2-Chloropyrimidine
|
1722-12-9 |
C4H3ClN2 |
详情 | 详情
|
(II) |
38398 |
methyl 2-pyrimidinyl ether; 2-methoxypyrimidine
|
|
C5H6N2O |
详情 |
详情
|
(III) |
38394 |
5-iodo-2-methoxypyrimidine; 5-iodo-2-pyrimidinyl methyl ether
|
|
C5H5IN2O |
详情 |
详情
|
(IV) |
14156 |
methyl acrylate
|
96-33-3 |
C4H6O2 |
详情 | 详情
|
(V) |
38395 |
methyl (E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoate
|
|
C9H10N2O3 |
详情 |
详情
|
(VI) |
38396 |
(E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoic acid
|
|
C8H8N2O3 |
详情 |
详情
|
(VII) |
11236 |
4-Nitrophenol; p-Nitrophenol
|
100-02-7 |
C6H5NO3 |
详情 | 详情
|
(VIII) |
38397 |
4-nitrophenyl (E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoate
|
|
C14H11N3O5 |
详情 |
详情
|
(IX) |
38365 |
methyl (3bR,4aS)-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate
|
|
C14H14N2O3 |
详情 |
详情
|
(X) |
38366 |
methyl (2R,3bR,4aS)-2-methyl-3,8-dioxo-6-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]-1,2,3,4,4a,5,6,8-octahydrocyclopropa[c]pyrrolo[3,2-e]indole-2-carboxylate
|
|
C26H25N3O8 |
详情 |
详情
|
(XI) |
38399 |
methyl (3bR,4aS)-6-[(E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoyl]-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate
|
|
C22H20N4O5 |
详情 |
详情
|
(XII) |
38400 |
methyl (8S)-8-(bromomethyl)-6-[(E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoyl]-2-methyl-4-oxo-3,4,6,7,8,8a-hexahydropyrrolo[3,2-e]indole-1-carboxylate
|
|
C22H21BrN4O5 |
详情 |
详情
|
(XIII) |
16605 |
4-Nitrophenyl chloroformate; 1-[(Chlorocarbonyl)oxy]-4-nitrobenzene
|
7693-46-1 |
C7H4ClNO4 |
详情 | 详情
|
(XIV) |
38401 |
methyl (8S)-8-(bromomethyl)-6-[(E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoyl]-2-methyl-4-[[(4-nitrophenoxy)carbonyl]oxy]-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate
|
|
C29H24BrN5O9 |
详情 |
详情
|
(XV) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线48
该中间体在本合成路线中的序号:
(IX) Catalytic hydrogenation of 1-acetyl-6-nitroindoline (V) afforded amine (VI). Condensation of (VI) with mechlorethamine hydrochloride (VIII) in the presence of K2CO3 in refluxing n-butanol produced piperazinylindoline (X). Alternatively, intermediate (X) was obtained by Sandmeyer reaction of amine (VI) in the presence of CuBr, followed by condensation of the resulting bromide (VII) with N-methylpiperazine (IX). Chlorination of (X) with N-chlorosuccinimide provided (XI). The acetamide function of (XI) was then hydrolyzed in refluxing 2M HCl to give amine (XII). Finally, coupling of (XII) with isocyanate (IV) gave rise to the corresponding urea.
【1】
Evans, M.; Gaster, L.M.; Gordon, l.; et al.; Mixed 5-HT1A/1B/1D receptor antagonists as novel antidepressants. 16th Int Symp Med Chem (Sept 18 2000, Bologna) 2000, Abst PB-77.
|
【2】
Gaster, L.M.; Rami, H.K.; Wyman, P.A. (SmithKline Beecham plc); Indole derivs. having combined 5HT1A, 5HT1B and 5HT1D receptor antagonist activity. EP 0975593; WO 9850358 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
44709 |
4-(4-pyridinyl)-1-naphthyl isocyanate; 4-(4-isocyanato-1-naphthyl)pyridine
|
|
C16H10N2O |
详情 |
详情
|
(V) |
44710 |
1-(6-nitro-2,3-dihydro-1H-indol-1-yl)-1-ethanone
|
|
C10H10N2O3 |
详情 |
详情
|
(VI) |
44711 |
1-(6-amino-2,3-dihydro-1H-indol-1-yl)-1-ethanone
|
|
C10H12N2O |
详情 |
详情
|
(VII) |
44712 |
1-(6-bromo-2,3-dihydro-1H-indol-1-yl)-1-ethanone
|
|
C10H10BrNO |
详情 |
详情
|
(VIII) |
44713 |
2-chloro-N-(2-chloroethyl)-N-methyl-1-ethanamine; N,N-bis(2-chloroethyl)-N-methylamine
|
|
C5H11Cl2N |
详情 |
详情
|
(IX) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(X) |
44714 |
1-[6-(4-methyl-1-piperazinyl)-2,3-dihydro-1H-indol-1-yl]-1-ethanone
|
|
C15H21N3O |
详情 |
详情
|
(XI) |
44715 |
1-[5-chloro-6-(4-methyl-1-piperazinyl)-2,3-dihydro-1H-indol-1-yl]-1-ethanone
|
|
C15H20ClN3O |
详情 |
详情
|
(XII) |
44716 |
5-chloro-6-(4-methyl-1-piperazinyl)indoline
|
|
C13H18ClN3 |
详情 |
详情
|
合成路线49
该中间体在本合成路线中的序号:
(II) Title compound was synthesized by condensation of ethyl 6-fluoro-4-quinolone-3-carboxylate (I) with N-methylpiperazine (II) in pyridine at 120 C under pressure.
【1】
Srivastava S; Srivastava, S.K.; Shukla, A.; Chauhan, P.M.; Puri, S.K.; Bhaduri, A.P.; Pandey, V.C.; Synthesis and methemoglobin toxicity of the amides of 6/7 mono or disubstituted quinolone. Bioorg Med Chem Lett 1999, 9, 1, 25.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19903 |
ethyl 6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C12H10FNO3 |
详情 |
详情
|
(II) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线50
该中间体在本合成路线中的序号:
(II) Title compound was synthesized by condensation of ethyl 7-chloro-6-fluoro-4-quinolone-3-carboxylate (I) with N-methylpiperazine (II) in pyridine at 120 C under pressure.
【1】
Srivastava S; Srivastava, S.K.; Shukla, A.; Chauhan, P.M.; Puri, S.K.; Bhaduri, A.P.; Pandey, V.C.; Synthesis and methemoglobin toxicity of the amides of 6/7 mono or disubstituted quinolone. Bioorg Med Chem Lett 1999, 9, 1, 25.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19904 |
ethyl 7-chloro-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
|
|
C12H9ClFNO3 |
详情 |
详情
|
(II) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线51
该中间体在本合成路线中的序号:
(VI) Friedel-Crafts acylation of chlorobenzene (I) with levulinic acid chloride (II) afforded diketone (III), which was converted to pyrrole (V) by condensation with 4-chloroaniline (IV) in the presence of a catalytic amount of HBr. Mannich reaction of (V) with formaldehyde and N-methylpiperazine (VI) then provided the target aminomethyl pyrrole.
【1】
Retico, A.; Cerreto, F.; Scalzo, M.; Villa, A.; Studies on anti-Candida agents with a pyrrole moiety. Synthesis and microbiological activity of some 3-aminomethyl-1,5-diaryl-2-methyl-pyrrole derivatives. Eur J Med Chem 1992, 27, 7, 701.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10190 |
1-Chlorobenzene
|
108-90-7 |
C6H5Cl |
详情 | 详情
|
(II) |
28526 |
4-oxopentanoyl chloride
|
|
C5H7ClO2 |
详情 |
详情
|
(III) |
28527 |
1-(4-chlorophenyl)-1,4-pentanedione
|
|
C11H11ClO2 |
详情 |
详情
|
(IV) |
12034 |
4-Chlorophenylamine; 4-Chloroaniline; p-Chloroaniline
|
106-47-8 |
C6H6ClN |
详情 | 详情
|
(V) |
28528 |
1,2-bis(4-chlorophenyl)-5-methyl-1H-pyrrole
|
|
C17H13Cl2N |
详情 |
详情
|
(VI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线52
该中间体在本合成路线中的序号:
(IV) The condensation of 4-chloro-2-(2-naphthyl)quinoline (I) with p-aminophenol (II) at 130 C provided the corresponding 4-anilinoquinoline (III). Then, Mannich reaction of (III) with N-methylpiperazine (IV) and formaldehyde furnished the title compound.
【1】
Kotecka, B.M.; Strekowski, L.; Say, M.; Manzel, L.; Henary, M.; Zegrocka, O.; Macfarlane, D.E.; Mokrosz, M.J.; Structure-activity relationship analysis of substituted 4-quinolinamines, antagonists of immunostimulatory CpG-oligodeoxynucleotides. Bioorg Med Chem Lett 1999, 9, 13, 1819. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34398 |
4-chloro-2-(2-naphthyl)quinoline
|
|
C19H12ClN |
详情 |
详情
|
(II) |
15715 |
4-Aminophenol
|
123-30-8 |
C6H7NO |
详情 | 详情
|
(III) |
34399 |
4-[[2-(2-naphthyl)-4-quinolinyl]amino]phenol
|
|
C25H18N2O |
详情 |
详情
|
(IV) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线53
该中间体在本合成路线中的序号:
(XI) Horner-Emmons condensation of 1-naphthaldehyde (VI) with triethyl phosphonoacetate (VII) using DBU as the base afforded naphthylacrylate (VIII). This was reacted with tosylmethylisocyanide and potassium tert-butoxide to produce pyrrole (IX). Hydrolysis of the ester group of (IX) with KOH gave rise to the carboxylic acid (X), which was coupled with N-methylpiperazine (XI) employing EDC and HOBt or, alternatively, by previous conversion to the corresponding acid chloride with SOCl2. The resulting amide (XII) was finally alkylated at the pyrrole N atom with chloride (V) in the presence of NaH.
【1】
Lee, J.; Lee, H.; Shin, Y.; et al.; Synthesis and structure-activity relationships of 1-(1(3)H-imidazole-5(4)-yl)-methylpyrroles as farnesyl protein transferase inhibitors (FTPI). 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst MEDI 210.
|
【2】
Lee, J.H.; Yoo, J.K.; Koh, J.S.; Choi, T.S.; Shin, Y.S.; Kim, K.H.; Jung, W.H.; Kim, J.H.; Lee, S.H.; Ahn, I.A.; Ro, S.G.; Lee, H.I.; Kim, H.S.; Chung, H.H.; Jeong, S.W.; Kwak, T.H. (LG Chem Ltd.); Imidazole derivs. having an inhibitory activity for farnesyl transferase and process for preparation thereof. WO 9928315 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
33672 |
1-(1,3-benzodioxol-5-ylmethyl)-5-(chloromethyl)-1H-imidazole
|
|
C12H11ClN2O2 |
详情 |
详情
|
(VI) |
12314 |
1-Naphthaldehyde
|
66-77-3 |
C11H8O |
详情 | 详情
|
(VII) |
10019 |
Ethyl 2-(diethoxyphosphoryl)acetate; Triethyl phosphonoacetate
|
867-13-0 |
C8H17O5P |
详情 | 详情
|
(VIII) |
25405 |
ethyl (E)-3-(1-naphthyl)-2-propenoate
|
|
C15H14O2 |
详情 |
详情
|
(IX) |
33673 |
ethyl 4-(1-naphthyl)-1H-pyrrole-3-carboxylate
|
|
C17H15NO2 |
详情 |
详情
|
(X) |
33674 |
4-(1-naphthyl)-1H-pyrrole-3-carboxylic acid
|
|
C15H11NO2 |
详情 |
详情
|
(XI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(XII) |
33675 |
(4-methyl-1-piperazinyl)[4-(1-naphthyl)-1H-pyrrol-3-yl]methanone
|
|
C20H21N3O |
详情 |
详情
|
合成路线54
该中间体在本合成路线中的序号:
(IV) The esterification of (rac)-6-(5-chloro-3-pyridyl)-5-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-7-one rac-(I) with vinyl chloroformate (II) in pyridine gives the racemic carbonate rac-(III), which is submitted to an enantioselective hydrolysis with Candida antarctica (SP 435L) lipase in dioxane/benzyl alcohol yielding a mixture of rac-(I), which is recycled, and enantiomerically pure (95% e.e.) (S)-(III). Finally, this compound is condensed with 1-methylpiperazine (IV) in acetone.
【1】
Culy, C.; Castañer, J.; Bayes, M.; Eszopiclone. Drugs Fut 2003, 28, 7, 640.
|
【2】
Cotrel, C.; Roussel, G. (Aventis Pharma SA); Optically active deriv. of 5H-pyrrolo[3,4-b]pyrazine, its preparation and pharmaceutical compsns. containing it. EP 0495717; EP 0609210; FR 2671800; JP 1994504548; WO 9212980 .
|
【3】
Gotor, V.; et al.; Enzymic resolution of (±)-6-(5-chloropyridin-2-yl)-7-vinyloxycarbonyloxy-6,7-dihydro[5H] pyrrolo[3,4-b]pyrazin-5-one. Synthesis of (+)-zopiclone. Tetrahedron Asymmetry 1997, 8, 7, 995. |
【4】
Bayod Jasanada, M.S.; Brieva Collado, R.; Linares López, F.J.; García Campos, R.; Gotor Santamaría, V. (Asturpharma SA); (+)-6-(5-Chloropyrid-2-yl)-7-oxo-vinylcarbonyloxy-5,6-dihydropyrrolo[3,4b]pyrazine and their use in a process for the preparation of (+)-6-(5-chloropyrid-2-yl)-5-(4-methylpiperazin-1-yl)-carbonyloxy-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine. ES 2101653 . |
【5】
Cotrel, C.; et al. (Aventis Pharma SA); Pyrrolo-[3,4,b]pyrazine derivatives. DE 2300491; GB 1358680; JP 52048687; US 3862149 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
rac-(I) |
32796 |
6-(5-chloro-2-pyridinyl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
|
|
C11H7ClN4O2 |
详情 |
详情
|
(S)-(III) |
32797 |
6-(5-chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl vinyl carbonate
|
|
C14H9ClN4O4 |
详情 |
详情
|
rac-(III) |
32798 |
(5S)-6-(5-chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl vinyl carbonate
|
|
C14H9ClN4O4 |
详情 |
详情
|
(II) |
28068 |
1-[(Chlorocarbonyl)oxy]ethylene; Vinyl chloroformate
|
5130-24-5 |
C3H3ClO2 |
详情 | 详情
|
(IV) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线55
该中间体在本合成路线中的序号:
(IV) The esterification of (rac)-6-(5-chloro-3-pyridyl)-5-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-7-one rac-(I) with chloromethyl chloroformate (V) in pyridine gives the racemic carbonate rac-(III), which is submitted to an enantioselective hydrolysis with Candida antarctica (SP 435L) lipase in dioxane/benzyl alcohol yielding a mixture of rac-(I), which is recycled, and enantiomerically pure (96% e.e.) (S)-(III). Finally, this compound is condensed with 1-methylpiperazine (IV) in acetone.
【1】
Culy, C.; Castañer, J.; Bayes, M.; Eszopiclone. Drugs Fut 2003, 28, 7, 640.
|
【2】
Solares, L.F.; Diaz, M.; Brieva, R.; Sanchez, V.M.; Bayod, M.; Gotor, V.; Enzymatic resolution of new carbonate intermediates for the synthesis of (S)-(+)-zopiclone. Tetrahedron Asymmetry 2002, 13, 23, 2577.
|
【3】
Gotor, V.; et al.; Enzymic resolution of (±)-6-(5-chloropyridin-2-yl)-7-vinyloxycarbonyloxy-6,7-dihydro[5H] pyrrolo[3,4-b]pyrazin-5-one. Synthesis of (+)-zopiclone. Tetrahedron Asymmetry 1997, 8, 7, 995. |
【4】
Cotrel, C.; et al. (Aventis Pharma SA); Pyrrolo-[3,4,b]pyrazine derivatives. DE 2300491; GB 1358680; JP 52048687; US 3862149 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
rac-(I) |
32796 |
6-(5-chloro-2-pyridinyl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
|
|
C11H7ClN4O2 |
详情 |
详情
|
rac-(III) |
62951 |
chloromethyl 6-(5-chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl carbonate
|
|
C13H8Cl2N4O4 |
详情 |
详情
|
(S)-(III) |
62952 |
chloromethyl (5S)-6-(5-chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl carbonate
|
|
C13H8Cl2N4O4 |
详情 |
详情
|
(IV) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(V) |
19249 |
Chloromethyl chloroformate; Chloro[(chlorocarbonyl)oxy]methane
|
22128-62-7 |
C2H2Cl2O2 |
详情 | 详情
|
合成路线56
该中间体在本合成路线中的序号:
(V) The condensation of ethyl 2-aminobenzo[b]thiophene-3-carboxylate (I) with 2,4-difluoronitrobenzene (II) afforded the diaryl amine (III). The nitro group of (III) was then reduced to amine (IV) by catalytic hydrogenation over Pd/C. Then, cyclization of amino ester (IV) with N-methylpiperazine (V) using TiCl4 in hot anisole produced the target benzothienobenzodiazepine, which was finally isolated as the corresponding maleate salt.
【1】
Fujimura, M.; Horiuchi, H.; Tanaka, H.; Kohara, T.; Hashimoto, K.; Kimura, K.; Seio, K.; Yasumatsu, H. (Welfide Corporation); Fused thiophene cpds. and medicinal use thereof. EP 1016664; JP 2001072684; WO 9911647 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46396 |
ethyl 2-amino-1-benzothiophene-3-carboxylate
|
|
C11H11NO2S |
详情 |
详情
|
(II) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(III) |
46397 |
ethyl 2-(5-fluoro-2-nitroanilino)-1-benzothiophene-3-carboxylate
|
|
C17H13FN2O4S |
详情 |
详情
|
(IV) |
46398 |
ethyl 2-(2-amino-5-fluoroanilino)-1-benzothiophene-3-carboxylate
|
|
C17H15FN2O2S |
详情 |
详情
|
(V) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线57
该中间体在本合成路线中的序号:
(V) In a related procedure, the condensation of 2-aminobenzo[b]thiophene-3-carbonitrile (VI) with 2,4-difluoronitrobenzene (II) produced the diaryl amine (VII). Reduction of the nitro group of (VII) using sodium hydrosulfite yielded diamine (VIII). Subsequent cyclization of amino nitrile (VIII) upon acidic treatment gave rise to the tetracyclic system (IX). This was then treated with refluxing N-methylpiperazine (V) to provide the title compound.
【2】
Fujimura, M.; Horiuchi, H.; Tanaka, H.; Kohara, T.; Hashimoto, K.; Kimura, K.; Seio, K.; Yasumatsu, H. (Welfide Corporation); Fused thiophene cpds. and medicinal use thereof. EP 1016664; JP 2001072684; WO 9911647 .
|
【1】
Horiuchi, H.; Kimura, K.; Tanaka, H.; et al.; Y-931, a novel antipsychotic with potential anti-NRH (NMDA receptor-hypofunction) activity: Synthesis and structure-activity relationships of 6H-[1]benzothieno[2,3-b][1,5]benzodiazepines. 16th Int Symp Med Chem (Sept 18 2000, Bologna) 2000, Abst PB-128. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(V) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(VI) |
46399 |
2-amino-1-benzothiophene-3-carbonitrile
|
|
C9H6N2S |
详情 |
详情
|
(VII) |
46400 |
2-(5-fluoro-2-nitroanilino)-1-benzothiophene-3-carbonitrile
|
|
C15H8FN3O2S |
详情 |
详情
|
(VIII) |
46401 |
2-(2-amino-5-fluoroanilino)-1-benzothiophene-3-carbonitrile
|
|
C15H10FN3S |
详情 |
详情
|
(IX) |
46402 |
8-fluoro-6H-[1]benzothieno[2,3-b][1,5]benzodiazepin-12-ylamine; 8-fluoro-6H-[1]benzothieno[2,3-b][1,5]benzodiazepin-12-amine
|
|
C15H10FN3S |
详情 |
详情
|
合成路线58
该中间体在本合成路线中的序号:
(XVI) Displacement of the mesylate group of (XV) with N-methylpiperazine (XVI) produced the disubstituted piperazine (XVII). The tert-butyl ester of (XVII) was cleaved to the corresponding carboxylic acid (XVIII) by means of trifluoroacetic acid in CH2Cl2. Then coupling of (XVIII) with 3-(aminomethyl)pyridine (XIX) gave rise to the title amide.
【1】
Bavetsias, V.; et al.; The design and synthesis of water-soluble analogues of CB30865, a quinazolin-4-one-based antitumor agent. J Med Chem 2002, 45, 17, 3692.
|
【2】
Bavetsias, V.; Jackman, A.; Skelton, L. (Cancer Research Campaign Technology Ltd.); Anti-cancer dihydroquinazoline derivs.. WO 0050417 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XV) |
46871 |
tert-butyl 4-[[(7-chloro-3-methyl-2-[[(methylsulfonyl)oxy]methyl]-4-oxo-3,4-dihydro-6-quinazolinyl)methyl](2-propynyl)amino]benzoate
|
|
C26H28ClN3O6S |
详情 |
详情
|
(XVI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(XVII) |
46872 |
tert-butyl 4-[([7-chloro-3-methyl-2-[(4-methyl-1-piperazinyl)methyl]-4-oxo-3,4-dihydro-6-quinazolinyl]methyl)(2-propynyl)amino]benzoate
|
|
C30H36ClN5O3 |
详情 |
详情
|
(XVIII) |
46873 |
4-[([7-chloro-3-methyl-2-[(4-methyl-1-piperazinyl)methyl]-4-oxo-3,4-dihydro-6-quinazolinyl]methyl)(2-propynyl)amino]benzoic acid
|
|
C26H28ClN5O3 |
详情 |
详情
|
(XIX) |
18731 |
3-pyridinylmethanamine; 3-pyridinylmethylamine
|
3731-52-0 |
C6H8N2 |
详情 | 详情
|
合成路线59
该中间体在本合成路线中的序号:
(IV) 3-Phenylisoquinolinone (II) was synthesized by addition of benzonitrile to the dilithium derivative of N-methyltoluamide (I). Conversion of (II) to the 1-chloroisoquinoline (III) was achieved by heating with POCl3. Then, displacement of the chlorine atom of (III) with N-methylpiperazine (IV) in refluxing DMF furnished the title compound.
【1】
Park, M.-J.; Chung, B.-H.; Cho, W.-J.; Lee, C.-O.; Yo, S.-J.; Synthesis and antitumor activity of 3-arylisoquinoline derivatives. Arch Pharmacal Res 1997, 20, 3, 264.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
47428 |
N,2-dimethylbenzamide
|
2170-09-4 |
C9H11NO |
详情 | 详情
|
(II) |
47429 |
3-phenyl-1(2H)-isoquinolinone
|
|
C15H11NO |
详情 |
详情
|
(III) |
47430 |
1-chloro-3-phenylisoquinoline
|
|
C15H10ClN |
详情 |
详情
|
(IV) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线60
该中间体在本合成路线中的序号:
(XIII) Alkylation of 4-hydroxy-5-methoxy benzoic acid methyl ester (I) with 3-chloropropyl p-toluene sulfonate (III) by means of K2CO3 and methyl-tricapryl ammonium chloride (Aliquat 128) in refluxing acetone affords compound (III), which is then nitrated by means of HNO3 in HOAc to furnish 2-nitro derivative (IV). Reduction of the nitro moiety of (IV) by means of Fe in H2O/MeOH in the presence of ammonium chloride yields 2-amino compound (V), which is subjected to reaction with refluxing dimethylformamide dimethylacetal (VI) to provide amidine (VII). Condensation of (VII) with acetonitrile by means of n-BuLi in hexane/THF/HOAc gives substituted quinoline-carbonitrile (IX), whose hydroxyl group is replaced by a chlorine by treatment of (IX) with refluxing POCl3 to afford compound (X). Coupling of (X) with 2,4-dichloro-5-methoxyaniline (XI) in 2-ethoxyethanol in the presence of pyridine hydrochloride yields compound (XII), which is finally converted into the desired compound by condensation with 1-methylpiperazine (XII) by means of NaI in refluxing ethylene glycol dimethyl ether.
【1】
Boschelli, D.H.; Ye, F.; Wang, Y.D.; Dutia, M.; Johnson, S.L.; Wu, B.; Miller, K.; Powell, D.W.; Yaczko, D.; Young, M.; Tischler, M.; Arndt, K.; Discafani, C.; Etienne, C.; Gibbons, J.; Grod, J.; Lucas, J.; Weber, J.M.; Boschelli, F.; Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity. J Med Chem 2001, 44, 23, 3965. |
【2】
Boschelli, D.H.; Dutia, M.; Ye, F.; et al.; Inhibition of SRC kinase activity by 4-phenylamino-3-quinolinecarbonitriles Part 2: Optimization of the side chain at C-7. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 145.
|
【3】
Boschelli, D.H.; Wang, Y.D.; Ye, F.; et al.; Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles. J Med Chem 2001, 44, 5, 822.
|
【4】
Tsou, H.-R.; Wissner, A.; Johnson, B.D.; Reich, M.F.; Floyd, M.B. Jr.; Kitchen, D.B. (American Cyanamid Co.); Substituted 3-cyano quinolines. US 6002008 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29176 |
methyl 4-hydroxy-3-methoxybenzoate
|
3943-74-6 |
C9H10O4 |
详情 | 详情
|
(II) |
19490 |
3-chloro-1-propanol
|
627-30-5 |
C3H7ClO |
详情 | 详情
|
(III) |
50008 |
methyl 4-(3-chloropropoxy)-3-methoxybenzoate
|
|
C12H15ClO4 |
详情 |
详情
|
(IV) |
50009 |
methyl 4-(3-chloropropoxy)-5-methoxy-2-nitrobenzoate
|
|
C12H14ClNO6 |
详情 |
详情
|
(V) |
50010 |
methyl 2-amino-4-(3-chloropropoxy)-5-methoxybenzoate
|
|
C12H16ClNO4 |
详情 |
详情
|
(VI) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(VII) |
50011 |
methyl 4-(3-chloropropoxy)-2-[[(E)-(dimethylamino)methylidene]amino]-5-methoxybenzoate
|
|
C15H21ClN2O4 |
详情 |
详情
|
(VIII) |
37210 |
acetonitrile
|
75-05-8 |
C2H3N |
详情 | 详情
|
(IX) |
50012 |
7-(3-chloropropoxy)-4-hydroxy-6-methoxy-3-quinolinecarbonitrile
|
|
C14H13ClN2O3 |
详情 |
详情
|
(X) |
48519 |
4-chloro-7-(3-chloropropoxy)-6-methoxy-3-quinolinecarbonitrile
|
|
C14H12Cl2N2O2 |
详情 |
详情
|
(XI) |
50013 |
2,4-dichloro-5-methoxyphenylamine; 2,4-dichloro-5-methoxyaniline
|
|
C7H7Cl2NO |
详情 |
详情
|
(XII) |
50014 |
7-(3-chloropropoxy)-4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-3-quinolinecarbonitrile
|
|
C21H18Cl3N3O3 |
详情 |
详情
|
(XIII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线61
该中间体在本合成路线中的序号:
(II) The condensation of 4-fluoro-3-nitrobenzoic acid (I) with 1-methylpiperazine (II) by means of oxalyl chloride in dichloromethane gives the expected acyl derivative (III), which is reduced with BH3/THF to yield the benzyl piperazine (IV). The condensation of (IV) with 2(R)-hydroxy-2-phenylethylamine (V) by means of DIEA in NMP affords the secondary amine (VI), which is reduced with H2 over Pd/C in ethanol, providing the phenylenediamine (VII). Finally, this compound is cyclized with 4-methoxybenzoyl isothiocyanate (VIII) by means of EDC in DMF to furnish the target benzimidazole.
【1】
Heyer, D.; et al.; 2-Aminobenzimidazoles: A class of orally bioavailable and brain permeable neuropeptide YY5 antagonists. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 284.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46937 |
4-fluoro-3-nitrobenzoic acid
|
453-71-4 |
C7H4FNO4 |
详情 | 详情
|
(II) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(III) |
54041 |
(4-fluoro-3-nitrophenyl)(4-methyl-1-piperazinyl)methanone
|
|
C12H14FN3O3 |
详情 |
详情
|
(IV) |
54042 |
1-(4-fluoro-3-nitrobenzyl)-4-methylpiperazine
|
|
C12H16FN3O2 |
详情 |
详情
|
(V) |
10173 |
(1R)-2-Amino-1-phenyl-1-ethanol
|
2549-14-6 |
C8H11NO |
详情 | 详情
|
(VI) |
54043 |
(1R)-2-{4-[(4-methyl-1-piperazinyl)methyl]-2-nitroanilino}-1-phenyl-1-ethanol
|
|
C20H26N4O3 |
详情 |
详情
|
(VII) |
54044 |
(1R)-2-{2-amino-4-[(4-methyl-1-piperazinyl)methyl]anilino}-1-phenyl-1-ethanol
|
|
C20H28N4O |
详情 |
详情
|
(VIII) |
54045 |
4-Methoxybenzoyl isothiocyanate
|
16778-84-0 |
C9H7NO2S |
详情 | 详情
|
合成路线62
该中间体在本合成路线中的序号:
(II) Alternatively, the reduction of 4-fluoro-3-nitrobenzoic acid (I) with BH3/THF gives the benzyl alcohol (IX), which is treated with PBr3 in ethyl ether to yield the benzyl bromide (X). Finally, this compound is condensed with 1-methylpiperazine (II) by means of DIEA in THF to afford the already reported benzyl piperazine intermediate (IV).
【1】
Heyer, D.; et al.; 2-Aminobenzimidazoles: A class of orally bioavailable and brain permeable neuropeptide YY5 antagonists. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 284.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46937 |
4-fluoro-3-nitrobenzoic acid
|
453-71-4 |
C7H4FNO4 |
详情 | 详情
|
(II) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(IV) |
54042 |
1-(4-fluoro-3-nitrobenzyl)-4-methylpiperazine
|
|
C12H16FN3O2 |
详情 |
详情
|
(IX) |
54046 |
(4-fluoro-3-nitrophenyl)methanol
|
|
C7H6FNO3 |
详情 |
详情
|
(X) |
47038 |
4-(bromomethyl)-1-fluoro-2-nitrobenzene
|
|
C7H5BrFNO2 |
详情 |
详情
|
合成路线63
该中间体在本合成路线中的序号:
(II) The reduction of 4-fluoro-3-nitrobenzoic acid (I) with BH3/THF gives the benzyl alcohol (IX), which is condensed with 2(R)-hydroxy-2-phenylethylamine (V) by means of DIEA in NMP to yield nitro compound (XI). Derivative (XI) is then converted into secondary amine (XII) by reduction either with H2 over Pd/C in EtOH or with Na2S·9H2O in dioxane/H2O or by treatment with Na2S2O4 in dioxane/NH4OH. Cyclization of (XI) with 4-methoxybenzoyl isothiocyanate (VIII) by means of EDC in DMF affords the benzimidazole (XIII), which is oxidized at the carbinol group by means of MnO2 in THF to provide the corresponding carbaldehyde (XIV). Finally, this compound is reductocondensed with 1-methylpiperazine (II) by means of NaBH(OAc)3 to furnish the target benzimidazole.
【1】
Heyer, D.; et al.; 2-Aminobenzimidazoles: A class of orally bioavailable and brain permeable neuropeptide YY5 antagonists. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 284.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46937 |
4-fluoro-3-nitrobenzoic acid
|
453-71-4 |
C7H4FNO4 |
详情 | 详情
|
(II) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(V) |
10173 |
(1R)-2-Amino-1-phenyl-1-ethanol
|
2549-14-6 |
C8H11NO |
详情 | 详情
|
(VIII) |
54045 |
4-Methoxybenzoyl isothiocyanate
|
16778-84-0 |
C9H7NO2S |
详情 | 详情
|
(IX) |
54046 |
(4-fluoro-3-nitrophenyl)methanol
|
|
C7H6FNO3 |
详情 |
详情
|
(XI) |
54047 |
(1R)-2-[4-(hydroxymethyl)-2-nitroanilino]-1-phenyl-1-ethanol
|
|
C15H16N2O4 |
详情 |
详情
|
(XII) |
54048 |
(1R)-2-[2-amino-4-(hydroxymethyl)anilino]-1-phenyl-1-ethanol
|
|
C15H18N2O2 |
详情 |
详情
|
(XIII) |
54049 |
N-{5-(hydroxymethyl)-1-[(2R)-2-hydroxy-2-phenylethyl]-1H-benzimidazol-2-yl}-4-methoxybenzamide
|
|
C24H23N3O4 |
详情 |
详情
|
(XIV) |
54050 |
N-{5-formyl-1-[(2R)-2-hydroxy-2-phenylethyl]-1H-benzimidazol-2-yl}-4-methoxybenzamide
|
|
C24H21N3O4 |
详情 |
详情
|
合成路线64
该中间体在本合成路线中的序号:
(II) Pyridazinylpiperazine (III) was prepared from 3,6-dichloropyridazine (I) and N-methylpiperazine (II) according to a literature method. Subsequent quaternization of piperazine (III) with methyl iodide gave the title ammonium salt.
【1】
Romanelli, M.N.; et al.; Structure-affinity relationships of a unique nicotinic ligand: N1-dimethyl-N4-phenylpiperazinium iodide (DMPP). J Med Chem 2001, 44, 23, 3946.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11292 |
3,6-Dichloropyridazine
|
141-30-0 |
C4H2Cl2N2 |
详情 | 详情
|
(II) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(III) |
53381 |
3-chloro-6-(4-methyl-1-piperazinyl)pyridazine
|
27464-17-1 |
C9H13ClN4 |
详情 | 详情
|
合成路线65
该中间体在本合成路线中的序号:
(XII) The phenolic hydroxyl group of (IX) is acylated by 4-nitrophenyl chloroformate (X), producing carbonate (XI). Then, displacement of the 4-nitrophenoxy group of (XI) with N-methylpiperazine (XII) yields carbamate (XIII). Finally, nitro group reduction in (XIII) gives rise to the title compound
【1】
McGee, D.P.C.; Saunders, O.L.; Martichonok, V.; Wu, G.; Ng, H.P.; Li, Z.; Yarranton, G.T. (Medarex, Inc.); Cytotoxic agents. US 2003050331; WO 0296910 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
63445 |
methyl 8-(chloromethyl)-4-hydroxy-2-methyl-6-[(5-{[(7-nitro-1H-indol-2-yl)carbonyl]amino}-1-benzofuran-2-yl)carbonyl]-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate
|
|
C32H24ClN5O8 |
详情 |
详情
|
(X) |
16605 |
4-Nitrophenyl chloroformate; 1-[(Chlorocarbonyl)oxy]-4-nitrobenzene
|
7693-46-1 |
C7H4ClNO4 |
详情 | 详情
|
(XI) |
63446 |
methyl 8-(chloromethyl)-2-methyl-6-[(5-{[(7-nitro-1H-indol-2-yl)carbonyl]amino}-1-benzofuran-2-yl)carbonyl]-4-({[(4-nitrophenyl)oxy]carbonyl}oxy)-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate
|
|
C39H27ClN6O12 |
详情 |
详情
|
(XII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(XIII) |
63447 |
methyl 8-(chloromethyl)-2-methyl-4-{[(4-methyl-1-piperazinyl)carbonyl]oxy}-6-[(5-{[(7-nitro-1H-indol-2-yl)carbonyl]amino}-1-benzofuran-2-yl)carbonyl]-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate
|
|
C38H34ClN7O9 |
详情 |
详情
|
合成路线66
该中间体在本合成路线中的序号:
(VIII) Acylation of the anilino ester (I) with 4-nitrobenzoyl chloride (II) affords amide (III). After reduction of the 4-nitrobenzamide (III) by catalytic hydrogenation, the resultant amine (IV) is condensed with (2-ethyl-1-imidazolyl)benzoyl chloride (V) to furnish diamide (VI). Subsequent ester group saponification in (VI) gives acid (VII). This is finally coupled with N-methylpiperazine (VIII) in the presence of EDC and HOBt to produce the title compound.
【1】
Kakefuda, A.; Kusayama, T.; Tahara, A.; Tsukamoto, S.-I.; Tsukada, J.; N-Methylbenzanilide derivatives as a novel class of selective V1A receptor antagonists. Bioorg Med Chem Lett 2002, 12, 2, 229.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
57789 |
ethyl 6-[5-methyl-2-(methylamino)phenoxy]hexanoate
|
|
C16H25NO3 |
详情 |
详情
|
(II) |
18941 |
p-nitrobenzoyl chloride; 4-nitrobenzoyl chloride
|
122-04-3 |
C7H4ClNO3 |
详情 | 详情
|
(III) |
57790 |
ethyl 6-{5-methyl-2-[methyl(4-nitrobenzoyl)amino]phenoxy}hexanoate
|
|
C23H28N2O6 |
详情 |
详情
|
(IV) |
57791 |
ethyl 6-{2-[(4-aminobenzoyl)(methyl)amino]-5-methylphenoxy}hexanoate
|
|
C23H30N2O4 |
详情 |
详情
|
(V) |
57792 |
2-(2-ethyl-1H-imidazol-1-yl)benzoyl chloride
|
|
C12H11ClN2O |
详情 |
详情
|
(VI) |
57793 |
ethyl 6-{2-[(4-{[2-(2-ethyl-1H-imidazol-1-yl)benzoyl]amino}benzoyl)(methyl)amino]-5-methylphenoxy}hexanoate
|
|
C35H40N4O5 |
详情 |
详情
|
(VII) |
57794 |
6-{2-[(4-{[2-(2-ethyl-1H-imidazol-1-yl)benzoyl]amino}benzoyl)(methyl)amino]-5-methylphenoxy}hexanoic acid
|
|
C33H36N4O5 |
详情 |
详情
|
(VIII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线67
该中间体在本合成路线中的序号:
(XI) Acid hydrolysis of the ethylene ketal function of (IX) afforded ketone (X). This was subjected to a reductive amination with N-methylpiperazine (XI) in the presence of sodium triacetoxyborohydride to produce the corresponding disubstituted cyclohexane compound as a 3:1 mixture of cis- and trans-isomers. The desired trans-compound (XII) was then isolated by column chromatography. Finally, acylation of (XII) with 2,3-dichlorobenzenesulfonyl chloride (XIII) provided the title sulfonamide.
【1】
Wishart, N.; Barlozzari, T.; Arnold, L.D.; et al.; Structure activity relationships for a novel series of pyrrolo[2,3-d]pyrimidine Tie-2 inhibitors. Proc Am Assoc Cancer Res 2002, 43, Abst 4205.
|
【2】
Hirst, G.C.; Ritter, K.; Arnold, L.D.; Wishart, N.; Calderwood, D. (BASF AG); Pyrrolopyrimidines as protein kinase inhibitors. EP 1114053; WO 0017203 .
|
【3】
Hirst, G.C.; Rafferty, P.; Arnold, L.D.; Johnston, D.N.; Calderwood, D.; Munschaufer, R. (BASF AG); Pyrrolopyrimidines as tyrosine kinase inhibitors. WO 0172751 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
53567 |
5-(4-amino-3-fluorophenyl)-7-(1,4-dioxaspiro[4.5]dec-8-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine; 4-[4-amino-7-(1,4-dioxaspiro[4.5]dec-8-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-fluorophenylamine
|
n/a |
C20H22FN5O2 |
详情 | 详情
|
(X) |
53568 |
4-[4-amino-5-(4-amino-3-fluorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexanone
|
n/a |
C18H18FN5O |
详情 | 详情
|
(XI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(XII) |
53569 |
5-(4-amino-3-fluorophenyl)-7-[4-(4-methyl-1-piperazinyl)cyclohexyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine; 5-(4-amino-3-fluorophenyl)-7-[4-(4-methyl-1-piperazinyl)cyclohexyl]-7H-pyrrolo[2,3-d]pyrimidin-4-ylamine
|
n/a |
C23H30FN7 |
详情 | 详情
|
(XIII) |
53570 |
2,3-Dichlorobenzenesulfonyl chloride
|
82417-45-6 |
C6H3Cl3O2S |
详情 | 详情
|
合成路线68
该中间体在本合成路线中的序号:
(VII) The condensation of 3-aminobenzoic acid (I) with 3-nitro-1,8-naphthalic anhydride (II) in hot DMSO/pyridine gives the corresponding cyclic naphthalmide (III), which is condensed with diethylenetriamine (IV) by means of CDI in DMF to yield the benzamide (V). The reaction of (V) with CDI in DMF affords the imidazolylcarbonyl derivative (VI), which is condensed with 1-methylpiperazine (VII) in THF to provide the piperazinocarbonyl compound (VIII). Finally, the amino group of (VIII) is condensed with 3-nitro-1,8-naphthalic anhydride (II) in DMSO/pyridine to give the target bis-cyclic imide.
【1】
Suzuki, K.; Yamada, Y.; Asao, T.; Noguchi, K.; Wakida, M. (Taiho Pharmaceutical Co., Ltd.); Naphthalimidobenzamide derivs.. EP 1020446; US 6300331; WO 0001672 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26638 |
3-Aminobenzoic acid
|
99-05-8 |
C7H7NO2 |
详情 | 详情
|
(II) |
15864 |
5-nitro-1H,3H-benzo[de]isochromene-1,3-dione; 3-Nitro-1,8-naphthalic anhydride
|
3027-38-1 |
C12H5NO5 |
详情 | 详情
|
(III) |
55382 |
3-[5-nitro-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl]benzoic acid
|
|
C19H10N2O6 |
详情 |
详情
|
(IV) |
55379 |
2,2'-Diaminodiethylamine; 2,2'-Iminodiethylamine; Bis(beta-Aminoethyl)amine; Diethylentriamine; N-(2-Aminoethyl)-1,2-ethanediamine
|
111-40-0 |
C4H13N3 |
详情 | 详情
|
(V) |
55383 |
N-{2-[(2-aminoethyl)amino]ethyl}-3-[5-nitro-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl]benzamide
|
|
C23H21N5O5 |
详情 |
详情
|
(VI) |
55384 |
N-{2-[(2-aminoethyl)amino]ethyl}-3-(1H-imidazol-1-ylcarbonyl)-5-[5-nitro-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl]benzamide
|
|
C27H23N7O6 |
详情 |
详情
|
(VII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(VIII) |
55385 |
N-{2-[(2-aminoethyl)amino]ethyl}-3-[(4-methyl-1-piperazinyl)carbonyl]-5-[5-nitro-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl]benzamide
|
|
C29H31N7O6 |
详情 |
详情
|
合成路线69
该中间体在本合成路线中的序号:
(XI) Acetylation of o-aminophenol (I) gives o-hydroxy acetanilide (II), which is then protected as the benzyl ether (III) with benzyl bromide and K2CO3. Treatment of acetamide (III) with P2S5 affords the corresponding thioamide (IV), and subsequent S-methylation of (IV) gives rise to the thioimidate (V). Cyclization of thioimidate (V) with 4-biphenylcarboxylic acid hydrazide (VI) in hot DMF leads to the triazole derivative (VII). After benzyl group hydrogenolysis in (VII), the resultant phenol (VIII) is alkylated with 1,6-dibromohexane (IX) to produce the bromohexyl ether (X). Finally, condensation of bromide (X) with N-methylpiperazine (XI) furnishes the title compound.
【1】
Kakefuda, A.; et al.; Synthesis and pharmacological evaluation of 5-(4-biphenyl)-3-methyl-4-phenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human vasopressin V1A receptor. J Med Chem 2002, 45, 12, 2589.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18663 |
o-aminophenol; 2-aminophenol
|
95-55-6 |
C6H7NO |
详情 | 详情
|
(II) |
56976 |
2-Acetamidophenol; 2-Hydroxyacetanilide; o-Acetamidophenol; o-Hydroxyacetanilide
|
614-80-2 |
C8H9NO2 |
详情 | 详情
|
(III) |
56977 |
N-[2-(benzyloxy)phenyl]acetamide
|
|
C15H15NO2 |
详情 |
详情
|
(IV) |
56978 |
N-[2-(benzyloxy)phenyl]ethanethioamide
|
|
C15H15NOS |
详情 |
详情
|
(V) |
56979 |
methyl N-[2-(benzyloxy)phenyl]ethanimidothioate
|
|
C16H17NOS |
详情 |
详情
|
(VI) |
56980 |
4-Biphenylcarboxylic acid hydrazide; 4-Phenylbenzhydrazide
|
18622-23-6 |
C13H12N2O |
详情 | 详情
|
(VII) |
56981 |
benzyl 2-(3-[1,1'-biphenyl]-4-yl-5-methyl-4H-1,2,4-triazol-4-yl)phenyl ether; 4-[2-(benzyloxy)phenyl]-3-[1,1'-biphenyl]-4-yl-5-methyl-4H-1,2,4-triazole
|
|
C28H23N3O |
详情 |
详情
|
(VIII) |
56982 |
2-(3-[1,1'-biphenyl]-4-yl-5-methyl-4H-1,2,4-triazol-4-yl)phenol
|
|
C21H17N3O |
详情 |
详情
|
(IX) |
24786 |
1,6-dibromohexane
|
629-03-8 |
C6H12Br2 |
详情 | 详情
|
(X) |
56983 |
3-[1,1'-biphenyl]-4-yl-4-{2-[(6-bromohexyl)oxy]phenyl}-5-methyl-4H-1,2,4-triazole; 2-(3-[1,1'-biphenyl]-4-yl-5-methyl-4H-1,2,4-triazol-4-yl)phenyl 6-bromohexyl ether
|
|
C27H28BrN3O |
详情 |
详情
|
(XI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线70
该中间体在本合成路线中的序号:
(XIV) Attachment of the sulfonylpyrimidine (X) to a Merrifield thiol resin in the presence of NaH in DMF provides resin-bounded compound (XI). Then, saponification of the methyl ester group of (XI) yields carboxylic acid (XII). After formation of the corresponding acid chloride (XIII), coupling with N-methylpiperazine (XIV) gives rise to amide (XV). Sulfide group oxidation in (XV) leads to the sulfonylpyrimidine resin (XVI). Finally, cleavage from the resin in the presence of cyclopropylmethylamine (XVII) in hot NMP affords the target 2-aminopyrimidine derivative
【1】
McKenna, J.M.; Halley, F.; Souness, J.E.; McLay, I.M.; Pickett, S.D.; Collis, A.J.; Page, K.; Ahmed, I.; An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally bioavailable p38 MAP kinase inhibitors. J Med Chem 2002, 45, 11, 2173. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(X) |
62740 |
methyl 2-{4-(4-fluorophenyl)-5-[2-(methylsulfonyl)-4-pyrimidinyl]-1H-imidazol-2-yl}-5-methyl-1,3-dioxane-5-carboxylate
|
|
C21H21FN4O6S |
详情 |
详情
|
(XI) |
62741 |
methyl 2-[4-(4-fluorophenyl)-5-(2-sulfanyl-4-pyrimidinyl)-1H-imidazol-2-yl]-5-methyl-1,3-dioxane-5-carboxylate
|
|
C20H19FN4O4S |
详情 |
详情
|
(XII) |
62742 |
2-[4-(4-fluorophenyl)-5-(2-sulfanyl-4-pyrimidinyl)-1H-imidazol-2-yl]-5-methyl-1,3-dioxane-5-carboxylic acid
|
|
C19H17FN4O4S |
详情 |
详情
|
(XIII) |
62743 |
2-[4-(4-fluorophenyl)-5-(2-sulfanyl-4-pyrimidinyl)-1H-imidazol-2-yl]-5-methyl-1,3-dioxane-5-carbonyl chloride
|
|
C19H16ClFN4O3S |
详情 |
详情
|
(XIV) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(XV) |
62744 |
{2-[4-(4-fluorophenyl)-5-(2-sulfanyl-4-pyrimidinyl)-1H-imidazol-2-yl]-5-methyl-1,3-dioxan-5-yl}(4-methyl-1-piperazinyl)methanone
|
|
C24H27FN6O3S |
详情 |
详情
|
(XVI) |
62745 |
{2-[5-[2-(dioxo-lambda~6~-sulfanyl)-4-pyrimidinyl]-4-(4-fluorophenyl)-1H-imidazol-2-yl]-5-methyl-1,3-dioxan-5-yl}(4-methyl-1-piperazinyl)methanone
|
|
C24H27FN6O5S |
详情 |
详情
|
(XVII) |
59524 |
Aminomethylcyclopropane; Cyclopropanemethylamine
|
2516-47-4 |
C4H9N |
详情 | 详情
|
合成路线71
该中间体在本合成路线中的序号:
(VII) Sulfonylation of methyl 5-bromo-3-methylanthranilate (I) with acid chloride (II) affords sulfonamide (III). Subsequent alkylation of the sulfonamide N of (III) with iodomethane and K2CO3 yields (IV). After protection of the phenolic hydroxyl group of (IV) as the silyl ether (V), benzylic halogenation with N-bromosuccinimide furnishes bromide (VI). Displacement of its benzylic bromide with 1-methylpiperazine (VII) occurs with concomitant desilylation to give (VIII). Mitsunobu coupling of phenol (VIII) with 2-butyn-1-ol (IX) leads to the propargyl ether (X). The methyl ester group of (X) is then hydrolyzed under alkaline conditions to furnish the carboxylic acid (XI).
【1】
Levin, J.I.; Chen, J.M.; Du, M.T.; Nelson, F.C.; Killar, L.M.; Skala, S.; Sung, A.; Jin, G.; Cowling, R.; Barone, D.; March, C.J.; Mohler, K.M.; Black, R.A.; Skotnicki, J.S.; Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group. Bioorg Med Chem Lett 2002, 12, 8, 1199. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
60447 |
methyl 2-amino-5-bromo-3-methylbenzoate
|
|
C9H10BrNO2 |
详情 |
详情
|
(II) |
54660 |
4-hydroxybenzenesulfonyl chloride
|
|
C6H5ClO3S |
详情 |
详情
|
(III) |
60448 |
methyl 5-bromo-2-{[(4-hydroxyphenyl)sulfonyl]amino}-3-methylbenzoate
|
|
C15H14BrNO5S |
详情 |
详情
|
(IV) |
60449 |
methyl 5-bromo-2-[[(4-hydroxyphenyl)sulfonyl](methyl)amino]-3-methylbenzoate
|
|
C16H16BrNO5S |
详情 |
详情
|
(V) |
60450 |
methyl 5-bromo-2-[[(4-{[tert-butyl(dimethyl)silyl]oxy}phenyl)sulfonyl](methyl)amino]-3-methylbenzoate
|
|
C22H30BrNO5SSi |
详情 |
详情
|
(VI) |
60451 |
methyl 5-bromo-3-(bromomethyl)-2-[[(4-{[tert-butyl(dimethyl)silyl]oxy}phenyl)sulfonyl](methyl)amino]benzoate
|
|
C22H29Br2NO5SSi |
详情 |
详情
|
(VII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(VIII) |
60452 |
methyl 5-bromo-2-[[(4-hydroxyphenyl)sulfonyl](methyl)amino]-3-[(4-methyl-1-piperazinyl)methyl]benzoate
|
|
C21H26BrN3O5S |
详情 |
详情
|
(IX) |
42514 |
2-butyn-1-ol
|
764-01-2 |
C4H6O |
详情 | 详情
|
(X) |
60453 |
methyl 5-bromo-2-[{[4-(2-butynyloxy)phenyl]sulfonyl}(methyl)amino]-3-[(4-methyl-1-piperazinyl)methyl]benzoate
|
|
C25H30BrN3O5S |
详情 |
详情
|
(XI) |
60454 |
5-bromo-2-[{[4-(2-butynyloxy)phenyl]sulfonyl}(methyl)amino]-3-[(4-methyl-1-piperazinyl)methyl]benzoic acid
|
|
C24H28BrN3O5S |
详情 |
详情
|
合成路线72
该中间体在本合成路线中的序号:
(V) Acylation of ethyl 2-amino-4-thiazolylacetate (I) with 3-chloro-2-methylbenzenesulfonyl chloride (II) in pyridine affords sulfonamide (III). After alkaline hydrolysis of the ethyl ester group of (III), the resultant carboxylic acid (IV) is coupled to N-methylpiperazine (V) by means of EDC to furnish the target amide.
【1】
Barf, T.; Vallgarda, J.; Emond, R.; Haggstrom, C.; Kurz, G.; Nygren, A.; Larwood, V.; Mosialou, E.; Axelsson, K.; Olsson, R.; Engblom, L.; Edling, N.; Ronquist-Nii, Y.; Ohman, B.; Alberts, P.; Abrahmsen, L.; Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1. J Med Chem 2002, 45, 18, 3813. |
【2】
Emond, R.; Barf, T.; Kurz, G.; Nilsson, M.; Vallgarda, J. (Biovitrum AB); Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. EP 1283831; WO 0190090 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
61407 |
Ethyl 2-amino-4-thiazoleacetate; Ethyl 2-aminothiazole-4-acetate; Ethyl-2-(2-Aminothiazole-4-Yl)acetate; (2-Amino-4-thiazolyl)acetic Acid Ethyl Ester; Ethyl (2-Amino-4-thiazolyl)acetate; Ethyl 2-(2-aminothiazol-4-yl)acetate; Ethyl 2-aminothiazol-4-yl-acetate |
53266-94-7 |
C7H10N2O2S |
详情 | 详情
|
(II) |
61408 |
3-Chloro-2-methylbenzenesulfonyl chloride; 3-Chloro-2-methylbenzenesulphonyl chloride
|
80563-86-6 |
C7H6Cl2O2S |
详情 | 详情
|
(III) |
61409 |
ethyl 2-(2-{[(3-chloro-2-methylphenyl)sulfonyl]amino}-1,3-thiazol-4-yl)acetate
|
|
C14H15ClN2O4S2 |
详情 |
详情
|
(IV) |
61410 |
2-(2-{[(3-chloro-2-methylphenyl)sulfonyl]amino}-1,3-thiazol-4-yl)acetic acid
|
|
C12H11ClN2O4S2 |
详情 |
详情
|
(V) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线73
该中间体在本合成路线中的序号:
(XI) Reduction of 1,4-cyclohexanedione mono-ethylene ketal (VII) with NaBH4 gives alcohol (VIII). This is then coupled with the pyrazolopyrimidine (VI) under Mitsunobu conditions to afford adduct (IX). Subsequent acidic ketal hydrolysis in (IX) leads to ketone (X). Finally, reductive condensation of (X) with N-methylpiperazine (XI) in the presence of NaBH(OAc)3 produces a mixture of cis and trans disubstituted cyclohexanes, from which the title trans isomer is isolated by flash column chromatography.
【1】
Hirst, G.C.; Rafferty, P.; Ritter, K.; Arnold, L.D.; Wishart, N.; Calderwood, D.; Friedman, M.M. (BASF AG); Pyrazolopyrimidines as therapeutic agents. EP 1212327; WO 0119829 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
57048 |
3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; 3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine
|
|
C17H13N5O |
详情 |
详情
|
(VII) |
11377 |
1,4-Dioxaspiro[4.5]decan-8-one
|
4746-97-8 |
C8H12O3 |
详情 | 详情
|
(VIII) |
53564 |
1,4-dioxaspiro[4.5]decan-8-ol
|
22428-87-1 |
C8H14O3 |
详情 | 详情
|
(IX) |
57049 |
1-(1,4-dioxaspiro[4.5]dec-8-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine; 1-(1,4-dioxaspiro[4.5]dec-8-yl)-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
|
C25H25N5O3 |
详情 |
详情
|
(X) |
57050 |
4-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanone
|
|
C23H21N5O2 |
详情 |
详情
|
(XI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线74
该中间体在本合成路线中的序号:
(VII) In an alternative synthetic route, cyclization of the aminopyrazole (I) with formamide gives the pyrazolopyrimidine (II), which is then iodinated to (III) by means of N-iodosuccinimide. Mitsunobu coupling of (III) with 4,4-(ethylenedioxy)cyclohexanol (IV) produces the cyclohexyl pyrazolopyrimidine derivative (V), and further ketal hydrolysis leads to ketone (VI). This is subjected to reductive amination with N-methylpiperazine (VII) in the presence of NaBH(OAc)3 to yield (VIII). Finally, Suzuki coupling of iodopyrazolopyrimidine (VIII) with 4-phenoxyphenylboronic acid (IX) gives rise to the title compound.
【1】
Burchat, A.F.; et al.; Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck - A selective insight. Bioorg Med Chem Lett 2002, 12, 12, 1687.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
57051 |
5-Amino-4-pyrazolecarbonitrile
|
|
C4H4N4 |
详情 |
详情
|
(II) |
41249 |
4-amine-1H-pyrazolo[3,4-d]pyrimidine; 1H-pyrazolo[3,4-d]pyrimidin-4-ylamine; 1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
2380-63-4 |
C5H5N5 |
详情 | 详情
|
(III) |
41250 |
3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine; 3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine
|
|
C5H4IN5 |
详情 |
详情
|
(IV) |
53564 |
1,4-dioxaspiro[4.5]decan-8-ol
|
22428-87-1 |
C8H14O3 |
详情 | 详情
|
(V) |
57052 |
1-(1,4-dioxaspiro[4.5]dec-8-yl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine; 1-(1,4-dioxaspiro[4.5]dec-8-yl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
|
C13H16IN5O2 |
详情 |
详情
|
(VI) |
57053 |
4-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexanone
|
|
C11H12IN5O |
详情 |
详情
|
(VII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(VIII) |
57054 |
3-iodo-1-[4-(4-methyl-1-piperazinyl)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine; 3-iodo-1-[4-(4-methyl-1-piperazinyl)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine
|
|
C16H24IN7 |
详情 |
详情
|
(IX) |
57055 |
4-Phenoxyphenylboronic acid
|
51067-38-0 |
C12H11BO3 |
详情 | 详情
|
合成路线75
该中间体在本合成路线中的序号:
(VIII) Treatment of 3-aminopyrazole-4-carbonitrile (I) with formamide at 180 C gives rise to the pyrazolopyrimidinyl amine (II). Subsequent iodination of (II) with N-iodosuccinimide in hot DMF affords 3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine (III). Reduction of 1,4-cyclohexanedione mono-ethylene ketal (IV) with NaBH4 furnishes alcohol (V). This is then subjected to Mitsunobu coupling with the pyrazolopyrimidine (III) to produce adduct (VI). Acidic hydrolysis of the ethylene ketal (VI) leads to the cyclohexanone (VII). The reductive amination of ketone (VII) with N-methylpiperazine (VIII), either employing NaBH(OAc)3 or via condensation in hot NMP, and then reduction of the resultant enamine with formic acid, produces a mixture of trans- (IX) and cis- (X) disubstituted cyclohexanes, with different ratios in each case.
【1】
Ferraris, D.; et al.; Design, synthesis and SAR of PARP-1 inhibitors. Drugs Fut 2002, 27, Suppl. A.
|
【2】
Hirst, G.C.; Rafferty, P.; Ritter, K.; Arnold, L.D.; Wishart, N.; Calderwood, D.; Friedman, M.M. (BASF AG); Pyrazolopyrimidines as therapeutic agents. EP 1212327; WO 0119829 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
57051 |
5-Amino-4-pyrazolecarbonitrile
|
|
C4H4N4 |
详情 |
详情
|
(II) |
41249 |
4-amine-1H-pyrazolo[3,4-d]pyrimidine; 1H-pyrazolo[3,4-d]pyrimidin-4-ylamine; 1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
2380-63-4 |
C5H5N5 |
详情 | 详情
|
(III) |
41250 |
3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine; 3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine
|
|
C5H4IN5 |
详情 |
详情
|
(IV) |
11377 |
1,4-Dioxaspiro[4.5]decan-8-one
|
4746-97-8 |
C8H12O3 |
详情 | 详情
|
(V) |
53564 |
1,4-dioxaspiro[4.5]decan-8-ol
|
22428-87-1 |
C8H14O3 |
详情 | 详情
|
(VI) |
57052 |
1-(1,4-dioxaspiro[4.5]dec-8-yl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine; 1-(1,4-dioxaspiro[4.5]dec-8-yl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
|
C13H16IN5O2 |
详情 |
详情
|
(VII) |
57053 |
4-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexanone
|
|
C11H12IN5O |
详情 |
详情
|
(VIII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(IX) |
57054 |
3-iodo-1-[4-(4-methyl-1-piperazinyl)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine; 3-iodo-1-[4-(4-methyl-1-piperazinyl)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine
|
|
C16H24IN7 |
详情 |
详情
|
(X) |
58340 |
3-iodo-1-[4-(4-methyl-1-piperazinyl)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine; 3-iodo-1-[4-(4-methyl-1-piperazinyl)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
|
C16H24IN7 |
详情 |
详情
|
合成路线76
该中间体在本合成路线中的序号:
(VII) The oxidation of 4,6-dichloro-2-(methylsulfanyl)pyrimidine (I) with MCPBA in dichloromethane gives 4,6-dichloro-2-(methylsulfonyl)pyrimidine (II), which is condensed with N-(4-sulfanylphenyl)cyclopropanecarboxamide (III) in hot butanol to yield the diaryl thioether (IV). The reaction of (IV) with 3-methyl-1H-pyrazol-5-amine (V) by means of DIEA in hot DMF affords the secondary amine (VI), which is finally condensed with 1-methylpiperazine (VII) by heating at 110 ºC to provide the target compound (1). Scheme 1.
【1】
Charrier, J.-D., Kay, D., Mazzei, F., Miller, A. (Vertex Pharmaceuticals, Inc.). Processes for preparing substd. pyrimidines and pyrimidine derivs. as inhibitors of protein kinase. EP 1517905, EP 1746093, JP 2005320351, JP 2006501176, US 2004049032, WO 2004000833. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
65246 |
4,6-Dichloro-2-(methylthio)pyrimidine;4,6-dichloro-2-(methylsulfanyl)pyrimidine |
6299-25-8 |
C5H4Cl2N2S |
详情 | 详情
|
(II) |
65247 |
4,6-Dichloro-2-(methylsulfonyl)pyrimidine; 2-(Methylsulfonyl)-4,6-Dichloropyrimidine; NSC 45040 |
4489-34-3 |
C5H4Cl2N2O2S |
详情 | 详情
|
(III) |
65248 |
N-(4-mercaptophenyl)cyclopropanecarboxamide |
639090-54-3 |
C10H11NOS |
详情 | 详情
|
(IV) |
65249 |
|
|
C13H11Cl2N3OS |
详情 | 详情
|
(V) |
65250 |
5-amino-3-methyl-1H-pyrazole |
|
C4H7N3 |
详情 | 详情
|
(VI) |
65251 |
|
|
C17H17ClN6OS |
详情 | 详情
|
(VII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线77
该中间体在本合成路线中的序号:
(VIII)
【1】
Kompella A, Bhujanga Rao AKS, Venkaiah Chowdary N, et aL 2004. Process for the preparation of the anti-cancer drug imatinib and its analogs via aminolysis of a (chloromethyl benzamide intermediate. WO 2004108699(本专利申请人为: Natco Pharma Limited, India) |
【2】
Szczepek W, Luniewski W, Kaczmarek L, et aL 2006.A process for preparation of imatinib base. W0 2006071130(本专利申请人为: Instytut Farmaceutyczny, Pol) |
【3】
Szakacs Z,Beni S,VargaZ,et aL 2005. Acid-base profiling of imatinib(gleevec) and its fragments. J Med Chem,8(1): 249一255 |
【4】
Zimmermann J.Buchdunger E, Mett H, et aL 1997. Potent and selective inhibitors of the abl-kinase: phenylaminopyrimidine (PAP) derivatives. Bioorg Med Chem Lett,7(2): 187~191 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
47518 |
2-Amino-4-nitrotoluene; 5-Nitro-o-toluidine; 4-Nitro-2-aminotoluene; 2-methyl-5-nitrophenylamine; 2-methyl-5-nitroaniline
|
99-55-8 |
C7H8N2O2 |
详情 | 详情
|
(II) |
47517 |
N-(2-methyl-5-nitrophenyl)guanidine
|
152460-07-6 |
C8H10N4O2 |
详情 | 详情
|
(III) |
47516 |
(E)-3-(dimethylamino)-1-(3-pyridinyl)-2-propen-1-one
|
123367-26-0 |
C10H12N2O |
详情 | 详情
|
(IV) |
47519 |
N-(2-methyl-5-nitrophenyl)-N-[4-(3-pyridinyl)-2-pyrimidinyl]amine; N-(2-methyl-5-nitrophenyl)-4-(3-pyridinyl)-2-pyrimidinamine
|
152460-09-8 |
C16H13N5O2 |
详情 | 详情
|
(V) |
47520 |
4-methyl-N(3)-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-benzenediamine; N-(5-amino-2-methylphenyl)-N-[4-(3-pyridinyl)-2-pyrimidinyl]amine
|
152460-10-1 |
C16H15N5 |
详情 | 详情
|
(VI) |
49112 |
4-(Chloromethyl)benzoyl chloride; p-(Chloromethyl)benzoyl chloride
|
876-08-4 |
C8H6Cl2O |
详情 | 详情
|
(VII) |
66476 |
4-(chloromethyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide |
404844-11-7 |
C24H20ClN5O |
详情 | 详情
|
(VIII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
合成路线78
该中间体在本合成路线中的序号:
(III) Reaction of 2,4-difluoronitrobenzene (I) with liquid ammonia gives 5-fluoro-2-nitroaniline (IIa) , which by subsequent displacement of the remaining fluoride group with N-methylpiperazine (III) in the presence of Et3N in NMP at 100 °C provides the piperazinyl aniline (IV) . Alternatively, nitroaniline (IV) can be prepared by condensation of 5-chloro-2-nitroaniline (IIb) with N-methylpiperazine (III) in hot EtOH , ethylene glycol or aqueous NaCl, optionally in the presence of NaOH . Catalytic hydrogenation of nitroaniline (IV) over Pd/C in EtOH at 40-45 °C yields the phenyldiamine (V) , wh ich by condensa t ion with ethyl 3-ethoxy-3-iminopropionate hydrochloride (VI) at reflux produces benzimidazole (VII) . Cyclocondensation of ethyl ester (VII) with 2-amino-6-fluorobenzonitrile (VIII) by means of LiHMDS , KHMDS or t-BuOK in THF or toluene furnishes dovitinib (IX ) , which is finally treated with racemic lactic acid in EtOH/H2O .
【1】
Machajewski, T., Shafer, C., McCrea, B. et al. (Novartis Vaccines and Diagnostics, Inc.). Quinolone derivatives. EP 1317442, EP 1650203, EP 1849782, JP 2004509112, US 2002107392, US 6605617, WO 2002022598. |
【2】
Harrison, S.D., Shafer, C.M., Pecchi, S. et al. (Novartis Vaccines and Diagnostics, Inc.). Benzimidazole quinolines and uses thereof. EP 1539754, JP 2006503919, JP 2011162563, US 200409235, US 2013018058, WO 2004018419. |
【3】
Renhowe, P.A., Pecchi, S., Machajewski, T.D. (Novartis Vaccines and Diagnostics, Inc.). Quinolone derivatives. JP 2005527587, US 2003028018, WO 2003087095. |
【4】
Cai, S., Chou, J., Harwood, E., Machajewski, T.D., Ryckman, D., Shang, X., Zhu, S. (Novartis Vaccines and Diagnostics, Inc.). Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties. CN 102225926, EP 1699421, JP 2007522098, JP 2011042687, WO 2005046589. |
【5】
Renhowe, P.A., Pecchi, S., Shafer, C.M. et al. Design, structure-activity relationships and in vivo characterization of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A novel class of receptor tyrosine kinase inhibitors. J Med Chem 2009, 52(2): 278-92. |
【6】
Calvin, G., Harwood, E., Ryckman, D., Zhu, S. (Novartis AG). Methods for synthesizing heterocyclic compounds. EP 1888556, EP 2465857, JP 2008540675, US 2011046376, US 8222413, WO 2006125130. |
【7】
Okhamafe, A., Chou, J., Gullapalli, R., Harwood, E., Ryckman, D., Zhu, S.,Shang, X. (Novartis Corp.). Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salts. CN 102070614, EP 1904480, EP 2266974, EP 2270000, JP 200854289, US 2011178097, US 2012208825, WO 2006127926. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IIa) |
67969 |
5-fluoro-2-nitroaniline |
2369-11-1 |
C6H5FN2O2 |
详情 | 详情
|
(IIb) |
15709 |
5-chloro-2-nitrophenylamine; 5-chloro-2-nitroaniline
|
1635-61-6 |
C6H5ClN2O2 |
详情 | 详情
|
(I) |
32036 |
2,4-difluoro-1-nitrobenzene
|
446-35-5 |
C6H3F2NO2 |
详情 | 详情
|
(III) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(IV) |
67970 |
5-(4-methylpiperazin-1-yl)-2-nitroaniline |
|
C11H16N4O2 |
详情 | 详情
|
(V) |
31430 |
2-amino-4-(4-methyl-1-piperazinyl)phenylamine; 4-(4-methyl-1-piperazinyl)-1,2-benzenediamine
|
54998-08-2 |
C11H18N4 |
详情 | 详情
|
(VI) |
67971 |
ethyl 3-ethoxy-3-iminopropionate hydrochloride |
2318-25-4 |
C7H13NO3.HCl |
详情 | 详情
|
(VII) |
67972 |
ethyl 2-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)acetate |
|
C16H22N4O2 |
详情 | 详情
|
(VIII) |
13857 |
5-Amino-2-fluorobenzonitrile; 2-Amino-6-fluorobenzonitrile
|
77326-36-4 |
C7H5FN2 |
详情 | 详情
|
(IX) |
67973 |
4-amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one |
405169-16-6 |
C21H21FN6O |
详情 | 详情
|
合成路线79
该中间体在本合成路线中的序号:
(VII) Oxidation of 4,6-dichloro-2-(methylsulfanyl)pyrimidine (I) with 3-chlorobenzoyl peroxide in CH2Cl2 gives the sulfonyl derivative (II), which is alkynylated with phenylacetylenyl magnesium bromide (III) in THF to provide 4,6-dichloro-2-(phenylethynyl)pyrimidine (IV). Condensation of the dichloropyrimidine derivative (IV) with 5-methyl-3-aminopyrazole (V) by means of NaI and DIEA in DMA at 90 °C affords amine (VI), which is coupled with N-methylpiperazine (VII) in the presence of DMAP and DIEA in 1,4-dioxane at 100 °C to furnish the piperazinyl derivative (VIII). Reduction of alkyne (VIII) by means of LiAlH4 in THF gives alkene (IX), which is finally treated with sodium potassium tartrate .
【1】
Xiao, X.-Y., Patel, D.V., Ward, J.S., Bray, M.R., Agoston, G.E., Treston, A.M.(Miikana Therapeutics, Inc.). Substituted pyrazole compounds. EP 1928456, JP 2009510107, US 2007142368, WO 2007041358. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
65246 |
4,6-Dichloro-2-(methylthio)pyrimidine;4,6-dichloro-2-(methylsulfanyl)pyrimidine |
6299-25-8 |
C5H4Cl2N2S |
详情 | 详情
|
(II) |
65247 |
4,6-Dichloro-2-(methylsulfonyl)pyrimidine; 2-(Methylsulfonyl)-4,6-Dichloropyrimidine; NSC 45040 |
4489-34-3 |
C5H4Cl2N2O2S |
详情 | 详情
|
(III) |
32758 |
bromo(2-phenylethynyl)magnesium;phenylacetylenyl magnesium bromide;(phenylethynyl)magnesium bromide |
|
C8H5BrMg |
详情 |
详情
|
(IV) |
68677 |
4,6-dichloro-2-(phenylethynyl)pyrimidine |
|
C12H6Cl2N2 |
详情 | 详情
|
(V) |
68679 |
5-methyl-3-aminopyrazole;3-Amino-5-methylpyrazole;3-Methyl-1H-pyrazol-5-amine |
31230-17-8 |
C4H7N3 |
详情 | 详情
|
(VI) |
68678 |
6-chloro-N-(5-methyl-1H-pyrazol-3-yl)-2-(phenylethynyl)pyrimidin-4-amine |
|
C16H12ClN5 |
详情 | 详情
|
(VII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(VIII) |
68680 |
N-(5-methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-(phenylethynyl)pyrimidin-4-amine |
|
C21H23N7 |
详情 | 详情
|
(IX) |
68681 |
N-(5-methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amine;6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine |
934353-76-1 |
C21H25N7 |
详情 | 详情
|
合成路线80
该中间体在本合成路线中的序号:
(VII) Treatment of cinnamonitrile (X) with HCl in toluene/EtOH gives the O-ethyl imidate.HCl (XI), which is aminated by means of methanolic ammonia in EtOH to provide amidine (XII). Cyclization of compound (XII) with dimethylmalonate (XIII) in the presence of NaOMe in MeOH at 90 °C affords the pyrimidindione (XIV), which is chlorinated with POCl3 to generate the dichloro derivative (XV). Coupling of dichloro compound (XV) with 5-methyl-3-aminopyrazole (V) by means of NaI and DIEA in DMA at 90 °C affords the secondary amine (XVI), which is finally condensed with Nmethylpiperazine (VII) to give the free base (IX) .
【1】
Xiao, X.-Y., Patel, D.V., Ward, J.S., Bray, M.R., Agoston, G.E., Treston, A.M.(Miikana Therapeutics, Inc.). Substituted pyrazole compounds. EP 1928456, JP 2009510107, US 2007142368, WO 2007041358. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
68679 |
5-methyl-3-aminopyrazole;3-Amino-5-methylpyrazole;3-Methyl-1H-pyrazol-5-amine |
31230-17-8 |
C4H7N3 |
详情 | 详情
|
(VII) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(IX) |
68681 |
N-(5-methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amine;6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine |
934353-76-1 |
C21H25N7 |
详情 | 详情
|
(X) |
68682 |
Cinnamonitrile;E-3-Phenyl-2-propenenitriletrans-Cinnamonitrile |
1885-38-7 |
C9H7N |
详情 | 详情
|
(XI) |
68683 |
ethyl cinnamimidate hydrochloride |
|
C11H13NO.HCl |
详情 | 详情
|
(XII) |
68684 |
cinnamimidamide |
|
C9H10N2 |
详情 | 详情
|
(XIII) |
19373 |
dimethyl malonate;Methyl malonate;Propanedioic acid dimethyl ester |
108-59-8 |
C5H8O4 |
详情 | 详情
|
(XIV) |
68685 |
(E)-2-styrylpyrimidine-4,6(1H,5H)-dione |
|
C12H10N2O2 |
详情 | 详情
|
(XV) |
68686 |
(E)-4,6-dichloro-2-styrylpyrimidine |
|
C12H8Cl2N2 |
详情 | 详情
|
(XVI) |
68687 |
(E)-6-chloro-N-(5-methyl-1H-pyrazol-3-yl)-2-styrylpyrimidin-4-amine |
|
C16H14ClN5 |
详情 | 详情
|
合成路线81
该中间体在本合成路线中的序号:
(III) Bromination of 1-methyl-4-nitro-2-(trifluoromethyl)benzene (I) with NBS in the presence of AIBN in refluxing CCl4 gives the corresponding bromomethyl derivative (II), which is condensed with 1-methylpiperazine (III) by means of Et3N in CH2Cl2 to afford 1-methyl-4-[4-nitro-2-(trifluoromethyl)benzyl]piperazine (IV). Reduction of compound (IV) with Na2S2O4 in refluxing acetone/H2O yields the aniline (V), which by coupling with 3-iodo-4-methylbenzoyl chloride (VI) (prepared by chlorinating acid [VII] with SOCl2 at reflux) in the presence of DIEA and DMAP in THF provides the corresponding amide (VIII). Finally, the iodobenzene derivative (VIII) is submitted to Sonogashira coupling with 3-ethynylimidazo[1,2-b]pyridazine (IX) by means of CuI, Pd(PPh3)4 and DIEA in DMF .
Intermediate (IX) is prepared by Sonogashira coupling of 3-bromoimidazo[1,2-b]pyridazine (X) with trimethylsilyl acetylene (XI) in the presence of CuI, PdCl2(PPh3)4 and DCHA in acetonitrile at 80 °C or CuI, Pd(PPh3)4 and DIEA in DMF to give 3-[(trimethylsilyl)ethynyl]imidazo[1,2-b]pyridazine (XII), which is deprotected by cleaving the trimethylsilyl moiety by means of TBAF in THF .
【1】
Huang, W.S., Metcalf, C., Sundaramoorthi, R. et al. Discovery of 3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a potent, orally active pan-inhibitor of breakpoint cluster region-Abelson (BCR-ABL) kinase including the T315I gatekeeper mutant. J Med Chem 2010, 53(12): 4701-19. |
【2】
Zou, D., Huang, W.-S., Thomas, R.M. et al. (Ariad Pharmaceuticals, Inc.).Bicyclic heteroaryl compounds. EP 1973545, JP 2009521462, US 2007191376, WO 2007075869. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
68863 |
1-methyl-4-nitro-2-(trifluoromethyl)benzene |
|
C8H6F3NO2 |
详情 | 详情
|
(II) |
68864 |
1-(bromomethyl)-4-nitro-2-(trifluoromethyl)benzene |
|
C8H5BrF3NO2 |
详情 | 详情
|
(III) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(IV) |
68865 |
1-methyl-4-(4-nitro-2-(trifluoromethyl)benzyl)piperazine |
|
C13H16F3N3O2 |
详情 | 详情
|
(V) |
68866 |
4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline |
694499-26-8 |
C13H18F3N3 |
详情 | 详情
|
(VI) |
68867 |
3-iodo-4-methylbenzoyl chloride |
|
C8H6ClIO |
详情 | 详情
|
(VII) |
68868 |
3-iodo-4-methylbenzoic acid |
|
C8H7IO2 |
详情 | 详情
|
(VIII) |
68869 |
3-iodo-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide |
|
C21H23F3IN3O |
详情 | 详情
|
(IX) |
68870 |
3-ethynylimidazo[1,2-b]pyridazine |
|
C8H5N3 |
详情 | 详情
|
(X) |
68871 |
3-bromoimidazo[1,2-b]pyridazine |
18087-73-5 |
C6H4BrN3 |
详情 | 详情
|
(XI) |
23897 |
ethynyl(trimethyl)silane;trimethylsilyl acetylene |
1066-54-2 |
C5H10Si |
详情 | 详情
|
(XII) |
68872 |
3-[(trimethylsilyl)ethynyl]imidazo[1,2-b]pyridazine |
|
C11H13N3Si |
详情 | 详情
|